The Value Of The Item, The Payment Of Health Care Covered By The Insurance For 2010

Original Language Title: Hodnoty bodu, úhrady zdravotní péče hrazené z pojištění pro r.2010

Read the untranslated law here: https://portal.gov.cz/app/zakony/download?idBiblio=69995&nr=471~2F2009~20Sb.&ft=txt

471/2009 Sb.



The DECREE



of 18 July 2003. December 2009



determining the point values, the amount of the reimbursement of health care paid for by the public

health insurance and regulatory restrictions on the volume of health

care paid from public health insurance for the year 2010



The Ministry of health shall determine in accordance with section 17 paragraph. 6 of Act No. 48/1997

Coll., on public health insurance and amending and supplementing certain

related laws, as amended by law No 117/2006 Coll., Act No.

245/2006 Coll. and Act No. 261/2007 Coll.:



§ 1



This Decree provides for the year 2010, the amount of the tender point values for health

care provided to the insured under section 2 (2). 1 of Act No. 48/1997 Coll., on

public health insurance and amending and supplementing certain

related laws, as amended by later regulations (hereinafter referred to as "the Act"), and

insurance policy holders from other Member States of the European Union, the European

economic area, and Switzerland in accordance with the relevant provisions

Of the European communities "^ 1") and the affiliated persons of other States with which it has

Czech Republic concluded an international social security agreement ^ 2)

(hereinafter referred to as "foreign to the beneficiary"), paid from public health

insurance and regulatory restrictions on the volume of health care for the ways

the remuneration referred to in sections 2 to 15, provided



and) in contractual healthcare facilities of institutional care, including

specialised therapeutic institutes for long-term patients, hospitals,

medical equipment, returning the length of the day no. 00005 according

the Decree, which publishes a list of medical procedures with spot

the values of ^ 3) (hereinafter referred to as "the list of performance"), and medical devices

the hospice type according to § 22a of the Act,



(b)) the practical doctors and practitioners for children and adolescents,



(c)) in contractual outpatient health care facilities providing

specialised outpatient medical care, including outpatient

health care facilities providing health care and hemodialysis

ortoptickou health care



(d)) in contractual outpatient health care facilities providing

health care in the fields of medicine and 604 603 by the performance,



e) Contracting dentists,



(f)) in contractual outpatient health care facilities providing

health care in the fields of medicine, 801, 802 222, 804, 805, 807, 809, 812 to

819, 822 and 823 under the list of performances (hereinafter referred to as "listed

the skill "),



(g)) in contractual outpatient health care facilities providing

health care in the fields of medicine, 911 914, 916, 921 and 925 by list

performance,



(h)) in contractual outpatient health care facilities providing

health care in 902 by the skill of performance,



I) by health establishments, medical rescue services,

the health establishments providing medical transport

service and medical service, first aid,



(j)) by the medical facilities of Spa care and ozdravovnami,



k) within the framework of emergency care in non-medical

devices.



§ 2



For the health care provided by the medical devices specified in §

1 (a). (b)), d), (e)) and to the contribution to be paid by), list of performances, including

health care provided by foreign insurance policy holders, shall be the value of the

the point of 0.95 Usd, unless otherwise specified.



§ 3



(1) For health care provided by health establishments of the constitutional

care, with the exception of health care provided by specialised therapeutic

institutes, institutes for long-term patients in health care facilities

returning the length of the day no. 00005, according to the list of performances, and in

Health Hospice, point value, the amount of the payments

health care and regulatory restrictions stipulated in the annexes, no. 1, 9 and 10 to

This Decree.



(2) For health care provided by specialised therapeutic institutes,

Sanatorium for long-term patients in health care facilities

returning the length of the day no. 00005, according to the list of performances, and in

Health hospice type, paid a flat rate for the

one day of hospitalization, or according to the list, the value of point,

the amount of the payment of health care and regulatory restrictions set out in annex No. 1 to the

This Decree.



§ 4



For the health care provided by practitioners and practitioners

for children and adolescents, paid a combined kapitačně power payment

combined kapitačně power payment with calling kapitace or

According to the list, the value of the item, the amount of the payment of health care and

regulatory restrictions set out in annex 2 to this Decree.



§ 5



For specialised outpatient healthcare provided in

outpatient medical facilities, paid for by the performance,

the value of the item, the amount of the payment of health care and regulatory limits, determined by

in annex 3 to this notice.



§ 6



For the ambulatory healthcare provided in out-patient

medical facilities in the fields of medicine and by the 603 604

performances, paid according to the list, the value of the item, the amount of the payments

health care and regulatory restrictions set out in annex 4 to this

the Decree.



section 7 of the



(1) For health care provided by dentists, paid by

list of performances, the value of the point set at EUR 0.95 Usd.



(2) Health care provided by doctors reimbursed under paragraph

1 shall be paid in accordance with the contractual arrangement between the health insurance company and

the medical establishment. The amount of such payments, health care and appropriate

regulatory restrictions are set out in annex 11 to this Decree, in accordance

with the rules on the regulation of prices ^ 4).



(3) the health insurance company is authorized, after consultation with the representatives of the

Professional Association of dental care providers participating in the

the conciliation procedure provided for in § 17 paragraph. 6 the law limit the amount of the remuneration

medical facilities so that the total amount of the cost of health

insurance companies spent on medical care provided by dentists in

the year 2010 does not exceed the total amount of these costs as provided for in

health insurance health insurance plan. If the crossing

the total amount of payment for health care provided by dentists,

provided for in the health insurance plan health insurance on this

health care, was due to the provision of greater volume of necessary and

emergency health care compared to 2009, health insurance this

more volume into account in the payment order.



§ 8



For the health care provided to ambulatory medical devices

in the listed fields of medicine, paid for by the performance,

the value of the item and the amount of reimbursement of health care lays down in annex 5 to this

the Decree.



§ 9



For the health care provided to ambulatory medical devices

in the fields of medicine, 911 914, 916, 921 and 925 by list of performances, paid

According to the list, the value of the item and the amount of reimbursement of health care

set out in annex 6 to this Ordinance.



§ 10



For the health care provided to ambulatory medical devices

in 902 by the skill of performance, paid according to the performance,

the value of the item and the amount of reimbursement of health care lays down in annex 7 to the

This Decree.



§ 11



For health care provided in the context of medical rescue services,

paid by list of performance shall be the value of the item in the amount of Czk 1.06.



§ 12



For the performances provided by the health service of transport, paid by

list of performances, the value of the item and the amount of reimbursement of health care provides in

Appendix 8 to this Ordinance.



section 13



For health care provided in the context of medical services, first aid,

paid by list of performance shall be the point value of 0.95 Usd.



§ 14



(1) for the complete spa care provided by health establishments

Spa care shall be payment for a one day stay in the amount that has been

agreed for the year 2009, at least in the amount of $ 850.



(2) For contributory Spa care provided by health

Spa care devices shall be payment for the stay of one day,

that has been agreed upon for the year 2009, at least in the amount of $ 280.



(3) for healthcare provided in ozdravovnách shall be the remuneration for the

one day stay in the amount that has been agreed upon for the year 2009, at least

However, in the amount of $ 540.



§ 15



Pursuant to section 2 to 14 shall, if the health insurance company and

medical equipment in compliance with the conditions laid down in § 17 paragraph. 6

the law otherwise.



section 16 of the



This Decree shall take effect on 1 January 2005. January 1, 2010.



Secretary:



Mgr. Jurásková, Ph.d., MBA in r.



Annex 1



The value of the item, the amount of the payment of health care and regulatory restrictions under section 3



And)



Institutional care according to § 3 (2). 1



1. Reimbursement of medical facilities in 2010 includes individually

the contractually agreed remuneration, flat-rate folder folder for

inpatient care, reimbursement in the form of flat-rate and outpatient case

component of remuneration. The reference period is the year 2008. In the reference

the period is included all health care provided in 2008

medical device declared to 31.5.2009 and health insurance company

recognised in 31.9.2009.
2. Individually contractually negotiated the payment includes remuneration for

health care, included under the classification of hospitalized

patients ^ 5) (hereinafter referred to as "the classification") into groups related to diagnosis:



and) 08021, 08022, 08023, 08041, 08042, 08043, 08181, 08182, 08183,



(b)), 05011, 05012 05013, 05070, 05161, 05162, 05163, 05111, 05112,

05113,



(c)), 02041 02042, 02043,



d) 01051 01052 01053,,,



(e)), 05191 05192, 05193,



(f)), 06062, 06061, 06063



g) 07041, 07042, 07043,



(h)), 08191 08192, 08193,



I) 13091, 13092, 13093,



listed in annex No. 9 (hereinafter referred to as "listed group") and the remuneration for the

medicines and foods for special medical purposes (hereinafter referred to as

"medicinal products") paid in 2010 to specialized

workplaces under section 15(2). 7 (b). (b)) of the Act. The amount and method of payment

This health care health insurance contract shall agree

the medical establishment. If health insurance is health

the device shall agree, individually contractually negotiated the payment may

include the reimbursement of health care, other than that referred to in the first sentence; in

this case is the remuneration, as well as remuneration for health care

classified according to the classification in the listed groups, not to

the remuneration referred to in paragraph 3.



3. The flat-rate component of the remuneration for inpatient care (PUhosp2010) for

2010 lays down the procedure referred to in points 3.1 to 3.5.



3.1 the lump sum remuneration for inpatient care (PUhosp2010)

shall be as follows:



PUhosp2010 = [PUhosp2008-(CMalfa2008 * IZSalfa2008)] Kn



PUhosp2008 = Vhosp * ICBref + ZUMhosp + ZULPhosp + LPhosp + KPhosp



where:



Vhosp the total number of medical facilities declared and health

insurance recognised points over the reference period, for performances made by the

During hospitalizations in the reference period, after the deduction of points for

the reference period for the performances (including performances in the listed

skills and konziliárních examination, according to the list of performances)

During hospitalizations in the reference period, which are according to the classification

included in the listed groups referred to in point 2; the number of points according to the

the first sentence shall be translated in accordance with the procedures applicable to January 1, 2010



ICBref calculated the individual price point of medical equipment, which

shall be determined as the quotient of Uref/Bref, where:



Uref total remuneration due the medical devices for all

medical care provided in the reference period, after the settlement of all

regulatory measures, with the exception of regulation at the prescribed medicinal

products and medical devices, reduced reimbursement for separately

medicinal products and separately charged posted material is provided in the

the reference period, declared and recognized by the health insurance company in

connection with the care of patients, on a flat-rate amount, which shall be borne by

medicinal products according to § 17 paragraph. 7 of the Act, and the payment of other

health care paid in Czech Crowns (KPref).



BREF total number of medical facilities declared and health

insurance company recognized by the points of annualised performance applicable to

January 1, 2010, for the health care provided in the reference period.



ZUMhosp the total amount of remuneration for medical facilities reported and

health insurance recognised separately posted material provided in

reference period in connection with the performances, that were made during the

hospitalizations in the reference period, excluding the separately posted

the material provided in the reference period in connection with the performances,

made during hospitalizations in the reference period, which is referred to in

The classification included in the listed groups referred to in point 2.



ZULPhosp the total amount of remuneration for medical facilities reported and

health insurance company separately charged recognised medicinal products

granted in the reference period in connection with the performances, made

During hospitalizations in the reference period, with the exception of separately charged

medicinal products granted in the reference period in connection with the

performances made during hospitalizations in the reference period, which

According to the classification are included in the listed groups listed in

point 2.



LPhosp flat-rate amount, which shall be borne by the medicinal products referred to in section 17

paragraph. 7 of the Act, the ošetřovacím days of the reported and health insurance company

recognised as the reference period, the time in reference to hospitalisations

period, with the exception of medicinal products granted in the reference period

in connection with the performances, made during hospitalizations in the reference

period, which are in accordance with the classification included in the listed groups

referred to in point 2.



KPhosp the total amount of remuneration for other health care expenses paid in

Crowns (in addition to ZUMhosp, ZULPhosp and LPhosp) reported, and health

insurance recognised over the reference period, granted by the medical

the equipment during hospitalizations in the reference period, with the exception of the

health care is provided in the reference period in connection with the performances,

made during hospitalizations in the reference period, which is referred to in

The classification included in the listed groups referred to in point 2.



CMalfa 2008 the number of cases terminated in hospitalizations reference

period, which are classified according to the classification of the groups related to the

diagnosis, multiplied by the indexes of these groups, which are listed in the annex

No 10.



IZSalfa2008 individual base rate, which is calculated as follows:



IZSalfa2008 = [(Valfa * ICBref) + ZUMalfa + ZULPalfa + LPalfa +

KPalfa]/CMalfa2008



where:



Valfa the total number of medical facilities declared and health

insurance recognised points over the reference period, for performances made by the

During hospitalizations in the reference period, which are according to the classification

included in the groups listed in annex No. 10; the number of points according to the sentence

the first shall be translated in accordance with the procedures applicable to January 1, 2010



ICBref calculated the individual price point of medical equipment



ZUMalfa the total amount of remuneration for medical facilities reported and

health insurance recognised separately posted material provided in

reference period in connection with the performances, that were made during the

hospitalizations in the reference period, which are according to the classification

included in the groups listed in annex No. 10



ZULPalfa the total amount of remuneration for medical facilities reported and

health insurance company separately charged recognised medicinal products

granted in the reference period in connection with the performances, made

During hospitalizations in the reference period, which are according to the classification

included in the groups listed in annex No. 10



LPalfa flat-rate amount, which shall be borne by the medicinal products referred to in section 17

paragraph. 7 of the Act, the ošetřovacím days of the reported and health insurance company

recognised as the reference period, the time in reference to hospitalisations

period, which are in accordance with the classification included in the groups listed in the

Annex No 10



KPalfa the total amount of remuneration for other health care expenses paid in

Crowns (in addition to ZUMalfa, ZULPalfa and LPalfa) reported, and health

insurance recognised over the reference period, granted by the medical

the equipment during hospitalizations in the reference period, which are

According to the classification included in the groups listed in annex No. 10



An increase in the flat-rate remuneration coefficient of the CN, which are for the year 2010 sets out in

the amount of 1.052



3.2 in the event that the number of hospital admissions for 2010 listed in groups

related to the diagnosis, according to the classification given in annex No 10, is

in the medical facilities of less than 200, the reading from the

the flat-rate compensation (PUhosp2008) referred to in section 3.1 of [flat-rate component of the remuneration for the

inpatient care (PUhosp2010) is calculated as PUhosp2008 * Kn] or

remuneration in the form of flat-rate case as provided for in point 4.



3.3 the lump the remuneration for inpatient care (PUhosp2010)

the medical device, if the medical device reports and

health insurance recognizes the number of hospital admissions of completed in 2010

included in the groups related to the diagnosis according to the classification,

multiplied by the indexes, which are listed in annex No 9, in the amount of at least

98% of the medical facilities reported and health insurance company

recognised by the number of hospital admissions, completed in 2008, included in the

groups related to the diagnosis, according to classification, multiplied by the annual indexes

which are listed in annex No 9 and at the same time, if medical

the device reports and health insurance recognizes the number of hospitalizations

completed in 2010, classified into groups related to diagnosis

According to the classification, which are listed in annex No 9, in the amount of at least

95% of medical facilities reported and health insurance company

recognised by the number of hospital admissions, completed in 2008, included in the

groups related to the diagnosis, according to the classification given in annex No.

9. For investigational or reference period are not counted

hospitalization, that are in accordance with the classification included in the listed

groups and groups referred to in annex No 10.



3.4 If medical facilities reported and health insurance company

recognised by the number of hospital admissions, completed in 2010, included in the

groups related to the diagnosis, according to classification, multiplied by the indexes,
which are listed in annex No. 9, will be less than 98% of the medical

the device reported and health insurance company recognized by number

hospitalizations, completed in 2008, classified into groups of related

to the diagnosis according to classification, multiplied by the indexes, which are listed in the

Annex No 9, or if medical facilities reported and health

insurance company recognized by the number of hospital admissions of completed in 2010

included in the groups related to the diagnosis according to the classification that

are listed in annex No. 9, will be less than 95% of the medical

the device reported and health insurance company recognized by number

hospitalizations, completed in 2008, classified into groups of related

to the diagnosis according to the classification, which are listed in annex No 9,

a flat-rate component of the remuneration for inpatient care (PUhosp2010) for the year

2010 shall be reduced by such a number of percentage points, corresponding to the higher of the two

the values of the 95% that was achieved, or 98%, the respective values

in accordance with section 3.3. In an investigational or reference period,

not hospitalization, that are in accordance with the classification included in the

the listed groups and groups referred to in annex No 10.



3.5 health insurance in 2010 will provide the contracted medical

the device in compliance with the conditions referred to in sections 3.3 and 3.4, in summary

remuneration for provided health care included under point 3.1 in

(PUhosp2010), and health care, included according to the classification in the

listed the groups referred to in paragraph 2, at least in the amount of the corresponding

107% reimbursement of such care in 2008.



4. remuneration in the form of flat-rate case (PUdrg2010) includes remuneration for

health care, included under the classification into groups related to the

the diagnosis given in annex No 10 and shall be as follows:



PUdrg2010 = CMred * ZSalfa2010



where:



CMred reduced the amount of CMalfa2010, which shall be in the amount of CMalfa2010 with

the following exceptions:



and if the ratio of CMalfa2010) is greater than/CMalfa2008, then CMred = 1.15

CMalfa2008 * 1.15



(b)) if the ratio of CMalfa2010/CMalfa2008 is in the interval from 1.05 to 1.15

and at the same time, that PPalfa is less than 0.98, then CMred = CMalfa2008

(PPalfa + 0.02)



where:



PPalfa ratio of the number of medical facilities declared and health

insurance recognised hospitalizations, completed in 2010, classified

the groups related to the diagnosis according to the classification that are listed in the

Annex No 10, and medical facilities reported and health

insurance company recognized the number of hospitalizations, completed in 2008,

included in the groups related to the diagnosis according to the classification that

are listed in annex No. 10



WS basic rate for reimbursement in the form of flat-rate case, which

alfa2010 for the year 2010 is calculated as follows:



ZSalfa2010 = [IZSalfa2008 * (1-Kp) + (ZSref * Kp)] * Knalfa



where:



CP proximity factor, which for the year 2010 shall be 0.2



ZSref reference (nationwide) the basic rate, which is determined in the amount of

24 615 Usd



Knalfa the coefficient of increase of the basic rate was fixed for the year alfa2010

2010 at 1.052



5. the payment of the reimbursement includes Outpatient specialised outpatient

health care, health care in the fields of medicine and 603 604, according to the list

performance, health care provided by the practitioners for adults and

practical doctors for children and adolescents, health care provided by

dentists, health care in the listed fields of medicine, health

transport, medical services, first aid and health care provided by

proficiency 902, 911, 914, 921 and 925 (hereinafter referred to as "ambulatory care")

the exception of the performance, which shows income and permit examination.



5.1 for specialised outpatient medical care, paid by

list of performances, the value of the item and the amount of reimbursement of health care provides in

Annex No. 3 to this notice. For the determination of the amount of the payment of this health

care shall not apply the calculated amount for each skill and the reduced

the value of the care provided to the point of this volume, that are

listed in annex No. 3) and 1 (b). (f)).



5.2 for healthcare provided in the fields of medicine and, in 603 604

list of performances, paid according to the list, the value of the item and the amount of

health care payments set out in annex 4 to this notice.



5.3 for the health care provided by general practitioners and

practical doctors for children and adolescents, paid a combined kapitačně

the performance payment, combined with kapitačně power payment

calling kapitace or according to the list, the value of point, all

health care payments set out in annex 2 to this Decree.



5.4 health care provided by dentists are reimbursed pursuant to section 7 of this

the Decree.



5.5 for healthcare provided in the mentioned fields of medicine,

paid by list of performances, the value of the item and the amount of the reimbursement of medical

care provides, in annex 5 to this Decree.



5.6 For the performances of the medical transport, paid according to the performance,

the value of the item and the amount of reimbursement of health care provides, in annex 8 to this

the Decree.



3.5 health care provided by the medical services, first aid,

under section 13 shall be borne by this Ordinance.



3.6 for healthcare provided in 902, according to the list of skills

performances, paid according to the list, the value of the item and the amount of the payments

health care lays down in annex 7 to this Decree.



3.7 for healthcare provided in the fields of medicine, 911 914, 921 and 925,

According to the list of performances, paid according to the list, the value of point and

the amount of the reimbursement of health care lays down in annex No 6 to this Ordinance.



5.10 For nasmlouvaný performance 09563, according to the list of performance shall be the

point value in the amount of Czk 0.91.



5.11 payment for health care provided in points 5.1 to 5.9, provided

in 2010, reported the medical establishment to 31. 3.2011 and

health insurance recognised until 31 March 2006. 5.2011 will be equal to the sum of the payments

calculated in accordance with points 5.1 to 5.9 in the event that this sum will not be

less than 105% of the value (Uamb2008) and at the same time will not be higher than 109%

value (Uamb2008).



Value (Uamb2008) is calculated as follows:



Uamb2008 = ICBref + ZUMamb * Vamb + ZULPamb + KPamb



where:



Vamb total number of medical facilities declared and health

insurance recognised points over the reference period, for performances made in the

the ambulatory care; the number of points referred to in the first sentence shall be translated in accordance with

list of performances on January 1st, 2010



ICBref calculated the individual price point of medical equipment, which

shall be laid down in section 3.1



ZUMamb the total amount of remuneration for medical facilities reported and

health insurance recognised separately posted material provided in

the reference period, in the context of out-patient care



ZULPamb the total amount of remuneration for medical facilities reported and

health insurance company separately charged recognised medicinal products

granted in the reference period in the context of out-patient care



KPamb the total amount of remuneration for other health care expenses paid in Czech Crowns

(in addition to ZUMamb and ZULPamb) declared and recognised by the health insurance for the

the period of reference under outpatient care



The payment for health care provided in points 5.1 to 5.9, does not include

health care, which was paid during the reference period in the framework of the

individually contractually agreed payment folder.



5.12 If the sum of the payments calculated in accordance with points 5.1 to 5.9 will be lower

than 105% of the value (Uamb2008), the resulting payment (UVamb2010)



such as: UVamb2010 = Uamb2008 * 1.05



5.13 If the sum of the payments calculated in accordance with points 5.1 to 5.9 will be higher

than the 109% of the value (Uamb2008), the resulting payment (UVamb2010)

as:



UVamb2010 = Uamb2008 * 1.09



5.14 If medical facilities reported and health insurance company

recognised by the number of points for the performance of ambulatory care for the year 2010 will be lower than

100% of the number of points of medical facilities declared and health

insurance company recognized for performance granted under outpatient care for

the reference period, and also in the event that the final payment for outpatient

care will be provided in accordance with sections 5.11 to 5.13, the resulting payment

(UVamb2010) for the year 2010 shall be reduced by the same number of percentage points,

that was achieved 100% of the value (Uamb2008) set out in section 5.11.



6. If the medical device amendments to the scope and

the structure provided by the paid care in comparison with the reference period, and

health insurance company agrees to take account of these changes, it is in the Treaty,

including enumerations increase (reduction) payments. In the context of the changes

referred to in the sentence the first health insurance company may edit a sign of total

remuneration for the medical establishment to the prescribed medicinal products and

medical devices referred to in subparagraph (a). (C)).



7. Health insurance shall take into account the change in the volume of reported and health

the insurance company accepted an extremely costly healthcare provided in

2010 compared to 2008. Extremely costly health care for the purposes of

This Decree means the health care provided by the medical establishment

policyholders, whose volume exceeds the amount of CZK 1 0000 0000. In the volume

health care will be included separately charged medicinal products, especially

charged material lump-sum amount that shall be paid to the medicinal products
According to § 17 paragraph. 7 of the Act and the point value of the medical procedures, according to the

list of performances, with the value in the amount of Czk 0.91. If an exceptionally

costly care includes individually contracted medicinal

preparations paid in 2010 to the specialised workplaces according to §

15 paragraph. 7 (b). (b)) of the Act, referred to in point 2 or health care paid for by the

in the form of flat-rate case referred to in point 4, the health insurance company will take into account

the difference between the calculated volume of this health care and provided

the payment of this health care. The extremely expensive care not

health care in accordance with point 2, classified according to the classification into groups

related to the diagnosis of 08021, 08022, 08023, 08041, 08042, 08043, 08181,

08182, 08183, 05011, 05012, 05013, 05070, 05161, 05162, 05163, 05111,

05112, 05113, 02041, 02042, 02043, 01051 01052 01053,,,,, 05191 05192

05193, 06061, 06062, 06063, 07041, 07042, 07043, 08191, 08192, 08193,

13091, 13092, 13093, referred to in annex 9.



8. The lump-sum payments for inpatient care folder in accordance with point 3,

excludes healthcare provided to the insured from the EU.



9. For health care expenses paid in accordance with the list of performance shall be the value of the

point in the amount of Czk 0.91.



(B))



Institutional care according to § 3 (2). 2



1. The flat rate for one day of hospitalization



and) flat rate for one day of hospitalization shall be determined for each

the category of the patient and the type of ošetřovacího the day separately and includes the value of

the competent ošetřovacího of the day, including the Director assigned to the ošetřovacímu the date of

and the categories of the patient, according to the list of performances, the flat-rate amount

shall be borne by the medicinal products referred to in section 17(2). 7 of the Act, and the health services

which shows income and layoff list examination

performances.



(b) the amount of the flat-rate) for one day of hospitalization, with the exception of

psychiatric specialised therapeutic institutes, returning the length of the days

00021 and 00026 according to the list, shall be at the rate of 107% flat-rate

the rates for the length of the day belonging to the medical facility in 2008.



(c) the amount of the flat-rate) for one day of hospitalisation in psychiatric

specialised therapeutic institutes, returning the length of the days and 00021 00026

According to the list of performance shall be in the amount of 113% flat rate for

the length of the day belonging to the medical facility in 2008.



(d)) if the medical device amendments to the scope and

the structure provided by the paid care in comparison with the year 2008 and health

the insurance company agrees to take account of these changes, it is in the Treaty, including

quantifying the increase (reduction) payments.



2. Reimbursement of ambulatory care, special care and special constitutional

care



and for outpatient health care) paid in accordance with the list of performances

the value of the point set at EUR 0.95 Usd.



(b)) for the special outpatient care provided under section 22 (b). (c))

the law, paid according to the list of performance shall be the value of the point of

0.90 CZK to 105% of the volume calculated as follows:

POPho

PBro x--------

POPro



where:



PBro total number of health facilities and health declared

insurance company recognized by the points of annualised performance applicable to

January 1, 2010, for the reference period. The reference period is the year 2008.



The number of unique POPho insured persons treated in medical facilities

the reviewed period. The rated period means the year 2010. Unique

beneficiary means a beneficiary, the competent health insurance company

treated medical facility in the expertise in the investigational, or

the reference period, at least once, and it is not decisive whether

This is a treatment within their own care or care requested. If he was

the beneficiary medical facility in the expertise of the treated in

the half times, includes the number of unique

competent health insurance policyholders, treated in the

expertise, only once.



POPro number of unique insured persons treated in medical facilities

the expertise in the reference period; in the case of merge healthcare

insurance companies are the number of unique treated policyholders means the sum of the

unique treated insured persons for health insurance, which is

merged (if it has been the beneficiary in the reference period had more

than one health insurance company, to the number of unique treated

insured persons are counted only once).



Health care provided by the medical establishment over 105% of the calculated

the volume shall be paid with the value point of 0.30 Usd.



(c)) for the special institutional care provided in health facilities

the hospice type according to § 22a of the law, according to the list of reimbursable performance,

provides the value of the point of 0.90 Czk.



C) regulatory restrictions



1. If the total remuneration for medicinal products and medical devices

prescribed by the medical device competent health insurance policy holders

insurance companies, which are insured (hereinafter referred to as "the relevant health

insurance company ") in 2010, with the exception of medical devices

approved review physician exceeds 105% of remuneration for medicinal products

and medical devices prescribed in 2008, with the exception of the

medical devices approved by the doctor, the medical audit

undertaking in the context of the overall payment of medical facility to reduce the payment

the amount corresponding to not more than 40% of such excess. In the total remuneration

will be included and supplements for medicinal products, for which the prescribing

the doctor has ruled out the possibility of replacement under section 32, paragraph. 2 of the Act. Health

the insurance company will take into account cases when medical device proves that

increased the total remuneration for the medical establishment to the prescribed medicinal

products and medical devices has been caused by a change in the amount or

the way their payment, where applicable, as a result of changes in the structure of the treated

policy holders.



2. in the event that the medical facilities provided in the 1. half or in the

2. half of 2010 health care 100 and less relevant to insurance policy holders

health insurance, health insurance does not apply the regulation referred to

in point 1.



(D) the increase in remuneration)



Medical device, which goes beyond the requirements of the personnel

equipment medical equipment set out a list of performances, health

the insurance company will provide an increase in remuneration in connection with the increase of the quality of

nursing care (NÚ2010). The above provided the increase is calculated

as follows:



NÚ2010 = PPS2010 * 30 USD * Kpp



where:



PPS number (FTE) of General nurses and midwives, which

is calculated as the sum of all the jobs of General nurses and midwives

midwives in the health care facility providing medical care in

the edge of the



The number of policyholders share coefficient of KPP competent health insurance company in

on the total number of insured persons in the region; the coefficients of the share

the number of policy holders of health insurance on the total number of insured persons

by region of the Czech Republic are set out in table no. 1



Table 1:

------------------------------------------------------ ------------------------------------ --------------------------------------------

The General Region Of The Military Guarded The Czech Industry ZdravotníZdravotní Health Health

health health health insurance industry insurance company pojišťovnapojišťovna fraternal Media

insurance insurance health insurance ŠkodaMinisterstva Treasury Metal-Alliance

pojišťovnavnitra

------------------------------------------------------ ------------------------------------ --------------------------------------------

Prague hl. m. 0.6242 0.0475 0.2258 0.0926 0.0035 0.0006 0.0005 0.0023 0.0030

Czech Republic 0.5816 0.0415 0.0146 0.0841 0.0777 0.0911 0.1053 0.0041 0.0002

South 0.6456 0.1307 0.0446 0.1319 0.0436 0.0001 0.0001 0.0003 0.0030

0.6225 0.0720 0.0459 0.0673 Plzeňský 0.0001 0.0001 0.0045 0.1311 0.0567

0.7108 0.0684 0.0799 0.0407 Karlovy Vary 0.0001 0.0002 0.0938 0.0009 0.0053

Ústí nad Labem 0.7038 0.0612 0.0338 0.0521 0.1126 0.0070 0.0199 0.0094 0.0003

Czech Republic 0.7615 0.0876 0.0363 0.0115 0.0698 0.0250 0.0001 0.0004 0.0077

0.6228 0.0870 0.0508 0.0397 Hradec Králové 0.0560 0.1371 0.0014 0.0051 0.0001

0.0620 0.0365 0.7281 0.0559 Pardubice 0.0004 0.1112 0.0002 0.0012 0.0045

0.7547 0.0331 0.0410 0.0244 Highlands 0.0001 0.0973 0.0003 0.0433 0.0057

South 0.6078 0.0562 0.0443 0.0434 0.1815 0.0217 0.0403 0.0047 0.0001

0.4498 0.0899 0.0849 0.0293 Olomouc 0.0001 0.1014 0.0114 0.2301 0.0031

0.6627 0.0204 0.0951 0.0269 Zlin 0.0000 0.0872 0.1031 0.0017 0.0029

Moravian-Silesian 0.37 0.02 0.02 0.27 0.00 0.00 0.00 0.06 0.25

------------------------------------------------------ ------------------------------------ --------------------------------------------



Annex 2



The value of the item, the amount of the payment of health care and regulatory restrictions pursuant to § 4



And)



The combined kapitačně power payment



1. the amount of the payment kapitační is calculated by the number of passenger policyholders
appropriate health insurance, multiplied by the base rate

one registered the relevant health insurance on the insured's

calendar month. The number of passenger, the competent health insurance clients

the insurance company shall be calculated by multiplying the number of medical facilities

corresponding insured health insurance companies in the individual

age groups according to point 7, násobených the index referred to in section 7. The amount of the

the basic rate, where applicable, the total amount of remuneration may be increased when

compliance with the conditions laid down in the contract between the health insurance company and

health facilities. The basic rate according to the first sentence shall be

the amount of the



and) 50 CZK for practitioners and general practitioners for children and adolescents,

who provide health care to the extent of at least 30 office hours

spaced within 5 working days a week, with at least one day in the

week to opening hours extended to 18 hours and allow you to

insurance policy holders to book at least two days a week on a fixed

an hour,



(b) $ 49) for medical practitioners, who provide health care to the extent

at least 25 office hours distributed within 5 working days a week,

with at least one day a week to opening hours extended

at least 18 hours. If the local conditions require it, you may

health insurance, medical equipment, agree on

extending Office hours differently.



(c)) 47 Czk for other practitioners.



(d)) 49 Czk for other general practitioners for children and adolescents.



2. performance by the list of performances included in kapitační payments in the

expertise, according to the list of performance 001:

---------- ----------------------------------------------------------------------------

No performance Name

---------- ----------------------------------------------------------------------------

01023 TARGETED SCREENING GP

01024 CONTROL EXAMINATIONS of the GENERAL PRACTITIONER

01025 CONSULTATION PRACTITIONER, the FAMILY MEMBERS of the PATIENT

01030 ADMINISTRATIVE TASKS of the MEDICAL PRACTITIONER

04508 TOPICAL TREATMENTS of GINGIVA/MUCOUS MEMBRANE

09215 INJECTED I.M., S.C., I.D.

09216 INJECTION into SOFT TISSUE or INTRADERMAL BUDS within the REFLEXNÍLÉČBY

09217 INTRAVENOUS INJECTION for INFANT or CHILD up to 10 years

09219 INTRAVENOUS INJECTION in adult or CHILD OVER 10 YEARS

09220 PERIPHERAL VEIN CANNULATION, INCLUDING INFUSION

09233 INJECTABLE ANESTHESIA WARD

09237 TREATMENT and PŘEVAZ WOUNDS FROM 1 CM2 10 CM2

09507 PSYCHOTHERAPY SUPPORT CARRIED OUT by DOCTOR NEPSYCHIATREM

09511 MINIMUM CONTACT DOCTOR with PATIENT

09513 PHYSICIAN PATIENT TELEPHONE CONSULTATIONS

09523 EDUCATIONAL INTERVIEW DOCTOR with SICK or FAMILY

09525 INTERVIEW with the family PHYSICIAN

44239 PŘEVAZ BÉRCOVÉHO ULCER TREATMENT and DOCTOR (1 LEG)

71511 REMOVAL FOREIGN BODY FROM the EAR CANAL

71611 EXEMPTION the FOREIGN BODY from the nose-SIMPLE

---------- ----------------------------------------------------------------------------



3. performance under the list of performances included in kapitační payments in the

expertise, according to the performance list 002:

-------------------------------------------------------------------------------------------------------

No performance Name

-------------------------------------------------------------------------------------------------------

01025 CONSULTATION PRACTITIONER, the FAMILY MEMBERS of the PATIENT

01030 ADMINISTRATIVE TASKS of the MEDICAL PRACTITIONER

02023 TARGETED EXAMINATIONS of the GENERAL PRACTITIONER for children and adolescents-a child up to 6 years

02024 CONTROL EXAMINATIONS of the GENERAL PRACTITIONER for children and adolescents-a child 6 YEARS

02033 TARGETED EXAMINATIONS of the GENERAL PRACTITIONER for children and adolescents-a child OVER 6 YEARS

02034 CONTROL EXAMINATION of a MEDICAL PRACTITIONER for children and adolescents-CHILD NAD6 YEARS

04508 TOPICAL TREATMENTS of GINGIVA/MUCOUS MEMBRANE

06111 complex-EXAMINATION of the STATE of the PATIENT'S SISTER in THEIR OWN SOCIAL ENVIRONMENT

06119 complex-the COLLECTION of BIOLOGICAL MATERIAL

06121 complex-TOPICAL TREATMENTS

06123 complex-EDUCATION, RE-EDUCATION, REHABILITATION NURSING

complex-06125 KLYSMA, perfusion, CATHETERIZATION, LAVAGE, TREATMENT of PERMANENT CATHETERS

06127 COMPLEX-INHALATION and therapeutic THERAPY P.O., S.C., I.M., I.V., UV, EVENT. ADDITIONAL APPLICATIONS

06129 rehearsal and COACHING APPLICATION INSULIN

09215 INJECTED I.M., S.C., I.D.

09216 INJECTION into SOFT TISSUE or INTRADERMAL BUDS within the REFLEXNÍLÉČBY

09217 INTRAVENOUS INJECTION for INFANT or CHILD up to 10 years

09219 INTRAVENOUS INJECTION in adult or CHILD OVER 10 YEARS

09220 PERIPHERAL VEIN CANNULATION, INCLUDING INFUSION

09221 INFUSION in INFANTS or CHILD up to 10 years

09233 INJECTABLE ANESTHESIA WARD

the REMOVAL of SMALL SKIN LESIONS 09235

09237 TREATMENT and PŘEVAZ WOUNDS FROM 1 CM2 10 CM2

09253 RELEASE of PREPUCIA, INCLUDING a NON-OPERATIONAL REPIZICE PARAFIMOZY

09507 PSYCHOTHERAPY SUPPORT CARRIED OUT by DOCTOR NEPSYCHIATREM

09511 MINIMUM CONTACT DOCTOR with PATIENT

09513 PHYSICIAN PATIENT TELEPHONE CONSULTATIONS

09523 EDUCATIONAL INTERVIEW DOCTOR with SICK or FAMILY

09525 INTERVIEW with the family PHYSICIAN

71511 REMOVAL FOREIGN BODY FROM the EAR CANAL

71611 EXEMPTION the FOREIGN BODY from the nose-SIMPLE

-------------------------------------------------------------------------------------------------------



4. For health performance not included in kapitační payments, health

performances for the competent health insurance company insured non-registered and

Foreign insured persons, medical facilities and health reported

the insurance company accepted, by a list of performance shall be the value of the

point in 1.05 EUR Czk.



5. For the performances, 01021 01022, 02022, 02031, 02021, 02032, 02110, 02120,

02125, 02127 02150, according to list of performance shall be the value of point in the

the amount of $ 1.10.



6. For transport in the guestbook service, paid by the performance,

shall be the value of the item in the amount of Czk 0.91.



7. Index expresses the ratio of the cost of insured persons in the age group

against the costs of insured persons in the age group 15 to 19 years.



Age group and indexes:

-------------------------

Age group Index

-------------------------

0-4 years 3.91

5-9 years, 1.70

10-14 years 1.35

15-19 years 1.00

20-24 years, 0.90

25-29 years 0.95

30-34 years, 1.00

35-39 years, 1.05

40-44 years, 1.05

45-49 years, 1.10

50-54 years 1.35

55-59 years 1.45

60-64 years 1.50

65-69 years, 1.70

70-74 years 2.00

75-79 years 2.40

80-84 years 2.90

85, and 3.40 more years

-------------------------



(B))



The combined kapitačně power payment with calling kapitace



1. the amount of the payment by calling kapitační with the kapitace determined in accordance with subparagraph (a).

And) point 1. Calling kapitace is provided in cases where practical

a doctor for adults or general practitioner for children and adolescents has, in the light of

on the geographical conditions, a small number of passenger policyholders

registered with the competent health insurance company, than the 70%

the national average number of such insured persons (national average

the number shall be fixed for the calendar year according to the data of the Central

insured persons registry, managed by the general health insurance company

The Czech Republic) and the provision of such health care is necessary to

health insurance obligations under section 46 paragraph. 1 of the Act.



2. Call kapitace can provide up to 90% of the kapitační of the payment

calculated on the average number of policyholders nationwide passenger

registered with the competent health insurance company. He is involved in

health insurance, medical device with which it has concluded a

contract for the provision and payment of health care share, which corresponds to the

the percentage of its policyholders from passenger policy holders of registered

This medical device.



3. For the payment of performance according to the list of performances (a). And points 4 and 6)

shall apply mutatis mutandis.



(C)) to be paid by health care according to the list of performances



For health care expenses paid in accordance with the list of performance shall be the value of the

point in the amount of CZK 1; for transport in the guestbook service shall be

point value in the amount of Czk 0.91.



D) regulatory restrictions



1. Regulation at the prescribed medicinal products and medical devices and

pull the care in the fields of Medicine (listed in the requested care

do not include the performance of mammography screening by health

the medical establishment, which has insurance on the

the provision of those health performance agreements):



1.1 if the average remuneration for medicinal products and medical devices

prescribed by the medical device related to one the equivalised

the insured person exceeds by more than 20% of the statewide average remuneration for the

prescribed medicinal products and medical devices, health

the insurance company shall be entitled to apply the regulatory reduction of up to 25% of the

the excess. The average payment per insured the equivalised

be included and supplements for medicinal products, for which the prescribing

the doctor has ruled out the possibility of replacement under section 32, paragraph. 2 of the Act and that

health insurance has paid. Health insurance shall take into account the cases

When medical device proves that increased the average remuneration for the

the medical establishment to the prescribed medicinal products and medical
resources related to one insured person was caused by the equivalised

by changing the amount or manner of their payment, or as a result of changes

the structure treated policyholders.



1.2 If the average payment for the requested care in listed

proficiency, according to the list of outputs, related to one of the equivalised

the insured person exceeds by more than 20% of the statewide average remuneration for the

pull the care in the listed fields of medicine, health insurance

entitled to exercise regulatory reduction of up to 25% of the excess.



2. Regulatory constraints referred to in point 1.1 and 1.2 shall not apply, if the

medical facilities justifying medical care provided on the

the basis has exceeded the average of payments referred to in point 1.1, where appropriate,

1.2.



3. Regulatory constraints referred to in point 1.1 and 1.2 shall further not apply if

medical facilities in 2009 or 2010, registered 50 and less

corresponding insured health insurance or provide health care

50 and less competent non-insured health insurance

or in the case of care provided to the foreign insurance policy holders.



4. Regulatory constraints referred to in point 1.1 shall not apply if the total remuneration

for all the medicinal products and medical devices prescribed by

practical medical and practical doctors for children and adolescents in 2010

shall not exceed the estimated amount of the payments on this type of health care for a year

2010 health insurance plan from the relevant health

the insurance company.



5. Regulatory restrictions in accordance with point 1.2 shall not apply if the total remuneration

for the requested care in the listed fields of medicine in 2010 shall not exceed

the estimated amount of payments on this type of health care in the year 2010

based on the health insurance plan of the appropriate health

the insurance company.



6. Health insurance is entitled to apply the regulatory reduction by

points 1.1 and 1.2 a maximum amount corresponding to 15% of the volume of payments

This provided health insurance medical devices for

kapitační payment and health performance, reduced by the amount of remuneration for particular

posted material and medicinal products particularly charged for the year 2010.



Annex 3



The value of the item, the amount of the payments and the regulatory restrictions pursuant to § 5



And)



The value of the item and the amount of the payments



1. the amount of the remuneration shall be determined in accordance with the remuneration for performance provided

Health performances with the value of the point of



1.08 Eur) for medical device reporting performance expertise-910

psychotherapy, according to the list of performances, together with the ošetřovacím the date of

the daily list of the performance and for health care facilities

Contracting expertise 901-clinical psychology, according to the list of outputs,



(b) Eur 1.08) for medical devices providing hemodialysis treatment,



(c)) $ 1 for health care facilities contracting expertise, 927-orthoptist,

According to the list of performances, and for health care facilities contracting expertise

903-clinical speech therapy, with the exception of performances, 72213 72211, 72215 and

72019, according to the list of performances, for which the value is determined in the amount of

0.70 Eur,



(d) Eur 0.71) for performances, 43311 43313, 43315, 43613, 43617, 43627, 43629,

43633, according the list, contracting expertise 403-radiation

Oncology, according to the list of outputs,



(e)), 0.96 CZK for performances and, according to 75347 75348 list performance contracting

expertise of the 705-ophthalmology,



(f)) for the rest of 1.02 Czk health establishments, to the volume calculated for the

individual expertise, according to the list, as follows:



POPho

PBro x--------

POPro



where:



PBro total number of medical facilities and health declared

insurance recognised points over the reference period. The reference period is

means the relevant half-year 2008.



The number of unique POPho insured persons treated in medical facilities

the expertise in the reviewed period. The rated period means

the relevant half-year 2010.



POPro number of unique insured persons treated in medical facilities

the expertise in the reference period; in the case of merge healthcare

insurance companies are the number of unique treated policyholders means the sum of the

unique treated insured persons for health insurance, which is

merged (if it has been the beneficiary in the reference period had more

than one health insurance company, to the number of unique treated

insured persons are counted only once).



Health care provided by the medical establishment over the calculated volume in

the expertise, expressed in number of points for the performances of the medical

the device reported and recognized by the health insurance for the period of reference,

shall be paid in accordance with the list of performances with the value point of 0.30 Usd.



2. in the case of medical devices, which did not exist in the reference period,

where appropriate, that provides care in the expertise, the health

the insurance company for the purpose of calculating the volume of use on the average number of points

one of the unique policyholder, treated in the expertise for

the reference period, comparable medical facilities.



3. in the case of medical devices, where there is compared to the reference period

the influence of changes in nasmlouvaného of the range provided by the health care in some of the

expertise (IE. change the spectrum of the contracted performance)

the average number of points on one of the unique number of the insured person, the volume

points, in accordance with point 1 (b). (f) the number of points), which corresponds to the

medical facilities and health insurance company reported that recognized the newly

nasmlouvaným health.



4. Reduced the value of point in the skills referred to in point 1 (f)) shall not apply:



and in the case of the medical zatřízení), that in the reference or

the assessment period within a single expertise treating 100 and less

unique insured, when the contracted value of maximum capacity

the numbers of 1.00. In the case of proportional capacity numbers less than 1.00,

the limit of 100 unique treated policyholders recalculates the contracted

the value of the maximum capacity numbers for that expertise. The proportional

capacitive number expresses the value nasmlouvaného size range

health care for the expertise provided by one carrier of 3)

the performance of the health insurance company,



(b)) in the case of healthcare provided by the foreign insurance policy holders.



In the cases referred to in (a). and (b))) and all performances shall be borne by the

the value of point 1 Kč.



5. Health insurance medical facility can provide a monthly

interim payment equal to one-sixth volume of the corresponding remuneration for the

the reference period or in the amount of medical facilities reported

and recognised health care for the relevant month. The selected form of preliminary

health insurance payments will maintain throughout the monitored period, if the

medical equipment during the period evaluated, the requested reduction

the amount of the advance payment. Advance payments for the rated period

financially settled in the framework of an overall financial settlement, including

regulatory restrictions, and no later than 120 days after the end of the investigational

the period.



B) regulatory restrictions



for medical device reporting performance expertise-910

psychotherapy, according to the list of performances, together with the ošetřovacím the date of

the daily list of the performance and for health care facilities

Contracting expertise 901-clinical psychology, according to the list of performances



1. If the medical device reaches the average of the remuneration on the one

unique insured separately charged for medicinal products [with the exception of

separately charged to the medicinal products covered by the specialized

workplaces under section 15(2). 7 (b). (b)) of the Act] and separately billed

the material in the assessment period, higher than the average of the remuneration of the

one of the unique policyholder in the reference period for a particularly charged

medicinal products [with the exception of specially charged to medicinal products

financed by the specialised workplaces under section 15(2). 7 (b). (b))

the law] and posted material, health insurance can

medical devices, after the end of the year 2010, to reduce the payment of the amount

corresponding to 40% of the additional costs charged separately on medicinal products

and posted the material and methods contained in the contract

medical facilities and health insurance. The value of the average of the remuneration

According to the first sentence is defined as 100% of the average remuneration for separately

charged to the medicinal products [with the exception of specially charged to medicinal

products covered by the specialised workplaces under section 15(2). 7

(a). (b)) of the Act] and posted the material on one of the unique

the insured person's relevant health insurance in 2009, however, the maximum

up to 108% of the average remuneration for medicinal products [post separately with

the exception specially charged to medicinal products covered by the

specialised workplaces under section 15(2). 7 (b). (b)) of the Act] and

separately charged material on one unique insured persons the competent

health insurance in the reference period.



2. If the medical device reaches the average of the remuneration on the one

unique insured for the prescribed medicines and medical
resources in the period, higher than the reference value of the average

remuneration to the insured in one unique reference period for

prescribed medicinal products and medical devices, health

the insurance company can medical facility, after the end of the year 2010, to reduce the

the payment of the amount corresponding to 40% of the additional cost of the prescribed

medicinal products and medical devices, and the ways in

contract medical equipment and health insurance. To the average

remuneration to the one unique insured persons will be included and supplements for

medicinal products for which the prescribing doctor ruled out the possibility of

replacement under section 32, paragraph. 2 of the Act. The value of the average of the remuneration referred to in the sentence

the first is defined as 100% of the average remuneration for medicinal products and

medical devices prescribed by the medical device on the one

unique insured the relevant health insurance in 2009,

However, up to a maximum of 108% of the average remuneration for medicinal products and

medical devices prescribed by the medical device on the one

unique competent health insurance policyholders in the reference

the period.



3. If the medical device reaches the average of the remuneration on the one

a unique policyholder for the requested care in listed skills in

the assessment period, higher than the average payment per unique

the insured person in the reference period, the health insurance company may

medical devices, after the end of the year 2010, to reduce the payment of the amount

corresponding to 40% of the additional costs for the requested care (over 100%),

methods contained in the contract of medical equipment and health

the insurance company. The value of the average of the remuneration referred to in the first sentence shall be as

100% of the average remuneration for the requested care in listed skills

one of the unique insured persons the competent health insurance company of the year

2009, with a maximum of up to 108% of the average remuneration for requested care in

listed on one of the unique skills of the policyholder, the competent

health insurance in the reference period.



4. Regulatory restrictions in accordance with point 1 to 3 shall not apply if the medical

reasons provided health care facilities, on the basis of an

exceeded the average of payments referred to in paragraph 1, in accordance with point 2, as appropriate,

point 3.



5. the regulatory restriction referred to in point 1 shall not apply if the total remuneration for the

all separately charged medicinal products and separately charged material in the

outpatient health care facilities providing out-patient

specialized care in the period shall not exceed the

100% health insurance payments on this type of health care in

2009.



6. the regulatory restriction referred to in point 2 shall not apply if the total remuneration for the

all medicinal products and medical devices prescribed in the

outpatient health care facilities providing out-patient

specialized care in the period shall not exceed the estimated amount of the

payments on this type of health care in the year 2010 based on the disabled

insurance plan appropriate health insurance.



7. in the case of medical devices, where there have been compared to the reference period

change the nasmlouvaného of the range provided by the health care provider (changing number of

holders of performance authorized to prescribe medicinal products and

medical devices and require care in a listed

fields of Medicine), health insurance, in agreement with the medical

the device, the value of the average payments in the reference period for these purposes

adjusts.



8. in the case of medical devices which, in the reference period, or in his

part did not exist, or not to contract with health

the insurance company, health insurance company may use for the purposes of the application of the

regulatory restrictions referred to in points 1 to 3 of the reference values comparable

health care facilities.



9. If medical facilities treating the reference or the investigational

period in the expertise of 50 and less unique policyholders,

the contracted value of the maximum capacity numbers 1.00, health

This does not include the insurance expertise to calculate the control provided for in points 1. up to

3. in the case of proportional numbers less than 1.00 capacity limit 50

the treated policyholders converted contracted value of unique

maximum capacity numbers for that expertise.



10. Regulatory constraints referred to in point 3 shall not apply if the total remuneration

for the requested care in the listed fields of medicine in 2010 shall not exceed

the estimated amount of payments on this type of health care in the year 2010

based on the health insurance plan of the appropriate health

the insurance company.



11. Health insurance is entitled to apply the regulatory reduction by

points 1 to 3, a maximum amount equal to 25% of the volume of payments

This provided health insurance medical devices for

health performance, reduced by the amount of remuneration for the separately posted material and

separately charged to the medicinal products for the monitored period.



12. If the medical device will prescribe medical device over the

15 000 Czk, the approved revision doctor health insurance will not

the amount included in the regulatory limit.



C) regulatory restrictions for health care facilities

hemodialysis care



1. If the medical device reaches the average of the remuneration on the one

unique insured separately charged for medicinal products [with the exception of

separately charged to the medicinal products covered by the specialized

workplaces under section 15(2). 7 (b). (b)) of the Act] and separately billed

the material in the assessment period, higher than 100% of the average remuneration per

unique insured separately charged for medicinal products [with the exception of

separately charged to the medicinal products covered by the specialized

workplaces under section 15(2). 7 (b). (b)) of the Act] and separately billed

the material in the reference period, can the medical health insurance

the device, after the end of the year 2010, to reduce the payment of the amount corresponding to 40

% of the additional costs charged separately for medicinal products and

posted material (over 100%), and ways the Treaty

medical facilities and health insurance.



2. If the medical device reaches the average of the remuneration on the one

unique insured for the prescribed medicines and medical

resources in the period of higher than 100% of the average of the remuneration of the

one of the unique insured for the prescribed medicines and

medical resources in the reference period, the health insurance company may

medical devices, after the end of the year 2010, to reduce the payment of the amount

corresponding to 40% of the additional costs at the prescribed medicinal products and

medical devices (over 100%), and ways the Treaty

medical facilities and health insurance. To the average of the remuneration of the

one of the unique insured persons will be included and supplements for medicinal

products, for which the prescribing doctor ruled out the possibility of replacing the

According to § 32 paragraph. 2 of the Act.



3. If the medical device reaches the average of the remuneration on the one

a unique policyholder for the requested care in listed skills in

the assessment period, higher than 100% of the average remuneration per unique

the insured person in the reference period, the health insurance company may

medical devices, after the end of the year 2010, to reduce the payment of the amount

corresponding to 40% of the additional costs for the requested care (over 100%),

methods contained in the contract of medical equipment and health

the insurance company. To the requested care do not include health performances

mammography screening and cervical cancer screening

carried out by the medical establishment, which has insurance on the

the provision of those health performance contract.



4. Regulatory restrictions in accordance with point 1 to 3 shall not apply if the medical

reasons provided health care facilities, on the basis of an

exceeded the average of payments referred to in paragraph 1, in accordance with point 2, as appropriate,

point 3.



5. the regulatory restriction referred to in point 1 shall not apply if the total remuneration for the

all separately charged medicinal products and separately charged material in the

outpatient health care facilities providing out-patient

specialized care in 2010 shall not exceed the relevant health

100% of the insurance payments on this type of health care in 2008.



6. the regulatory restriction referred to in point 2 shall not apply if the total remuneration for the

all medicinal products and medical devices prescribed in the

outpatient health care facilities providing out-patient

specialized care in 2010 shall not exceed the estimated amount of the payments to the

This kind of health care for 2010 based on the disabled

insurance plan appropriate health insurance.



7. in the case of medical devices, where there have been compared to the reference period

change the nasmlouvaného of the range provided by the health care provider (changing number of

holders of performance authorized to prescribe medicinal products and
medical devices and require care in a listed

fields of Medicine), health insurance, in agreement with the medical

the device, the value of the average payments in the reference period for these purposes

adjusts.



8. in the case of medical devices which, in the reference period, or in his

part did not exist, or not to contract with health

the insurance company, health insurance company may use for the purposes of the application of the

regulatory restrictions referred to in points 1 to 3 of the reference values comparable

health care facilities.



9. If medical facilities treating the reference or the investigational

period in the expertise of 50 and less unique policyholders,

the contracted value of the maximum capacity numbers 1.00, health

undertaking this expertise does not include in the calculation of the regulation referred to in points 1 to

3. in the case of proportional numbers less than 1.00 capacity limit 50

the treated policyholders converted contracted value of unique

maximum capacity numbers for that expertise.



10. Regulatory constraints referred to in point 3 shall not apply if the total remuneration

for the requested care in the listed fields of medicine in 2010 shall not exceed

the estimated amount of payments on this type of health care in the year 2010

based on the health insurance plan of the appropriate health

the insurance company.



11. Health insurance is entitled to apply the regulatory reduction by

points 1 to 3, a maximum amount equal to 25% of the volume of payments

This provided health insurance medical devices for

health performance, reduced by the amount of remuneration for the separately posted material and

separately charged medicinal products for the year 2010.



12. If the medical device will prescribe medical device over the

15 000 Czk, the approved revision doctor health insurance will not

the amount included in the regulatory limit.



D) regulatory restrictions for other medical devices



1. If the medical device reaches the average of the remuneration on the one

unique insured separately charged for medicinal products [with the exception of

separately charged to the medicinal products covered by the specialized

workplaces under section 15(2). 7 (b). (b)) of the Act] and separately billed

the material in the assessment period, higher than 110% of the average remuneration per

unique insured separately charged for medicinal products [with the exception of

separately charged to the medicinal products covered by the specialized

workplaces under section 15(2). 7 (b). (b)) of the Act] and separately billed

the material in the reference period, can the medical health insurance

the device, after the end of the year 2010, to reduce the payment of the amount corresponding to 40

% of the additional costs of medicines, and particularly charged separately

posted material (over 110%), and ways the Treaty

medical facilities and health insurance.



2. If the medical device reaches the average of the remuneration on the one

unique insured for the prescribed medicines and medical

resources in the period of greater than 105% of the average of the remuneration of the

one of the unique insured for the prescribed medicines and

medical resources in the reference period, the health insurance company may

medical devices, after the end of the year 2010, to reduce the payment of the amount

corresponding to 40% of the additional costs at the prescribed medicinal products and

medical devices (over 105%), and ways the Treaty

medical facilities and health insurance. To the average of the remuneration of the

one of the unique insured persons will be included and supplements for medicinal

products, for which the prescribing doctor ruled out the possibility of payment by the

§ 32 paragraph. 2 of the Act.



3. If the medical device reaches the average of the remuneration on the one

a unique policyholder for the requested care in listed skills in

the assessment period, higher than 110% of the average remuneration per unique

the insured person in the reference period, the health insurance company may

medical devices, after the end of the year 2010, to reduce the payment of the amount

corresponding to 40% of the additional costs for the requested care (over 110%), and

methods contained in the contract of medical equipment and health

the insurance company. To the requested care do not include health performances

mammography screening, cervical cancer screening, and

Colorectal cancer screening by the medical establishment,

that has health insurance is to provide these health

performance of contract. For the purposes of determining the amount of the average of payments and

the amount of the deduction, if any, referred to in the first sentence, with the performance of requested care in

the investigational and reference period will be appreciated according to the procedures applicable to the

1.1. 2010 value point valid in the period.



4. Regulatory restrictions in accordance with point 1 and 3 shall not apply if the medical

reasons provided health care facilities, on the basis of an

exceeded the average of payments referred to in paragraph 1, in accordance with point 2, as appropriate,

point 3.



5. the regulatory restriction referred to in point 1 shall not apply if the total remuneration for the

all separately charged medicinal products and separately charged material in the

outpatient health care facilities providing out-patient

specialized care in 2010 shall not exceed the relevant health

106% of the insurance payments on this type of health care in 2008.



6. the regulatory restriction referred to in point 2 shall not apply if the total remuneration for the

all medicinal products and medical devices prescribed in the

outpatient health care facilities providing out-patient

specialized care in 2010 shall not exceed the estimated amount of the payments to the

This kind of health care for 2010 based on the disabled

insurance plan appropriate health insurance.



7. in the case of medical devices, where there have been compared to the reference period

change the nasmlouvaného of the range provided by the health care provider (changing number of

holders of performance authorized to prescribe medicinal products and

medical devices and require care in a listed

fields of Medicine), health insurance, in agreement with the medical

the device, the value of the average payments in the reference period for these purposes

adjusts.



8. in the case of medical devices which, in the reference period, or in his

part did not exist, or not to contract with health

the insurance company, health insurance company may use for the purposes of the application of the

regulatory restrictions referred to in points 1 to 3 of the reference values comparable

health care facilities.



9. If medical facilities treating the reference or the investigational

period in the expertise of 50 and less unique policyholders,

the contracted value of the maximum capacity numbers 1.00, health

undertaking this expertise does not include in the calculation of the regulation referred to in points 1 to

3. in the case of proportional numbers less than 1.00 capacity limit 50

the treated policyholders converted contracted value of unique

maximum capacity numbers for that expertise.



10. Regulatory constraints referred to in point 3 shall not apply if the total remuneration

for the requested care in the listed fields of medicine in 2010 shall not exceed

the estimated amount of payments on this type of health care in the year 2010

based on the health insurance plan of the appropriate health

the insurance company.



11. Health insurance is entitled to apply the regulatory reduction by

points 1 to 3 above, corresponding to a maximum of 15% of the volume of payments

This provided health insurance medical devices for

health performance, reduced by the amount of remuneration for the separately posted material and

separately charged medicinal products for the year 2010.



12. If the medical device will prescribe medical device over the

15 000 Czk, the approved revision doctor health insurance will not

the amount included in the regulatory limit.



Annex 4



The value of the item, the amount of the payments and the regulatory restrictions in accordance with § 6



And)



The value of the item and the amount of the payments



1. the amount of the remuneration shall be determined in accordance with the remuneration for performance provided

Health performances with the value of the item in the amount of Czk 1.06.



2. the total amount of the reimbursement of the medical equipment



and providing health care in) the expertise of the 603 or 604 does not exceed

the amount, which is calculated as follows: POPzpo x PUROo x Inu



where:



POPzpo number of unique expertise in the treated policyholders

medical facilities in the period. IMP, the period is the year

2010.



PUROo the average remuneration for health, including especially the posted

material and medicinal products, especially those posted on one of the unique

insured persons treated in the expertise of the medical facility in the

the reference period. The reference period is the year 2008.



Well, tender growth index is at least 1.06



(b)) providing health care at the same time in the expertise of the 603 and

604 does not exceed the amount of skill equal to the sum of the amounts for

individual expertise, where the amount calculated for individual expertise

as follows: POPzpo x PUROo x Inu



where:



POPzpo number of unique expertise in the treated policyholders

medical facilities in the period
PUROo is calculated as: PUROo = PPBROo x RDHB + PUZUMROo + PUZULPROo



where:



PPBROo average number of medical facilities declared and health

insurance recognised points on one unique insured persons treated in

the expertise of the medical establishment in the reference period,

passenger list of performances on January 1st, 2010



RDHB realistically achieved point value for the health care provided

medical facilities in the 603 and 604 skills, according to the list, for

health insurance in the reference period, shall be fixed as a proportion of

the total remuneration provided by the medical facility health insurance

for health care provided by the medical establishment in the expertise of 603

and, according to the performances of the 604, reduced by the amount of remuneration for separately billed

material and separately charged for the medicinal product, the reference period and

the total number of points for health care provided by the medical

the device in the expertise of the 603 and 604 reported for the reference period and the

health insurance company approved



PUZUMROo the average remuneration for the separately posted material on the one

unique in the insured person's expertise in health care facilities in the

the reference period



PUZULPROo the average remuneration of a particularly charged on medicinal products

one of the unique expertise of the insured in the health

the device in the reference period



Well, tender growth index is at least 1.06



3. The total amount of remuneration referred to in paragraph 2 shall, subject to conditions

laid down in the contract between health insurance and health care

equipment increased in the same manner as in 2009, if

health insurance, medical institutions have agreed otherwise.



4. in the case of medical devices, which did not exist in the reference period,

where appropriate, that provides care in a given skill, health

the insurance company authorized for the purposes of calculating the total amount of payment use

the average payment per unique insured for the period of reference

comparable medical facilities.



5. in the case of medical devices, where there is compared to the reference period

the influence of changes in nasmlouvaného of the range provided by the health care in some of the

expertise (i.e. change the spectrum of the contracted performance) to the increase in the average

remuneration to the one unique insured persons, the total amount of the remuneration

medical device referred to in point 2 for the value of health care

the device reported and health insurance company recognized the newly nasmlouvaným

health interventions, including especially the posted material, and especially

posted in medicinal products. The newly contracted performances for these

the purpose of the performance by the list will appreciate using the point values of CZK 1.0.



6. Health insurance in the Bill take account of cases where an increase in

the cost is in relation with the increase of pregnant pojištěnek.



7. Health insurance on account of the cases in which medical

the device proves that increased the average cost of separately billed

material and posted on one of the unique medicinal products

the insured person in a given skill were caused by changing the amount or the method of

their payment, where applicable, as a result of changes in the structure of the treated

policy holders.



(B))



Regulatory restrictions



1. Regulations for the prescribed medicines and medical devices and

for the requested care in the listed fields of medicine.



1.1 if the medical device reaches the average of the remuneration on the one

unique insured for the prescribed medicines and medical

resources in the period, higher than the average payment per

unique insured for the prescribed medicines and medical

resources in the reference period, the health insurance company is authorised to

medical facility, to reduce the payment of the amount corresponding to 40% of the

the additional cost of the prescribed medicinal products and medical

the means and methods contained in the contract of medical equipment and

health insurance companies. The average payment per unique

the policyholder will be included and supplements for medicinal products, for which

prescribing doctor ruled out the possibility of replacement under section 32, paragraph. 2

the law. The average remuneration referred to in the first sentence shall be established as 100% of the average

remuneration for medicinal products and medical devices prescribed by

medical facilities on one unique insured persons the competent

health insurance in 2009, with a maximum of up to 108% of the average

remuneration for medicinal products and medical devices prescribed by

medical facilities on one unique insured persons the competent

health insurance in the reference period.



1.2 If the medical device reaches the average of the remuneration on the one

a unique policyholder for the requested care in listed skills in

the assessment period, higher than the average payment per unique

in the reference period, the insured person's health insurance company is authorised to

medical facility, to reduce the payment of the amount corresponding to 40% of the

increased costs for care, and pull methods contained in the contract

medical facilities and health insurance. The average remuneration in accordance with

the first sentence is defined as 100% of the average remuneration for requested care in

listed on one of the unique skills of the policyholder, the competent

health insurance in 2009, with a maximum of up to 108% of the average

remuneration for the requested care in listed skills, on one

unique competent health insurance policyholders in the reference

the period. To the requested care do not include health performance of mammography

screening, screening for cervical and colorectal

cancer, carried out by the medical establishment, which has with the insurance company on the

the provision of those health performance contract.



2. Regulatory constraints referred to in point 1.1 and 1.2 shall not apply, if the

medical facilities justifying medical care provided on the

the basis has exceeded the average of payments referred to in point 1.1, where appropriate,

1.2.



3. Regulatory constraints referred to in point 1.1 shall not apply if the total remuneration

for all the medicinal products and medical devices prescribed in the

outpatient health care facilities providing out-patient care in the

proficiency in the 603 and 604 of the period shall not exceed 108% of the average

remuneration for medicinal products and medical devices prescribed in the

603 and 604 proficiency in the reference period.



4. when compared to the reference period there was a change nasmlouvaného

the range of provided health care (changing the number of holders of the performance

authorized to prescribe medicinal products and medical devices and

require care in the listed fields of Medicine), health insurance after

the agreement with the medical establishment in the average value of payments

the reference period for these purposes they adjusted.



5. in the event that the medical device in the reference period or in its

part did not exist, or not to contract with health

the insurance company is entitled to use the health insurance company for the purpose of

the application of regulatory limits in sections 1.1 and 1.2 of the reference value

comparable medical facilities.



6. If medical facilities treating the reference or the investigational

period in the expertise of 50 and less unique policyholders,

the contracted value of the maximum capacity numbers 1.00; health

undertaking this expertise does not include in the calculation of the regulation referred to in points 1.1 and

1.2. in the case of proportional numbers less than 1.00 capacity limit 50

the treated policyholders converted contracted value of unique

maximum capacity numbers for that expertise.



7. the undertaking does not apply the regulation referred to in point 1.2, if the total remuneration

for the requested care in the listed fields of medicine in 2010 shall not exceed

on this kind of health care to the estimated amount of payments for the year 2010,

based on the health insurance plan health insurance.



8. Health insurance is entitled to apply the regulatory reduction by

points 1.1 and 1.2, a maximum amount equal to 25% of the volume of payments

provided by health insurance medical equipment for health

performance reduced by the amount of remuneration for the separately posted material and especially

posted medicinal products for the year 2010.



9. If the medical device medical device reports over 15

USD, these costs are not included in the regulatory limit.



Annex 5



The value of the item and the amount of the payments referred to in section 8



1. for the performance of the contracted screening mammography, according to a list

performance, shall be the value of the item in the amount of Czk 1.10, cervical screening

the throat and the screening of colorectal cancer, according to a list of performances,

provides the value of the item in the amount of Czk 1.03.



2. For health care provided in the expertise of 809, according to the list

performance, to the volume calculated according to section 5 sets out the value of point in the

the amount of Eur 1.10 except the contracted performance 89711 89725 and up

89611 89619 to performance, according to a list of performances, for which the volume of the

calculated in accordance with point 5 point value in the amount of Eur 0.70.



3. For health care provided in the fields of medicine, listed with the
the exception of expertise, according to the performance of 809, to the volume calculated

According to point 5 point value set at EUR 0.70 Eur, if the health

the insurance company, the medical establishment have agreed otherwise under section 15.



4. for the health care provided by a foreign insurance policy holders shall be

the value of the item in accordance with points 1 to 3.



5. Health care is provided in the assessment period in listed

proficiency shall be paid with the value referred to in point 2 and point 3 to 100%

medical facilities and health insurance company declared the recognised

points over the reference period; above this volume of health care shall be borne by the

the value of point 0.36 Eur. IMP, the period is the relevant half-year

2010, the reference period, the competent half-year of 2008.



6. in the case of medical devices which, in the assessment of the period did not exist,

where appropriate, that provides care in a given skill or

total payment volume cannot be set, the health insurance for the

the purposes of the calculation referred to in point 5 of the volume of the average remuneration per

unique insured persons for the reference period of comparable health

the device.



7. the provisions of paragraph 5 shall not apply, if the medical equipment provided

health care 50 and less unique to the insured. The provisions of point 5,

Furthermore, it shall not apply in the case of the health care provided by foreign

to the insured.



Annex 6



The value of the item and the amount of the payments referred to in section 9



1. For outpatient health care facilities providing health care in

925, according to the list of skill performance, shall be established in the amount of 1 point value

CZK.



2. For outpatient health care facilities providing health care in

expertise of 911, 914, 916, 921, and according to the procedures, shall be adopted

point value of 0.90 Czk.



3. For transport in the guestbook service, paid by the performance,

shall be the value of the item in the amount of Czk 0.91. These performances not covered by the

the provisions of paragraphs 4 and 5.



4. the health care provided by the medical establishment to 105%

the calculated volume, where appropriate, adjusted in accordance with section 6, shall be paid by the

list of performances with the value of the point referred to in points 1 and 2. This volume is

calculated as follows:



POPho

PBro x--------

POPro



where:



PBro total number of medical facilities and health declared

insurance recognised points over the reference period, annualised, according

list of performances on January 1st, 2010. The reference period shall mean the

the relevant half-year 2008.



The total number of unique POPho policyholders treated medical

equipment in the period. The rated period means the competent

half of 2010.



POPro the total number of unique policy holders treated medical

the device in the reference period; in the case of merge healthcare

the number of unique insurance policyholders means the sum of the unique

insured persons for health insurance companies, which merged (if it has been

the beneficiary during the reference period had more than one health

the insurance companies, the number of unique treated policyholders are counted

only once).



6. the health care provided by the medical establishment over 105% volume

calculated in accordance with point 4, where appropriate, adjusted in accordance with point 6, in

expertise with point 925 pays the value in the amount of Eur 0.70 and proficiency

911, 914, 916, and 921-valued point of 0.63 Czk.



7. If the medical device amendments to the scope and

the structure provided by the paid care in comparison with the reference period, and

health insurance company agrees to take account of these changes, it is in the Treaty,

including enumerations increase (reduction) payments.



8. the provisions of paragraphs 4 and 5 shall not apply if the health care facility

treating 50 and less unique policyholders in the reference period.



9. Health insurance medical facility may arrange for monthly

a preliminary payment of the value of medical facilities reported and

health insurance company recognized healthcare for the month

This form of health insurance will maintain throughout the relevant semester.

A preliminary payment of health insurance for the half-year financial

enquiry no later than 120 days after the end of the period evaluated.



Annex 7



The value of the item and the amount of the payments referred to in section 10



1. the value of point is set at EUR 0.80 Czk.



2. For transport in the guestbook service, paid by the performance,

the value of the point set at EUR 0.91 Eur. These performances not covered by the

the provisions of point 3.



3. the health care provided by the medical establishment over the calculated

volume, where appropriate, adjusted in accordance with paragraph 4, shall be paid in accordance with the list of performances with the

the value of the item in the amount of $ 0.50. This volume is calculated as follows:



POPho

PBro x--------

POPro



where:



PBro total number of medical facilities and health declared

insurance recognised points over the reference period, annualised, according

list of performances on January 1st, 2010. The reference period shall mean the

the relevant half-year 2008.



The total number of unique POPho policyholders treated medical

equipment in the period. The rated period means the competent

half of 2010.



POPro the total number of unique policy holders treated medical

the device in the reference period; in the case of merge healthcare

the number of unique insurance policyholders means the sum of the unique

insured persons for health insurance companies, which merged (if it has been

the beneficiary during the reference period had more than one health

the insurance companies, the number of unique treated policyholders are counted

only once).



4. If the medical device amendments to the scope and

the structure provided by the paid care in comparison with the reference period, and

health insurance company agrees to take account of these changes, it is in the Treaty,

including enumerations increase (reduction) payments.



5. the provisions of paragraph 3 shall not apply if the medical facilities treating

50 and less unique policyholders in the reference period.



6. If the average number of points the medical establishment declared and

health insurance approved on one unique insured for

rated at least 98% of the period reaches the average number of points per

unique insured over the reference period and at the same time the average remuneration

one of the unique in the period of the insured person, provided

medical devices, health insurance is less than 103% of the

the average payment to the insured in one unique reference period,

health insurance in the framework of the financial settlement of medical

the device raises the average payment per unique insured on the

103% of the average remuneration per unique policyholder in the reference

the period.



7. If the average number of points the medical establishment declared and

health insurance approved on one unique insured for

rated at least 98% of the period reaches the average number of points on the

one of the unique insured persons for the reference period, the health

the insurance company within the financial settlement of medical devices shall be reduced

the average payment per unique insured about the same number of

percentage points, of which 98% was achieved by the values specified in the sentence

the first.



8. For the calculation of the average number of points on one unique insured

referred to in points 6 and 7 are for investigational and reference period used list

valid to 1 January 2010 performance.



9. Health insurance medical facility may arrange for monthly

interim payment either in the amount of the value declared to the medical facility,

and health insurance company recognized, health care for the month, or

in the amount of 100% of the volume of one sixth of the remuneration in the reference period, and

the selected form of health insurance will maintain throughout the relevant semester.

A preliminary payment of health insurance for the half-year financial

enquiry no later than 120 days after the end of the period evaluated.



Annex 8



The value of the item and the amount of the payments referred to in section 12 of the



1. The value of the point shall be



and in the amount of $ 0.95) for health care facilities providing transport

health service in continuous operation,



(b)) in the amount of Czk 0.90 for medical devices does not provide pertinent traffic

health service in continuous operation.



2. the health care provided by the medical establishment to 100%

the calculated volume shall be paid in accordance with the list of performances with the value of point

provided for in point 1. This volume is calculated as follows:



POPho

PBro x--------

POPro



where:



PBro total number of medical facilities and health declared

insurance recognised points over the reference period, adjusted according to the

list of performances on January 1st, 2010. The reference period is the year

2008.



The total number of insured persons převezených POPho, which was in the

period granted to transport medical service. Převezeným the policyholder is

means the insured party, which was banned on the basis of the performance of the transport

the medical transport. The rated period means the year

2010.



Převezených POPro the total number of insured persons, which was in the reference

period granted to transport medical service; in the case of merge

health insurance is the number of převezených means the sum insured
převezených insured persons for health insurance companies that were merged.



3. Over 100% of the volume is calculated in accordance with point 2 of the health insurance

shall be entitled to modify the value of the point referred to in paragraph 1, for the health

the device referred to in point 1 (a). and to 0.90 Czk) and for health

the device referred to in point 1. (a). (b)) to 0.80 Czk.



4. the provisions of paragraph 3, shall not apply to medical devices, which

reference period provided the transport or the assessment of the health service

less than 50 převezeným affiliated persons competent health insurance company.



5. If the medical device amendments to the scope and

the structure provided by the paid care in comparison with the reference period, and

health insurance company agrees to take account of these changes, it is in the Treaty,

including enumerations increase (reduction) payments.



6. Health insurance may provide for medical devices 1. and

2. half-year 2010 interim payment in the amount of 100% of the remuneration in the

the half-year 2008.



Annex 9



The group related to the diagnosis, according to Klasifikace5), with indexes of these groups

--------- -----------------------------------------------------------------------

IR-DRG ^ 5) group name Index

--------- -----------------------------------------------------------------------

00011 HEART TRANSPLANTS and/or LUNG without CC 23.2508

00012 HEART TRANSPLANTS and/or LUNG with CC 23.2508

00013 HEART TRANSPLANTS and/or LUNG with MCC 53.1143

00021 LIVER TRANSPLANTATION without CC 17.6970

00022 LIVER TRANSPLANTATION with CC 17.6970

00023 LIVER TRANSPLANTATION with MCC 37.7494

00031 ALLOGENEIC BONE MARROW TRANSPLANTATION without CC 38.6473

00032 ALLOGENEIC BONE MARROW RANSPLANTACE with CC 38.6473

00033 ALLOGENEIC BONE MARROW TRANSPLANTATION with MCC 44.3433

00041 LONG-TERM MECHANICAL VENTILATION 12.1166 > 240 HOURS

(11-21 days) WITHOUT CC

00042 LONG-TERM MECHANICAL VENTILATION 12.1166 > 240 HOURS

(11-21 days) WITH CC

00043 LONG-TERM MECHANICAL VENTILATION 17.4213 > 240 HOURS

(11-21 days) WITH MCC

00051 LONG-TERM MECHANICAL VENTILATION 96 HOURS > 7.2631

(5-10 days) WITHOUT CC

00052 LONG TERM MECHANICAL VENTILATION 96 HOURS > 7.6415

(5-10 days) WITH CC

00053 LONG TERM MECHANICAL VENTILATION 96 HOURS > 9.0900

(5-10 days) WITH MCC

00060 LONG-TERM MECHANICAL VENTILATION > 95.4949 1 800 HOURS

(MORE THAN 75 days)

00070 LONG-TERM MECHANICAL VENTILATION 1 008 HOURS > 122.3876

(MORE THAN 43 days) WITH TRANSPLANTS OF THE HEART, LUNGS, LIVER,

BONE MARROW

00080 LONG-TERM MECHANICAL VENTILATION 1 008 HOURS > 71.3005

(43-75 days) WITH ECONOMICALLY CHALLENGING PERFORMANCE

00090 LONG-TERM MECHANICAL VENTILATION 1 008 HOURS > 41.9233

(43-75 days)

00100 LONG-TERM MECHANICAL VENTILATION > 504 HOURS 42.7458

(22-42 days) WITH ECONOMICALLY CHALLENGING PERFORMANCE

00110 LONG-TERM MECHANICAL VENTILATION > 504 HOURS 36.9353

(22-42 days)

00121 LONG-TERM MECHANICAL VENTILATION 19.7036 > 240 HOURS

(11-21 days) WITH ECONOMICALLY CHALLENGING PERFORMANCE WITHOUT CC

00122 LONG-TERM MECHANICAL VENTILATION 21.5892 > 240 HOURS

(11-21 days) WITH ECONOMICALLY CHALLENGING PERFORMANCE WITH CC

00123 LONG-TERM MECHANICAL VENTILATION 23.9254 > 240 HOURS

(11-21 days) WITH ECONOMICALLY CHALLENGING PERFORMANCE WITH MCC

00131 LONG-TERM MECHANICAL VENTILATION 96 HOURS > 10.0294

(5-10 days) WITH ECONOMICALLY CHALLENGING PERFORMANCE WITHOUT CC

00132 LONG-TERM MECHANICAL VENTILATION 96 HOURS > 11.6454

(5-10 days) WITH ECONOMICALLY CHALLENGING PERFORMANCE WITH CC

00133 LONG-TERM MECHANICAL VENTILATION 96 HOURS > 15.3824

(5-10 days) WITH ECONOMICALLY CHALLENGING PERFORMANCE WITH MCC

00141 AUTOLOGOUS BONE MARROW TRANSPLANTATION without CC 3.8397

00142 AUTOLOGOUS BONE MARROW TRANSPLANTATION with CC 5.5645

00143 AUTOLOGOUS BONE MARROW TRANSPLANT with MCC 10.0940

00151 SEPARATION of BONE MARROW without CC 2.1958

00152 SEPARATION of BONE MARROW with CC 2.6818

00153 SEPARATION of BONE MARROW with MCC 2.6818

00161 EARLY REHABILITATION AFTER INJURY or DISEASE of the SPINAL CORD 14.1939

WITH ECONOMICALLY SERIOUS PERFORMANCE WITHOUT CC

00162 EARLY REHABILITATION AFTER INJURY or DISEASE of the SPINAL CORD 14.1939

WITH ECONOMICALLY SERIOUS PERFORMANCE WITH CC

00163 EARLY REHABILITATION AFTER INJURY or DISEASE of the SPINAL CORD 14.1939

WITH ECONOMICALLY SERIOUS PERFORMANCE ISSUES WITH MCC

00171 EARLY REHABILITATION AFTER INJURY or DISEASE of the SPINAL CORD 9.5187

WITHOUT CC

00172 EARLY REHABILITATION AFTER INJURY or DISEASE of the SPINAL CORD 9.5187

WITH CC

00173 EARLY REHABILITATION AFTER INJURY or DISEASE of the SPINAL CORD 9.5187

WITH MCC

01011 CRANIOTOMY without CC 3.7467

01012 CRANIOTOMY with CC 5.1674

01013 CRANIOTOMY with MCC 7.6718

01021 SPINAL PERFORMANCES without CC 2.5487

01022 SPINAL PERFORMANCES with CC 4.1580

01023 SPINAL PERFORMANCES with MCC 6.6736

01031 PERFORMANCES on EXTRACRANIAL ARTERIES without CC 2.4418

01032 PERFORMANCES on EXTRACRANIAL ARTERIES with CC 2.9308

01033 PERFORMANCES on EXTRACRANIAL ARTERIES with MCC 3.7121

01041 PERFORMANCES on the CRANIAL and PERIPHERAL NERVES without CC 0.3814

01042 PERFORMANCES on the CRANIAL and PERIPHERAL NERVES with CC 0.3814

01043 PERFORMANCES on the CRANIAL and PERIPHERAL NERVES with MCC0, 7168

01051 CARPAL TUNNEL RELEASE without CC 0.1779

01052 CARPAL TUNNEL RELEASE with CC 0.2013

01053 CARPAL TUNNEL RELEASE with MCC 0.2321

OTHER PERFORMANCES at 01061 diseases and DISORDERS of the NERVOUS 1.1220

SYSTEM WITHOUT CC

OTHER PERFORMANCES in 01062 diseases and DISORDERS of the NERVOUS 2.1426

SYSTEM WITH CC

01063 OTHER PERFORMANCES in diseases and DISORDERS of the NERVOUS 10.7525

SYSTEM WITH MCC

01301 DISORDERS and SPINAL CORD INJURIES without CC 0.6243

01302 DISORDERS and SPINAL CORD INJURIES with CC 0.9406

01303 DISORDERS and SPINAL CORD INJURIES with MCC 1.7955

01311 MALIGNANT DISEASE, SOME INFECTIONS and DEGENERATIVE 0.7903

NERVOUS SYSTEM DISORDERS WITHOUT CC

01312 MALIGNANT DISEASE, SOME INFECTIONS and DEGENERATIVE 0.8368

NERVOUS SYSTEM DISORDERS WITH CC

01313 MALIGNANT DISEASE, SOME INFECTIONS and DEGENERATIVE 1.1757

NERVOUS SYSTEM DISORDERS WITH MCC

01321 MULTIPLE SCLEROSIS and CEREBELLAR ATAXIA without CC 0.4185

01322 MULTIPLE SCLEROSIS and CEREBELLAR ATAXIA with CC 0.5468

01323 MULTIPLE SCLEROSIS and CEREBELLAR ATAXIA with MCC 0.7413

01331 NETRAUMATICKÉ INTRACRANIAL BLEEDING without CC 1.3518

01332 NETRAUMATICKÉ INTRACRANIAL HEMORRHAGE with CC 1.9419

01333 NETRAUMATICKÉ INTRACRANIAL HEMORRHAGE with MCC 3.1915

01341 STROKE with MYOCARDIAL FREE CC 0.8109

01342 STROKE with MYOCARDIAL with CC 1.0514

01343 STROKE with MYOCARDIAL with MCC 1.6322

01351 NON-SPECIFIC STROKE and PRECEREBRÁLNÍ 0.6548

OCCLUSION WITHOUT MYOCARDIAL WITHOUT CC

01352 NON-SPECIFIC STROKE and PRECEREBRÁLNÍ 0.7858

OCCLUSION WITHOUT MYOCARDIAL WITH CC

01353 NON-SPECIFIC STROKE and PRECEREBRÁLNÍ 1.1040

OCCLUSION WITHOUT MYOCARDIAL WITH MCC

01361 TRANSIENT ISCHEMIC ATTACKS without CC 0.4714

01362 TRANSIENT ISCHEMIC ATTACKS with CC 0.5461

01363 of TRANSIENT ISCHEMIC ATTACK with MCC 0.6632

01371 CRANIAL and PERIPHERAL NERVES DISORDERS without CC 0.5569

01372 CRANIAL and PERIPHERAL NERVES DISORDERS with CC 0.6547

01373 CRANIAL and PERIPHERAL NERVES DISORDERS with MCC 0.7254

01381 bacterial and TUBERCULOUS INFECTION of the NERVOUS SYSTEM 2.1980

WITHOUT CC

01382 bacterial and TUBERCULOUS INFECTION of the NERVOUS SYSTEM 2.8291

WITH CC

01383 bacterial and TUBERCULOUS INFECTION of the NERVOUS SYSTEM 6.0061

WITH MCC

01391 NEBAKTERIÁLNÍ INFECTION of the NERVOUS SYSTEM, in ADDITION to the 0.9240

VIRAL MENINGITIS WITHOUT CC

01392 NEBAKTERIÁLNÍ INFECTION of the NERVOUS SYSTEM, in ADDITION to the 1.5731

VIRAL MENINGITIS WITH CC

01393 NEBAKTERIÁLNÍ INFECTION of the NERVOUS SYSTEM, in ADDITION to the 3.7541

VIRAL MENINGITIS WITH MCC

01401 VIRAL MENINGITIS without CC 1.2198

01402 VIRAL MENINGITIS with CC 1.4668

01403 VIRAL MENINGITIS with MCC 2.3400

01411 NETRAUMATICKÁ DISORDER of consciousness and COMA without CC 0.5423

01412 NETRAUMATICKÁ DISORDER of consciousness and COMA with CC 0.9739

01413 NETRAUMATICKÁ DISORDER of consciousness and COMA with MCC 3.0077

01421 EPILEPTIC SEIZURES without CC 0.4581

01422 EPILEPTIC SEIZURE with CC 0.5780

01423 EPILEPTIC SEIZURE with MCC 1.0264

01431 MIGRAINE and other HEADACHES without CC 0.4197

01432 MIGRAINE and other HEADACHES with CC 0.5151

01433 MIGRAINE and other HEADACHES with MCC 0.5745

01441 CRANIAL and intracranial INJURIES without CC 0.8061

01442 CRANIAL and intracranial injury with CC 1.3170

01443 CRANIAL and intracranial INJURIES with MCC 4.1295

01451 CONCUSSION without CC 0.2424
01452 CONCUSSION with CC 0.2721

01453 CONCUSSION with MCC 0.4606

01461 OTHER NERVOUS SYSTEM DISORDERS without CC 0.4280

01462 OTHER NERVOUS SYSTEM DISORDERS with CC 0.5976

01463 OTHER NERVOUS SYSTEM DISORDERS with MCC 0.9010

02011 ENUKLEACE, and PERFORMANCES on the BUILDUP BEHIND the EYES without CC 0.8411

02012 ENUKLEACE and PERFORMANCES on the BUILDUP BEHIND the EYES with CC 1.1282

02013 ENUKLEACE and PERFORMANCES on the BUILDUP BEHIND the EYES with MCC 1.1282

EXTRAOKULÁRNÍ in ADDITION to the performances, 02021 EYECUP without CC 0.3273

EXTRAOKULÁRNÍ in ADDITION to the performances, 02022 EYECUP with CC 0.3866

EXTRAOKULÁRNÍ in ADDITION to the performances, 02023 EYECUP with MCC 0.4209

02031 INTRAOCULAR LENSES, EXCEPT without the CC 0.7944

02032 INTRAOCULAR LENSES, in ADDITION to PERFORMANCES with CC 0.8727

in ADDITION to the PERFORMANCES, 02033 INTRAOCULAR LENSES with MCC 0.8727

02041 PERFORMANCES on the LENS with or without VITREKTOMIE without-CC 0.3508

02042 the PERFORMANCES on the LENS with or without VITREKTOMIE with CC 0.3508

02043 PERFORMANCES on the LENS with or without VITREKTOMIE with MCC 0.3789

02301 ACUTE and serious INFECTION of the EYE without the CC 0.2767

ACUTE and SEVERE INFECTION 02302 eye with CC 0.3730

the ACUTE and serious 02303 EYE INFECTION with MCC 0.3730

02311 NEUROLOGICAL and VASCULAR DISORDERS of the EYE without the CC 0.4406

02312 NEUROLOGICAL and VASCULAR DISORDERS of the EYE with CC 0.4799

02313 NEUROLOGICAL and VASCULAR DISORDERS of the EYE with MCC 0.4799

OTHER DISORDERS of the EYE without 02321 CC 0.2643

OTHER DISORDERS of the eye with the 02322 CC 0.3109

OTHER DISORDERS of the EYE with 02323 MCC 0.3725

03011 GREAT PERFORMANCES on the LARYNX and TRACHEA without CC 2.6842

03012 GREAT PERFORMANCES on the LARYNX and TRACHEA with CC 5.5992

03013 GREAT PERFORMANCES on the LARYNX and TRACHEA with MCC 5.5992

03021 OTHER LARGE PERFORMANCES on his head and neck without CC 2.2384

03022 OTHER LARGE FEATS on the head and NECK with CC 3.3941

OTHER GREAT PERFORMANCES on 03023 HEAD and neck with MCC 4.8936

03031 PERFORMANCES on FACIAL BONES, in ADDITION to the LARGE 1.2343

PERFORMANCES ON THE HEAD AND NECK WITHOUT CC

03032 PERFORMANCES on FACIAL BONES, in ADDITION to the LARGE 1.2343

PERFORMANCES ON THE HEAD AND NECK WITH CC

03033 PERFORMANCES on FACIAL BONES, in ADDITION to the LARGE 3.5231

PERFORMANCES ON THE HEAD AND NECK WITH MCC

03041 PERFORMANCES on the MOUTH without CC 0.6290

03042 PERFORMANCES on MOUTH with CC 0.6681

03043 PERFORMANCES on MOUTH with MCC 1.1812

03051 PERFORMANCES on a the SINUSES and MASTOIDU without-CC 0.7930

03052 PERFORMANCES on a the SINUSES and MASTOIDU with CC 0.8532

03053 PERFORMANCES on the SINUSES and MASTOIDU with MCC 1.0249

03061 PERFORMANCES on SALIVARY GLAND without CC 0.7122

03062 PERFORMANCES on SALIVARY GLAND with CC 0.8531

03063 PERFORMANCES on SALIVARY GLAND with MCC 1.1991

03071 AXLE of cleft lip and PALATE without CC 1.1499

03072 AXLE of cleft lip and PALATE with CC 1.1499

03073 AXLE of cleft lip and PALATE with MCC 1.1499

03081 PERFORMANCES on the neck and NOSE TONSILS without CC 0.3527

03082 PERFORMANCES on the CERVICAL and NASAL ALMONDS with CC 0.4480

03083 PERFORMANCES on the CERVICAL and NASAL ALMONDS with MCC 0.7265

03091 OTHER PERFORMANCES with FAULTS and DISEASES of ears, nose, 0.3109

MOUTH AND THROAT WITHOUT CC

03092 OTHER PERFORMANCES with FAULTS and DISEASES of ears, nose, 0.4757

MOUTH AND THROAT WITH CC

03093 OTHER PERFORMANCES with FAULTS and DISEASES of ears, nose, 0.6052

MOUTH AND THROAT WITH MCC

03100 COCHLEAR IMPLANT 26.6665

03301 MALIGNANT DISEASE of the EAR, nose, mouth, and NECK without the CC0, 8985

03302 MALIGNANT DISEASE of the EAR, nose, mouth and throat with CC 0.8985

03303 MALIGNANT DISEASE of the EAR, nose, mouth and throat with MCC 1.2731

03311 BALANCE DISORDERS without CC 0.4264

03312 DISORDERS balance with CC 0.4985

BALANCE DISORDERS with MCC 03313 0.5455

03321 EPISTAXIS without CC 0.2494

03322 EPISTAXIS with CC 0.3032

03323 EPISTAXIS with MCC 0.4016

03331 EPIGLOTTITIS, OTITIS MEDIA, INFECTION of the UPPER 0.3142

RESPIRATORY, LARYNGOTRACHEITIS WITHOUT CC

03332 EPIGLOTTITIS, OTITIS MEDIA, INFECTION of the UPPER 0.4341

RESPIRATORY, LARYNGOTRACHEITIS WITH CC

03333 EPIGLOTTITIS, OTITIS MEDIA, INFECTION of the UPPER 0.5872

RESPIRATORY, LARYNGOTRACHEITIS WITH MCC

DISEASES of the TEETH and mouth 03341 without CC 0.4970

03342 DISEASES of the TEETH and mouth with CC 0.5843

DISEASES of the TEETH and mouth 03343 with MCC 0.8715

03351, OTHER DISORDERS of the ears, nose, mouth and throat without CC 0.3150

03352 OTHER DISORDERS of the ears, nose, mouth and throat with CC 0.4109

OTHER DISORDERS 03353 ears, nose, mouth and throat with MCC 0.5869

04011 LARGE THORACIC PERFORMANCES without CC 3.0043

04012 LARGE CHEST with CC 3.6247

04013 BIG CHEST with MCC 5.1696

04021 SMALLER CHEST PERFORMANCES without CC 2.3662

04022 SMALLER CHEST with CC 2.5022

04023 SMALLER CHEST with MCC 3.6202

04031 OTHER PERFORMANCES of the DISORDERS and ILLNESSES of the RESPIRATORY 1.0769

SYSTEM WITHOUT CC

04032 OTHER PERFORMANCES of the DISORDERS and ILLNESSES of the RESPIRATORY 1.6480

SYSTEM WITH CC

04033 OTHER PERFORMANCES in DISORDERS and DISEASES of the RESPIRATORY 3.6314

SYSTEM WITH MCC

04301 CYSTIC FIBROSIS without CC 2.3175

04302 CYSTIC FIBROSIS with CC 2.3175

04303 CYSTIC FIBROSIS with MCC 3.3069

04310 RESPIRATORY FAILURE 3.6205

04321 PULMONARY EMBOLISM without CC 1.0492

04322 PULMONARY EMBOLISM with CC 1.1577

04323 PULMONARY EMBOLISM with MCC 1.3548

04331 SEVERE TRAUMA to the CHEST without CC 0.4256

04332 SERIOUS TRAUMA to the CHEST with CC 0.7614

SEVERE CHEST TRAUMA 04333 with MCC 1.3671

04341 MALIGNANT DISEASE of the RESPIRATORY SYSTEM without CC 0.7966

04342 MALIGNANT DISEASE of the RESPIRATORY SYSTEM with CC 0.8944

04343 MALIGNANT DISEASE of the RESPIRATORY SYSTEM with MCC 1.1011

04351 RESPIRATORY SYSTEM infection and inflammation without CC 1.1119

04352 RESPIRATORY SYSTEM infection and inflammation with CC 1.5364

04353 RESPIRATORY SYSTEM infection and inflammation with MCC 3.5769

04361 SIMPLE PNEUMONIA and WHOOPING COUGH without CC 0.7099

04362 SIMPLE PNEUMONIA and whooping cough with CC 0.9272

04363 SIMPLE PNEUMONIA and whooping cough with MCC 1.4439

04371 CHRONIC OBSTRUCTIVE PULMONARY DISEASE without CC 0.5838

04372 CHRONIC OBSTRUCTIVE PULMONARY DISEASE with CC 0.7056

04373 CHRONIC OBSTRUCTIVE PULMONARY DISEASE with MCC 0.9500

04381 of BRONCHIOLITIS asthma and NO CC 0.4432

04382 ASTHMA and of BRONCHIOLITIS with CC 0.6053

04383 ASTHMA and of BRONCHIOLITIS with MCC 0.7786

04391 INTERSTITIAL LUNG DISEASE without CC 0.7743

04392 INTERSTITIAL LUNG DISEASE with CC 0.8131

04393 INTERSTITIAL LUNG DISEASE with MCC 1.1161

04401 PNEUMOTHORAX and PLEURÁNÍ EFFUSION without CC 0.8762

04402 PNEUMOTHORAX and PLEURÁNÍ EFFUSION with CC 1.1091

04403 PNEUMOTHORAX and PLEURÁNÍ EFFUSION with MCC 1.5130

04411 signs, symptoms and DIAGNOSES of OTHER RESPIRATORY SYSTEM 0.4586

WITHOUT CC

04412 signs, symptoms and DIAGNOSES of OTHER RESPIRATORY SYSTEM 0.6555

WITH CC

04413 signs, symptoms and DIAGNOSES of OTHER RESPIRATORY SYSTEM 0.8804

WITH MCC

05000 DEATHS within 5 days FROM RECEIPT when the MAIN DIAGNOSIS 0.6306

THE CIRCULATORY SYSTEM

05011 HEART DEFIBRILLATOR and IMPLANT for 45.4085 SUPPORT

THE HEART WITHOUT CC

05012 CARDIAC DEFIBRILLATOR and IMPLANT for 45.4085 SUPPORT

HEART WITH CC

05013 CARDIAC DEFIBRILLATOR and IMPLANT for 48.1928 SUPPORT

HEART WITH MCC

05021 PERFORMANCES at the HEART the HEART is LEFT SYLVIAN FISSURE 15.9076 FLAP

WITHOUT CC

05022 PERFORMANCES on the HEART, the HEART LEFT SYLVIAN FISSURE FLAP with CC 16.8148

05023 PERFORMANCES at the HEART the HEART is LEFT SYLVIAN FISSURE 20.1459 FLAP

WITH MCC

the OPERATION and PROCEDURES for 05031 CONGENITAL HEART DEFECTS without CC 9.7968

05032 operations and INTERVENTIONS for CONGENITAL HEART DEFECTS with CC 9.7968

05033 operations and INTERVENTIONS for CONGENITAL HEART DEFECTS with MCC 9.7968

05041 PERFORMANCES on the FLAP without CARDIAC CATHETERIZATION HEART 11.5768

WITHOUT CC

05042 PERFORMANCES on the FLAP without CARDIAC CATHETERIZATION HEART 12.1642

WITH CC

05043 PERFORMANCES on the FLAP without CARDIAC CATHETERIZATION HEART 16.3775

WITH MCC

05051 CORONARY BYPASS SURGERY with HEART LEFT SYLVIAN FISSURE without CC 9.5838

05052 CORONARY BYPASS SURGERY with HEART LEFT SYLVIAN FISSURE with CC 9.5838

05053 CORONARY BYPASS SURGERY with HEART LEFT SYLVIAN FISSURE with MCC 11.0004

05061 CORONARY BYPASS SURGERY without CARDIAC CATHETERIZATION without CC 7.5139

05062 CORONARY BYPASS SURGERY without CARDIAC CATHETERIZATION with CC 7.9754

05063 CORONARY BYPASS SURGERY without CARDIAC CATHETERIZATION with MCC 8.8554

IMPLANTATION of PERMANENT PACEMAKER 05070 for ACUTE 10.1994

MYOCARDIAL INFARCTION, HEART FAILURE OR SHOCK

OTHER PERFORMANCES of the CARDIOTHORACIC 05081 without CC 5.8189

05082 OTHER CARDIOTHORACIC PERFORMANCES with CC 5.8189
05083 OTHER CARDIOTHORACIC PERFORMANCES with MCC 5.8189

05091 LARGE ABDOMINAL VASCULAR PERFORMANCE without CC 4.8006

05092 LARGE ABDOMINAL VASCULAR PERFORMANCE with CC 7.5126

05093 LARGE ABDOMINAL VASCULAR PERFORMANCE with MCC 9.1483

05101 OTHER PERCUTANEOUS CARDIOVASCULAR PERFORMANCE DURING ACUTE 4.8038

MYOCARDIAL INFARCTION WITHOUT CC

05102 OTHER PERCUTANEOUS CARDIOVASCULAR PERFORMANCE DURING ACUTE 4.8038

MYOCARDIAL INFARCTION WITH CC

05103 OTHER PERCUTANEOUS CARDIOVASCULAR PERFORMANCE DURING ACUTE 6.2605

MYOCARDIAL INFARCTION WITH MCC

IMPLANTATION of PERMANENT PACEMAKER 05111 without ACUTE 5.6161

MYOCARDIAL INFARCTION, SHOCK, HEART FAILURES OR WITHOUT CC

IMPLANTATION of PERMANENT PACEMAKER 05112 without ACUTE 5.6161

MYOCARDIAL INFARCTION, HEART FAILURE OR SHOCK WITH CC

05113 IMPLANTATION of PERMANENT PACEMAKER without the ACUTE 6.0902

MYOCARDIAL INFARCTION, HEART FAILURE OR SHOCK WITH MCC

THORACIC VASCULAR 05121 GREAT PERFORMANCES without CC 8.6872

THORACIC VASCULAR 05122 GREAT PERFORMANCES with CC 11.8339

05123 LARGE THORACIC VASCULAR PERFORMANCE with MCC 14.6945

05131 OTHER PERCUTANEOUS CARDIOVASCULAR PERFORMANCE without ACUTE 4.5080

MYOCARDIAL INFARCTION WITHOUT CC

05132 OTHER PERCUTANEOUS CARDIOVASCULAR PERFORMANCE without ACUTE 4.5080

MYOCARDIAL INFARCTION WITH CC

05133 OTHER PERCUTANEOUS CARDIOVASCULAR PERFORMANCE without ACUTE 4.9639

MYOCARDIAL INFARCTION WITH MCC

OTHER VASCULAR 05141 PERFORMANCES without CC 2.7619

OTHER VASCULAR 05142 PERFORMANCES with Ccna, 2007

05143 OTHER VASCULAR PERFORMANCE with MCC 4.4143

DUE to the FAILURE of 05151 AMPUTATION of the CIRCULATORY SYSTEM, in ADDITION to the 1.9141

THE UPPER LIMBS AND FINGERS WITH LEGS WITHOUT CC

05152 AMPUTATION DUE to FAILURE of the CIRCULATORY SYSTEM, in ADDITION to the 2.5869

THE UPPER LIMBS AND FINGERS AT THE FOOT WITH CC

DUE to the FAILURE of 05153 AMPUTATION of the CIRCULATORY SYSTEM, in ADDITION to the 4.2702

THE UPPER LIMBS AND FINGERS AT THE FOOT WITH MCC

PACEMAKER REPLACEMENT without CC 05161 4.2723

05162 PACEMAKER REPLACEMENT with CC 4.2723

PACEMAKER REPLACEMENT with MCC 05163 4.2723

05171 AMPUTATION of UPPER LIMBS and the FINGER for the DISORDER at the foot of 1.1112

THE CIRCULATORY SYSTEM WITHOUT CC

05172 AMPUTATION of the UPPER LIMB and TOE with FEET for FAILURE 1.5340

THE CIRCULATORY SYSTEM WITH THE CC

05173 AMPUTATION of UPPER LIMBS and the FINGER for the DISORDER at the foot of 3.2858

THE CIRCULATORY SYSTEM WITH MCC

PACEMAKER and DEFIBRILLATOR 05181 CHECK, in ADDITION to the 1.2104

EXCHANGE OF THE DEVICE WITHOUT CC

PACEMAKER and DEFIBRILLATOR 05182 CHECK, in ADDITION to the 1.2104

EXCHANGE OF THE DEVICE WITH THE CC

PACEMAKER and DEFIBRILLATOR 05183 CHECK, in ADDITION to the 1.2104

EXCHANGE OF THE DEVICE WITH THE MCC

05191 LIGATURE and STRIPPING the VESSELS without CC 0.3491

05192 LIGATURE and STRIPPING the VESSELS with CC 0.3754

05193 LIGATURE and STRIPPING the VESSELS with MCC 0.4273

05201 OTHER PERFORMANCES in diseases and DISORDERS of the CIRCULATORY 1.1961

SYSTEM WITHOUT CC

05202 OTHER PERFORMANCES in diseases and DISORDERS of the CIRCULATORY 1.7656

SYSTEM WITH CC

05203 OTHER FEATS when diseases and DISORDERS of the CIRCULATORY 7.6836

SYSTEM WITH MCC

05221 PERCUTANEOUS CORONARY ANGIOPLASTY, > = 3 COATED 16.5466

STENTS IN ACUTE MYOCARDIAL INFARCTION WITHOUT CC

05222 PERCUTANEOUS CORONARY ANGIOPLASTY, > = 3 COATED 16.5466

STENTS IN ACUTE MYOCARDIAL INFARCTION WITH CC

05223 PERCUTANEOUS CORONARY ANGIOPLASTY, > = 3 COATED 16.5466

STENTS IN ACUTE MYOCARDIAL INFARCTION WITH MCC

PERCUTANEOUS CORONARY angioplasty, 05231 < = 2 COATED 7.1902

STENTS IN ACUTE MYOCARDIAL INFARCTION WITHOUT CC

05232 PERCUTANEOUS CORONARY angioplasty, COATED 8.3739 < = 2

STENTS IN ACUTE MYOCARDIAL INFARCTION WITH CC

05233 PERCUTANEOUS CORONARY ANGIOPLASTY, COATED 10.0806 < = 2

STENTS IN ACUTE MYOCARDIAL INFARCTION WITH MCC

05241 PERCUTANEOUS CORONARY angioplasty, STENTS when > = 3 9.3031

ACUTE MYOCARDIAL INFARCTION WITHOUT CC

05242 PERCUTANEOUS CORONARY ANGIOPLASTY, STENTS when > = 3 10.3474

ACUTE MYOCARDIAL INFARCTION WITH CC

05243 PERCUTANEOUS CORONARY ANGIOPLASTY, STENTS when > = 3 13.0239

ACUTE MYOCARDIAL INFARCTION WITH MCC

PERCUTANEOUS CORONARY angioplasty, 05261 > = 3 COATED 12.7973

STENTS WITHOUT ACUTE MYOCARDIAL INFARCTION WITHOUT CC

PERCUTANEOUS CORONARY angioplasty, 05262 > = 3 COATED 13.4586

STENTS WITHOUT ACUTE MYOCARDIAL INFARCTION WITH CC

05263 PERCUTANEOUS CORONARY ANGIOPLASTY, > = 3 COATED 13.4586

STENTS WITHOUT ACUTE MYOCARDIAL INFARCTION WITH MCC

05271 PERCUTANEOUS CORONARY ANGIOPLASTY, COATED 6.1329 < = 2

STENTS WITHOUT ACUTE MYOCARDIAL INFARCTION WITHOUT CC

05272 PERCUTANEOUS CORONARY ANGIOPLASTY, COATED 6.7609 < = 2

STENTS WITHOUT ACUTE MYOCARDIAL INFARCTION WITH CC

05273 PERCUTANEOUS CORONARY ANGIOPLASTY, COATED 7.3592 < = 2

STENTS WITHOUT ACUTE MYOCARDIAL INFARCTION WITH MCC

05281 PERCUTANEOUS CORONARY ANGIOPLASTY, > = 3 COATED 8.6966

STENTS WITHOUT ACUTE MYOCARDIAL INFARCTION WITHOUT CC

05282 PERCUTANEOUS CORONARY ANGIOPLASTY, > = 3 COATED 9.3463

STENTS WITHOUT ACUTE MYOCARDIAL INFARCTION WITH CC

05283 PERCUTANEOUS CORONARY ANGIOPLASTY, > = 3 COATED 11.2260

STENTS WITHOUT ACUTE MYOCARDIAL INFARCTION WITH MCC

05291 PERCUTANEOUS CATHETER ABLATION without ACUTE MYOCARDIAL 9.8480

INFARCTION WITHOUT CC

05292 PERCUTANEOUS CATHETER ABLATION without ACUTE MYOCARDIAL 9.8480

INFARCTION WITH CC

05293 PERCUTANEOUS CATHETER ABLATION without ACUTE MYOCARDIAL 9.8480

INFARCTION WITH MCC

05301 CARDIAC CATHETERIZATION for ACUTE MYOCARDIAL INFARCTION 1.0793

WITHOUT CC

05302 CARDIAC CATHETERIZATION in ACUTE MYOCARDIAL INFARCTION 1.2848

WITH CC

05303 CARDIAC CATHETERIZATION in ACUTE MYOCARDIAL INFARCTION 1.8551

WITH MCC

05311 CARDIAC CATHETERIZATION in the ISCHEMIC HEART 0.6336

WITHOUT CC

05312 CARDIAC CATHETERIZATION in the ISCHEMIC HEART 0.7368

WITH CC

05313 CARDIAC CATHETERIZATION in the ISCHEMIC HEART 0.8109

WITH MCC

05321 CARDIAC CATHETERIZATION when OTHER CIRCULATORY DISORDERS 0.9148

SYSTEM WITHOUT CC

05322 CARDIAC CATHETERIZATION when OTHER CIRCULATORY DISORDERS 1.1069

SYSTEM WITH CC

05323 CARDIAC CATHETERIZATION when OTHER CIRCULATORY DISORDERS 1.7496

SYSTEM WITH MCC

05331 ACUTE MYOCARDIAL INFARCTION without CC 0.6210

05332 ACUTE MYOCARDIAL INFARCTION with CC 0.9813

05333 ACUTE MYOCARDIAL INFARCTION with MCC 1.6296

05341 ACUTE and subacute ENDOCARDITIS without CC 2.8754

the acute and subacute ENDOCARDITIS 05342 with CC 2.8754

the acute and subacute ENDOCARDITIS 05343 with MCC 5.0252

05351 HEART FAILURE without CC 0.7217

05352 HEART FAILURE with CC 0.8228

05353 HEART FAILURE with MCC 1.2758

05361 DEEP VEIN THROMBOSIS without CC 0.5085

05362 DEEP VENOUS THROMBOSIS with CC 0.5914

05363 DEEP VENOUS THROMBOSIS with MCC 0.7207

05371 UNEXPLAINED CARDIAC ARREST without CC 1.6398

05372 UNEXPLAINED CARDIAC ARREST with CC 2.8617

05373 UNEXPLAINED CARDIAC ARREST with MCC 5.5209

05381 PERIPHERAL and other VASCULAR DISORDERS without CC 0.5162

05382 PERIPHERAL and other VASCULAR DISORDERS with CC 0.6766

05383 PERIPHERAL and other VASCULAR DISORDERS with MCC 0.9008

05391 ATHEROSCLEROSIS without CC 0.4390

05392 ATHEROSCLEROSIS with CC 0.6042

05393 ATHEROSCLEROSIS with MCC 0.9448

05401 HYPERTENSION without CC 0.3958

05402 HYPERTENSION with CC 0.4661

05403 HYPERTENSION with MCC 0.5487

05411 CONGENITAL HEART and VALVULAR DISORDERS without CC 0.4393

05412 VALVULAR and CONGENITAL HEART DISORDERS with CC 0.6861

05413 CONGENITAL HEART and VALVULAR DISORDERS with MCC 1.3525

05421 CARDIAC ARRHYTHMIAS and CONDUCTION DISORDERS without CC 0.4848

CARDIAC ARRHYTHMIA DISORDERS 05422 and LEADERSHIP with CC 0.6758

05423 CARDIAC ARRHYTHMIAS and CONDUCTION DISORDERS with MCC 0.9481

05431 ANGINA and CHEST PAIN without CC 0.3942

05432 ANGINA and CHEST PAIN with CC 0.5235

05433 ANGINA and CHEST PAIN with MCC 0.6257

05441 syncope and COLLAPSE without CC 0.3990

05442 syncope and COLLAPSE with CC 0.5492

05443 syncope and COLLAPSE with MCC 0.6951

05451 CARDIOMYOPATHY without CC 0.5156

05452 CARDIOMYOPATHY with CC 0.6799

05453 CARDIOMYOPATHY with MCC 1.2738

05461 FAILURES, reactions and complications of the HEART or 1.4503

VASCULAR INSTRUMENTS OR PERFORMANCE WITHOUT CC

05462 failures, reactions and complications of the HEART or 1.4503

VASCULAR INSTRUMENTS OR PERFORMANCE WITH CC

05463 failures, reactions and complications of the HEART or 1.4503

VASCULAR INSTRUMENTS OR PERFORMANCE WITH MCC

OTHER DISORDERS of the CIRCULATORY SYSTEM 05471 without CC 0.4836

OTHER DISORDERS of the CIRCULATORY SYSTEM 05472 with CC 0.6688

05473 OTHER DISORDERS of CIRCULATORY SYSTEM with MCC 0.9744

06011 LARGE PERFORMANCES on THICK and THIN STŘEVU without-CC 3.3212

GREAT PERFORMANCE on FAT 06012 and THIN STŘEVU with CC 3.9606
GREAT PERFORMANCE on FAT 06013 and THIN STŘEVU with MCC 5.9249

06021 GREAT PERFORMANCES on the STOMACH, ESOPHAGUS and duodenum without CC 3.1468

06022 GREAT PERFORMANCES on the STOMACH, ESOPHAGUS and duodenum with CC 4.3838

06023 GREAT PERFORMANCES on the STOMACH, ESOPHAGUS and duodenum with MCC 5.5431

06031 LESS PERFORMANCE on FAT and THIN STŘEVU without-CC 1.5396

06032 LESS PERFORMANCE on FAT and THIN STŘEVU with CC 2.2202

06033 LESS PERFORMANCES on the FAT and THIN STŘEVU with MCC 4.3199

06041 RELEASE SRŮSTŮ PERITONITIS without CC 0.9200

06042 SRŮSTŮ RELEASING the PERITONEUM with CC 1.2993

06043 RELEASE SRŮSTŮ the PERITONEUM with MCC 2.0945

06051 PERFORMANCES on APENDIX without CC 0.7566

06052 PERFORMANCES on APENDIX with CC 0.9897

06053 PERFORMANCES on the APENDIX with MCC 1.6828

06061 LAPAROSCOPIC PERFORMANCE in INGUINAL, Femoral, 0.9838

EPIGASTRIC OR UMBILICAL KÝLE WITHOUT-CC

06062 LAPAROSCOPIC PERFORMANCE in INGUINAL, Femoral, 1.1019

EPIGASTRIC OR UMBILICAL KÝLE WITH CC

06063 LAPAROSCOPIC PERFORMANCE in INGUINAL, Femoral, 1.1827

EPIGASTRIC OR UMBILICAL KÝLE WITH MCC

06071 LESS PERFORMANCES on the STOMACH, ESOPHAGUS and duodenum without CC 1.6817

06072 LESS PERFORMANCES on the STOMACH, ESOPHAGUS and duodenum with CC 1.9418

06073 SMALLER PERFORMANCES on the STOMACH, ESOPHAGUS and duodenum with MCC 3.3884

LAPAROTOMICKÉ PERFORMANCES when 06081 INGUINAL, Femoral, 0.4694

EPIGASTRIC OR UMBILICAL KÝLE WITHOUT-CC

06082 LAPAROTOMICKÉ PERFORMANCES in the INGUINAL, Femoral, 0.6714

EPIGASTRIC OR UMBILICAL KÝLE WITH CC

LAPAROTOMICKÉ PERFORMANCES when 06083 INGUINAL, Femoral, 1.0373

EPIGASTRIC OR UMBILICAL KÝLE WITH MCC

06091 ANAL and OSTOMY PERFORMANCES without CC 0.4365

06092 ANAL and OSTOMY PERFORMANCES with CC 0.5594

06093 ANAL and OSTOMY PERFORMANCES with MCC 0.7146

06101 OTHER PERFORMANCES with FAULTS and DISEASES of the DIGESTIVE 0.8888

SYSTEM WITHOUT CC

06102 OTHER PERFORMANCES with FAULTS and DISEASES of the DIGESTIVE 1.5677

SYSTEM WITH CC

06103 OTHER PERFORMANCES with FAULTS and DISEASES of the DIGESTIVE 3.5777

SYSTEM WITH MCC

06111 PERFORMANCES on the MAIN DIAGNOSIS in APENDIX COMPLICATING 1.1399

WITHOUT CC

06112 PERFORMANCES on the MAIN DIAGNOSIS in APENDIX COMPLICATING 1.8360

WITH CC

06113 PERFORMANCES on the MAIN DIAGNOSIS in APENDIX COMPLICATING 2.1950

WITH MCC

06301 MALIGNANT DISEASE DIGESTIVE SYSTEM without CC 0.5607

06302 MALIGNANT DISEASE DIGESTIVE SYSTEM with CC 0.8424

06303 MALIGNANT DISEASES of the DIGESTIVE SYSTEM with MCC 1.0620

06311 PEPTIC ULCER and GASTRITIS without CC 0.4680

06312 PEPTIC ULCER and GASTRITIS with CC 0.7827

06313 PEPTIC ULCER and GASTRITIS with MCC 1.2081

06321 ESOPHAGEAL DISORDERS without CC 0.4208

ESOPHAGEAL DISORDERS 06322 with CC 0.6186

06323 ESOPHAGEAL DISORDERS with MCC 1.0354

06331 DIVERTICULITIS, DIVERTICULOSIS and INFLAMMATORY DISEASE 0.5033

THE INTESTINE WITHOUT CC

06332 DIVERTICULITIS, DIVERTICULOSIS and INFLAMMATORY DISEASE 0.6548

THE INTESTINES WITH CC

06333 DIVERTICULITIS, DIVERTICULOSIS and INFLAMMATORY DISEASE 1.4263

THE INTESTINES WITH MCC

06341 VASCULAR INSUFFICIENCY, GASTROINTESTINAL SYSTEM 0.4009

WITHOUT CC

06342 VASCULAR INSUFFICIENCY, GASTROINTESTINAL SYSTEM 1.0397

WITH CC

06343 VASCULAR INSUFFICIENCY, GASTROINTESTINAL SYSTEM 1.0397

WITH MCC

06351 OBSTRUCTION of the GASTROINTESTINAL SYSTEM without CC 0.4254

OBSTRUCTION of the GASTROINTESTINAL SYSTEM 06352 with CC 0.6122

06353 OBSTRUCTION of the GASTROINTESTINAL SYSTEM with MCC 1.3090

SERIOUS INFECTIONS of the GASTROINTESTINAL SYSTEM 06361 without CC 1.2204

SERIOUS INFECTIONS of the GASTROINTESTINAL SYSTEM 06362 with CC 1.2204

SERIOUS INFECTIONS of the GASTROINTESTINAL SYSTEM 06363 with MCC 2.5359

06371 OTHER GASTROENTERITIS and ABDOMINAL PAIN without CC 0.2834

06372 OTHER GASTROENTERITIS and ABDOMINAL PAIN with CC 0.4209

06373 OTHER GASTROENTERITIS and ABDOMINAL PAIN with MCC 0.5866

OTHER DISORDERS of the DIGESTIVE SYSTEM 06381 without CC 0.3230

06382 OTHER DISORDERS of the DIGESTIVE SYSTEM with CC 0.5048

06383 OTHER DISORDERS of the DIGESTIVE SYSTEM with MCC 0.7735

07011 PERFORMANCES on the PANCREAS, liver and JOINTS without CC 3.3976

07012 PERFORMANCES on the PANCREAS, liver and JOINTS with CC 4.7627

07013 PERFORMANCES on the PANCREAS, liver and JOINTS with MCC 7.6174

07021 GREAT PERFORMANCES on the BILIARY without CC 3.1826

07022 GREAT PERFORMANCES on the BILIARY with CC 3.4352

07023 GREAT PERFORMANCES on the BILIARY with MCC 4.9767

07031 CHOLECYSTECTOMY, LAPAROSCOPIC 1.2600 in ADDITION without CC

07032 CHOLECYSTECTOMY, LAPAROSCOPIC 1.8644 in ADDITION with CC

in ADDITION to LAPAROSCOPIC CHOLECYSTECTOMY, 07033 with MCC 3.1713

07041 LAPAROSCOPIC CHOLECYSTECTOMY without CC 1.0821

07042 LAPAROSCOPIC CHOLECYSTECTOMY with CC 1.2702

07043 LAPAROSCOPIC CHOLECYSTECTOMY with MCC 1.5914

07051 OTHER PERFORMANCES of the DISORDERS and DISEASES 1.4287

HEPATOBILIÁRNÍHO SYSTEM AND PANCREAS WITHOUT CC

07052 OTHER PERFORMANCES of the DISORDERS and DISEASES 2.2708

HEPATOBILIÁRNÍHO SYSTEM AND PANCREAS WITH CC

07053 OTHER PERFORMANCES of the DISORDERS and DISEASES 4.4339

HEPATOBILIÁRNÍHO SYSTEM AND PANCREAS WITH MCC

an ALCOHOLIC HEPATITIS and CIRRHOSIS 07301 without CC 0.7262

07302 CIRRHOSIS and an ALCOHOLIC HEPATITIS with CC 0.8315

07303 CIRRHOSIS and an ALCOHOLIC HEPATITIS with MCC 1.2718

07311 MALIGNANT DISEASE HEPATOBILIÁRNÍHO SYSTEM 0.6824

AND PANCREATIC CANCER WITHOUT CC

07312 HEPATOBILIÁRNÍHO SYSTEM 0.9454 MALIGNANT DISEASE

AND PANCREAS WITH CC

07313 MALIGNANT DISEASE HEPATOBILIÁRNÍHO SYSTEM 1.0225

AND PANCREAS WITH MCC

07321 PANCREATIC DISORDERS, in ADDITION to the MALIGNANT DISEASE without CC 0.7740

07322 PANCREATIC DISORDERS, in ADDITION to the MALIGNANT disease with CC 1.0917

07323 PANCREATIC DISORDERS, in ADDITION to the MALIGNANT disease with MCC 2.4184

07331 LIVER DISORDERS, in ADDITION to ALCOHOLIC CIRRHOSIS and MALIGNANT 0.4428

HEPATITIS WITHOUT CC

07332 LIVER DISORDERS, in ADDITION to ALCOHOLIC CIRRHOSIS and MALIGNANT 0.7291

HEPATITIS WITH CC

07333 LIVER DISORDERS, in ADDITION to ALCOHOLIC CIRRHOSIS and MALIGNANT 1.0786

HEPATITIS WITH MCC

OTHER DISORDERS of the BILIARY TRACT 07341 without CC 0.5266

OTHER DISORDERS of the BILIARY TRACT 07342 with CC 0.7564

07343 OTHER DISORDERS of the BILE DUCTS with MCC 1.0783

the FUSION of the SPINE when 08011 DEFORMITÁCH and SCOLIOSIS without CC 17.7636

08012 FUSION of SPINE in SCOLIOSIS with DEFORMITÁCH and CC 17.7636

the FUSION of the SPINE when 08013 DEFORMITÁCH and SCOLIOSIS with MCC 17.7636

08021 BILATERAL and multiple GREAT PERFORMANCES on the JOINTS 3.7491

LOWER EXTREMITIES WITHOUT CC

08022 BILATERAL and multiple GREAT PERFORMANCES on the JOINTS 3.7491

THE LOWER LIMBS WITH CC

08023 BILATERAL and multiple GREAT PERFORMANCES on the JOINTS 3.7491

LOWER EXTREMITY WITH MCC

08031 FUSION of SPINE, not for the DEFORMITY without CC 5.2310

08032 FUSION of the SPINE, NOT for DEFORMITY with CC 5.9789

08033 FUSION of the SPINE, NOT for DEFORMITY with MCC 7.5760

GREAT PERFORMANCES 08041 REPLANTACE lower limbs and THEIR 3.3718

THE JOINTS WITHOUT CC

GREAT PERFORMANCES 08042 REPLANTACE lower limbs and THEIR 3.3718

JOINTS WITH CC

GREAT PERFORMANCES REPLANTACE 08043 lower limbs and THEIR 3.7804

JOINTS WITH MCC

08051 RECONSTRUCTIVE FACIAL and CRANIAL 5.1408 PERFORMANCE

BONES WITHOUT CC

08052 CRANIAL and FACIAL RECONSTRUCTION PERFORMANCE 5.1408

BONES WITH CC

08053 CRANIAL and FACIAL RECONSTRUCTION PERFORMANCE 5.1408

BONES WITH MCC

08061 BIG PERFORMANCES REPLANTACE the UPPER LIMBS and their 3.1763

THE JOINTS WITHOUT CC

08062 LARGE PERFORMANCES REPLANTACE the UPPER LIMBS and their 3.1763

JOINTS WITH CC

GREAT PERFORMANCES 08063 REPLANTACE UPPER EXTREMITIES and their 3.1763

JOINTS WITH MCC

08071 AMPUTATION DISORDERS MUSCULOSKELETAL SYSTEM 2.1776

AND CONNECTIVE TISSUE WITHOUT CC

08072 AMPUTATION DISORDERS MUSCULOSKELETAL SYSTEM 2.2938

AND CONNECTIVE TISSUE WITH CC

08073 AMPUTATION DISORDERS MUSCULOSKELETAL SYSTEM 2.2938

AND CONNECTIVE TISSUE WITH MCC

08081 PERFORMANCES on the HIPS and thigh BONES, in ADDITION REPLANTACE 2.0973

THE LARGE JOINTS WITHOUT CC

08082 PERFORMANCES on the HIPS and thigh BONES, in ADDITION REPLANTACE 2.4736

THE LARGE JOINTS WITH CC

08083 PERFORMANCES on the HIPS and THIGH BONES, in ADDITION REPLANTACE 3.2418

THE LARGE JOINTS WITH MCC

08091 SKIN GRAFTING or TISSUE DISORDERS 0.6728

THE MUSCULOSKELETAL SYSTEM OR CONNECTIVE

IN ADDITION TO THE TISSUES WITHOUT CC

08092 SKIN GRAFTING or TISSUE DISORDERS 2.2018

THE MUSCULOSKELETAL SYSTEM OR CONNECTIVE

TISSUE IN ADDITION TO HAND WITH CC

08093 SKIN GRAFTING or TISSUE DISORDERS 3.4085

THE MUSCULOSKELETAL SYSTEM OR CONNECTIVE

TISSUE IN ADDITION TO HAND WITH MCC

08101 PERFORMANCES on HIS BACK and neck, in ADDITION to the FUSION of the SPINE without CC 1.2288
08102 PERFORMANCES on HIS BACK and neck, in ADDITION to the FUSION of the SPINE with CC 1.7562

08103 PERFORMANCES on HIS BACK and neck, in ADDITION to the FUSION of the SPINE with MCC 2.3104

08111 PERFORMANCES on the KNEE, LOWER LEG and HAS, in addition to the FEET of the 0.6440

WITHOUT CC

08112 PERFORMANCES on the KNEE, LOWER LEG and HAS, in addition to the FEET of the 0.8283

WITH CC

08113 PERFORMANCES on the KNEE, LOWER LEG and HAS, in addition to the FEET of the 1.2059

WITH MCC

08121 CUT INTERNAL FIXATION DEVICE without CC 0.2950

REMOVAL of INTERNAL FIXATION DEVICES 08122 with CC 0.3239

REMOVAL of INTERNAL FIXATION DEVICES 08123 with MCC 0.4559

08131 LOCAL RESECTION on the MUSCULOSKELETAL SYSTEM without CC 0.5559

08132 LOCAL RESECTION on the MUSCULOSKELETAL SYSTEM with CC 1.3226

08133 LOCAL RESECTION on the MUSCULOSKELETAL SYSTEM with MCC 1.5956

08141 PERFORMANCES on the SOLE of the FOOT without CC 0.4585

PERFORMANCES on the SOLE of the FOOT with 08142 CC 0.6088

08143 PERFORMANCES on the SOLE of the FOOT with MCC 0.8834

08151 PERFORMANCES on UPPER LIMBS without CC 0.7096

08152 PERFORMANCES on UPPER LIMBS with CC 1.1029

on the UPPER LIMBS 08153 PERFORMANCES with MCC 1.5566

08161 PERFORMANCES on SOFT TISSUE without CC 0.4371

08162 PERFORMANCES on SOFT TISSUE with CC 0.7491

08163 PERFORMANCE on the SOFT TISSUE with the MCC 1.1300

OTHER PERFORMANCES DURING 08171 and 0.4560 DISEASES

THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT CC

08172 OTHER PERFORMANCES of the DISORDERS and DISEASES 1.0418

THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH CC

08173 OTHER PERFORMANCES of the DISORDERS and DISEASES 3.1896

THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH MCC

08181 GREAT PERFORMANCES on the KNEE JOINT without CC 4.1049

08182 GREAT PERFORMANCES on the KNEE JOINT with CC 4.1049

08183 LARGE FEATS on the KNEE JOINT with MCC 4.6425

08191 ARTHROSCOPY without CC 0.3313

08192 ARTHROSCOPY with CC 0.3530

08193 ARTHROSCOPY with MCC 0.3530

08301 FRACTURES of the FEMUR without CC 0.7874

08302 FRACTURES of the FEMUR with CC 0.9710

08303 FRACTURES of the FEMUR with MCC 1.2260

08311 FRACTURE DISLOCATION of the HIP, PELVIS, or without CC 0.6314

08312 FRACTURE pan, or DISLOCATION of the HIP with CC 0.7139

08313 FRACTURE pan, or DISLOCATION of the HIP with MCC 1.0979

08321 FRACTURE or DISLOCATION, in ADDITION to the THIGH BONE 0.3213

AND PELVIS WITHOUT CC

08322 FRACTURE or DISLOCATION, in ADDITION to the THIGH BONE 0.5724

AND PELVIS WITH CC

08323 FRACTURE or DISLOCATION, in ADDITION to the THIGH BONE 0.9180

AND PELVIS WITH MCC

08331 MALIGNANT DISEASE MUSCULOSKELETAL SYSTEM 0.7308

AND CONNECTIVE TISSUE, PATHOLOGICAL FRACTURES WITHOUT CC

08332 MALIGNANT DISEASE of the MUSCULOSKELETAL SYSTEM 1.1981

AND CONNECTIVE TISSUE, PATHOLOGICAL FRACTURES WITH CC

08333 MALIGNANT DISEASE of the MUSCULOSKELETAL SYSTEM 1.4172

AND CONNECTIVE TISSUE, PATHOLOGICAL FRACTURES WITH MCC

08341 OSTEOMYELITIS without CC 0.9370

08342 OSTEOMYELITIS with CC 1.3498

08343 OSTEOMYELITIS with MCC 1.3498

08351 SEPTIC ARTHRITIS without CC 0.8492

08352 SEPTIC ARTHRITIS with CC 1.1277

08353 SEPTIC ARTHRITIS with MCC 2.1781

08361 CONNECTIVE TISSUE DISORDERS without CC 0.7901

08362 CONNECTIVE TISSUE DISORDERS with CC 0.8471

08363 CONNECTIVE TISSUE DISORDERS with MCC 1.1690

08371 CONSERVATIVE TREATMENT for BACK PROBLEMS without CC 0.5020

08372 CONSERVATIVE TREATMENT of BACK PROBLEMS with CC 0.6009

08373 the CONSERVATIVE TREATMENT of BACK PROBLEMS with MCC 0.7086

08381 OTHER DISEASES of the bones and joints without CC 0.6286

08382 OTHER bones and joints DISORDERS with CC 0.6844

08383 OTHER DISEASES of the bones and joints with MCC 0.8905

08391 FAILURES, reactions and complications ORTHOPEDIC APPLIANCE 0.6237

OR PERFORMANCE WITHOUT CC

08392 FAILURES, reactions and complications ORTHOPEDIC APPLIANCE 0.7978

OR PERFORMANCE WITH CC

08393 FAILURES, reactions and complications ORTHOPEDIC APPLIANCE 0.9425

OR PERFORMANCE WITH MCC

08401 MUSCULOSKELETAL SYMPTOMS, symptoms, SPRAINS and LESS 0.4023

MAJOR INFLAMMATORY DISEASE WITHOUT CC

08402 MUSCULOSKELETAL SYMPTOMS, symptoms, SPRAINS and LESS 0.5543

MAJOR INFLAMMATORY DISEASE WITH CC

08403 MUSCULOSKELETAL SYMPTOMS, symptoms, SPRAINS and LESS 0.6434

MAJOR INFLAMMATORY DISEASE WITH MCC

OTHER DISORDERS of the MUSCULOSKELETAL SYSTEM 08411 and CONNECTIVE 0.3997

TISSUE WITHOUT CC

OTHER DISORDERS of the MUSCULOSKELETAL SYSTEM 08412 and CONNECTIVE 0.5976

TISSUE WITH CC

OTHER DISORDERS of the MUSCULOSKELETAL SYSTEM 08413 and CONNECTIVE 1.0416

TISSUE WITH MCC

09011 SKIN GRAFT and/or DEBRIDEMENT without CC 0.6595

09012 SKIN GRAFT and/or DEBRIDEMENT with CC 1.2457

09013 SKIN GRAFT and/or DEBRIDEMENT with MCC 1.8033

09021 PERFORMANCES on the BREASTS without CC 0.7788

09022 PERFORMANCES on the BREASTS with CC 0.9928

09023 PERFORMANCES on the BREASTS with MCC 1.1827

OTHER PERFORMANCES DURING 09031 and DISEASES of the SKIN, 0.4138

THE SUBCUTANEOUS TISSUE AND BREAST WITHOUT CC

09032 OTHER PERFORMANCES with FAULTS and DISEASES of the SKIN, 0.8539

THE SUBCUTANEOUS TISSUE AND BREAST WITH CC

09033 OTHER PERFORMANCES with FAULTS and DISEASES of the SKIN, 1.8740

THE SUBCUTANEOUS TISSUE AND BREAST WITH MCC

09301 SERIOUS SKIN DISORDERS without CC 0.7900

09302 SERIOUS DISORDERS of the skin with CC 0.8304

09303 SERIOUS DISORDERS of the skin with MCC 0.9999

MALIGNANT BREAST DISEASE without 09311 CC 0.8275

09312 MALIGNANT DISEASE BREAST with CC 0.9346

MALIGNANT BREAST DISEASE 09313 with MCC 0.9346

09321 FLEGMÓNA without CC 0.4996

09322 FLEGMÓNA with CC 0.7410

09323 FLEGMÓNA with MCC 0.9489

09331 INJURY to the SKIN, SUBCUTANEOUS TISSUE and BREAST without CC 0.2531

09332 INJURY to the SKIN, SUBCUTANEOUS TISSUE and BREAST with CC 0.3738

09333 INJURY of the skin, SUBCUTANEOUS TISSUE and BREAST with MCC 0.5486

09341 OTHER DISORDERS of the skin and the BREAST without the CC 0.4071

09342 OTHER DISORDERS of skin and BREAST with CC 0.5775

OTHER SKIN DISORDERS and 09343 BREAST with MCC 0.7576

10011 PERFORMANCES on the ADRENAL GLANDS and the PITUITARY without CC 2.2261

10012 PERFORMANCES on the ADRENAL GLANDS and the PITUITARY GLAND with CC 2.6948

10013 PERFORMANCES on the ADRENAL GLANDS and the PITUITARY GLAND with MCC 2.6948

10021 a SKIN GRAFT and DEBRIDEMENT of the WOUND when the ENDOCRINE, 1.6511

NUTRITIONAL AND METABOLIC DISORDERS WITHOUT CC

10022 a SKIN GRAFT and DEBRIDEMENT of the WOUND when the ENDOCRINE, 1.6511

NUTRITIONAL AND METABOLIC DISORDERS WITH CC

10023 a SKIN GRAFT and DEBRIDEMENT of the WOUND when the ENDOCRINE, 1.6511

NUTRITIONAL AND METABOLIC DISORDERS WITH MCC

10031 PERFORMANCES for OBESITY without CC 3.3071

10032 PERFORMANCES for OBESITY with CC 3.3071

10033 PERFORMANCES for OBESITY with MCC 3.3071

10041 AMPUTATION of the LOWER LIMB in the ENDOCRINE, NUTRITIONAL 1.8811

AND METABOLIC DISORDERS WITHOUT CC

10042 AMPUTATION of the LOWER LIMB in the ENDOCRINE, NUTRITIONAL 2.2460

AND METABOLIC DISORDERS WITH CC

10043 AMPUTATION of the LOWER LIMB in the ENDOCRINE, NUTRITIONAL 2.2460

AND METABOLIC DISORDERS WITH MCC

10051 PERFORMANCES on the THYROID and the PARATHYROID GLAND, THYROGLOSSÁLNÍ 0.9157

PERFORMANCES WITHOUT CC

10052 PERFORMANCES on the THYROID and the PARATHYROID GLAND, THYROGLOSSÁLNÍ 1.0090

PERFORMANCES WITH CC

10053 PERFORMANCES on the THYROID and the PARATHYROID GLAND, THYROGLOSSÁLNÍ 1.1147

PERFORMANCES WITH MCC

10061 DIFFERENT PERFORMANCES in the ENDOCRINE, NUTRITIONAL 1.8554

AND METABOLIC DISORDERS WITHOUT CC

10062 OTHER PERFORMANCES in the ENDOCRINE, NUTRITIONAL 2.7137

AND METABOLIC DISORDERS WITH CC

10063 OTHER PERFORMANCES in the ENDOCRINE, NUTRITIONAL 8.5468

AND METABOLIC DISORDERS WITH MCC

10301 DIABETES, NUTRITIONAL and other METABOLIC DISORDERS without CC 0.4919

10302 DIABETES, NUTRITIONAL and other METABOLIC DISORDERS with CC 0.6040

10303 DIABETES, NUTRITIONAL and other METABOLIC DISORDERS with MCC 0.9586

10311 HYPOVOLÉMIE and ELECTROLYTE DISORDERS without CC 0.4049

10312 HYPOVOLÉMIE and ELECTROLYTE DISORDERS with CC 0.5431

10313 HYPOVOLÉMIE and ELECTROLYTE DISORDERS with MCC 0.6374

10321 CONGENITAL METABOLIC DISORDERS without CC 0.5574

10322 CONGENITAL METABOLIC DISORDERS with CC 0.6821

10323 CONGENITAL METABOLIC DISORDERS with MCC 1.1686

10331 OTHER ENDOCRINE DISORDERS without CC 0.7621

10332 OTHER ENDOCRINE DISORDERS with CC 0.7621

10333 OTHER ENDOCRINE DISORDERS with MCC 0.9859

11011 RENAL TRANSPLANTATION without CC 6.8830

11012 KIDNEY TRANSPLANTATION with CC 6.8830

11013 KIDNEY TRANSPLANTATION with MCC 8.0493

11021 GREAT PERFORMANCES on the BLADDER without CC 5.8459

11022 GREAT PERFORMANCES on the BLADDER with CC 6.5262

11023 GREAT PERFORMANCES on the BLADDER with MCC 8.3427
11031 GREAT PERFORMANCES on the KIDNEYS and the URINARY TRACT without CC 1.8064

11032 GREAT PERFORMANCES on the KIDNEYS and the URINARY TRACT with CC 2.1764

11033 GREAT PERFORMANCES on the KIDNEYS and the URINARY TRACT with MCC 3.2505

11041 OPERATING the ESTABLISHMENT or REVISION of the CATHETER for 1.4831

PERITONEAL DIALYSIS WITHOUT CC

11042 OPERATING the ESTABLISHMENT or REVISION of the CATHETER for 1.8176

PERITONEAL DIALYSIS WITH CC

11043 OPERATING the ESTABLISHMENT or REVISION of the CATHETER for 4.0993

PERITONEAL DIALYSIS WITH MCC

11051 LESS PERFORMANCES on the KIDNEYS, URINARY TRACT 0.9339

AND THE BLADDER WITHOUT CC

11052 LESS PERFORMANCES on the KIDNEYS, URINARY TRACT 0.9817

AND THE BLADDER WITH CC

11053 LESS PERFORMANCES on the KIDNEYS, URINARY TRACT 1.4489

AND THE BLADDER WITH MCC

11061 PROSTATECTOMY without CC 0.9986

11062 PROSTATECTOMY with CC 1.1386

11063 PROSTATECTOMY with MCC 1.3764

11071 URETHRAL and TRANSURETHRAL PERFORMANCES without CC 0.4571

11072 URETHRAL and TRANSURETHRAL PERFORMANCES with CC 0.5501

11073 URETHRAL and TRANSURETHRAL PERFORMANCES with MCC 0.6704

11081 OTHER PERFORMANCES with FAULTS and DISEASES of the KIDNEY 0.7159

AND THE URINARY TRACT WITHOUT CC

11082 OTHER PERFORMANCES with FAULTS and DISEASES of the KIDNEY 0.7589

AND URINARY TRACT WITH CC

11083 OTHER PERFORMANCES with FAULTS and DISEASES of the KIDNEY 3.3684

AND URINARY TRACT WITH MCC

11301 MALIGNANT DISEASE of the KIDNEY and urinary tract 0.4557

AND KIDNEY FAILURE WITHOUT CC

11302 MALIGNANT DISEASE of the KIDNEY and urinary tract 0.7281

AND RENAL FAILURE WITH CC

11303 MALIGNANT DISEASE of the KIDNEY and urinary tract 1.1922

AND RENAL FAILURE WITH MCC

11311 NEPHRITIS without CC 0.4794

11312 NEPHRITIS with CC 0.6109

11313 NEPHRITIS with MCC 1.4663

11321 KIDNEY INFECTION and urinary tract without CC 0.4442

11322 KIDNEY INFECTION and urinary tract with CC 0.6081

11323 KIDNEY INFECTION and urinary tract with MCC 0.8134

11331 BLADDER STONES with EXTRACORPOREAL SHOCK WAVE LITOTRYPSÍ 0.4037

WITHOUT CC

11332 BLADDER STONES with EXTRACORPOREAL SHOCK WAVE LITOTRYPSÍ 0.5688

WITH CC

11333 BLADDER STONES with EXTRACORPOREAL SHOCK WAVE LITOTRYPSÍ 0.5688

WITH MCC

11341 BLADDER STONES without EXTRACORPOREAL LITOTRYPSE without-CC 0.2971

11342 BLADDER STONES without EXTRACORPOREAL LITOTRYPSE with CC 0.4181

11343 BLADDER STONES without EXTRACORPOREAL LITOTRYPSE with MCC 0.5754

11351 FAILURES, reactions and complications GENITOURETRÁLNÍHO 0.3385

DEVICE, OR OF THE TRANSPLANT GRAFT WITHOUT CC

11352 FAILURES, reactions and complications GENITOURETRÁLNÍHO 0.7989

DEVICE, OR OF THE TRANSPLANT GRAFT WITH CC

11353 FAILURES, reactions and complications GENITOURETRÁLNÍHO 1.2890

DEVICE, OR OF THE TRANSPLANT GRAFT WITH MCC

11361 signs and symptoms on the KIDNEYS and the URINARY TRACT 0.3222

WITHOUT CC

11362 signs and symptoms on the KIDNEYS and the URINARY TRACT 0.3777

WITH CC

11363 signs and symptoms on the KIDNEYS and the URINARY TRACT 0.4873

WITH MCC

11371 OTHER DISORDERS renal and URINARY TRACT without CC 0.3000

11372 OTHER DISORDERS renal and URINARY TRACT with CC 0.4410

11373 OTHER DISORDERS renal and URINARY TRACT with MCC 0.7883

12011 GREAT PERFORMANCES in the pelvic region for MEN without CC 1.9128

12012 GREAT PERFORMANCES in the pelvic region for MEN with CC 1.9128

12013 GREAT PERFORMANCES in the pelvic region for MEN with MCC 2.0539

12021 PERFORMANCES on the PENIS without CC 0.3858

12022 PERFORMANCES on the PENIS with CC 0.5571

12023 PERFORMANCES on the PENIS with MCC 0.5571

12031 TRANSURETHRAL PROSTATECTOMY without CC 0.8386

12032 TRANSURETHRAL PROSTATECTOMY with CC 1.0148

12033 TRANSURETHRAL PROSTATECTOMY with MCC 1.0148

12041 PERFORMANCES on the TESTICLES without CC 0.3803

12042 PERFORMANCES on the TESTICLES with CC 0.5053

12043 PERFORMANCES on the TESTICLES with MCC 0.7931

12051 CIRCUMCISION without CC 0.2569

12052 CIRCUMCISION with CC 0.2800

12053 CIRCUMCISION with MCC 0.3494

12061 OTHER PERFORMANCES on the MALE REPRODUCTIVE SYSTEM without CC 0.5582

12062 OTHER PERFORMANCES on the MALE REPRODUCTIVE SYSTEM with CC 0.8503

12063 OTHER PERFORMANCES on the MALE REPRODUCTIVE SYSTEM with MCC 0.8503

12301 MALIGNANT DISEASES of the MALE REPRODUCTIVE SYSTEM 0.5072

WITHOUT CC

12302 MALIGNANT DISEASES of the MALE REPRODUCTIVE SYSTEM 0.8001

WITH CC

12303 MALIGNANT DISEASES of the MALE REPRODUCTIVE SYSTEM 1.0031

WITH MCC

12311 DISORDERS of the MALE REPRODUCTIVE SYSTEM, in ADDITION to the 0.2350

MALIGNANT DISEASE WITHOUT CC

12312 DISORDERS of the MALE REPRODUCTIVE SYSTEM, in ADDITION to the 0.3214

MALIGNANT DISEASE WITH CC

12313 DISORDERS of the MALE REPRODUCTIVE SYSTEM, in ADDITION to the 0.3676

MALIGNANT DISEASES WITH MCC

13011 EXENTERACE PANS, RADICAL HYSTERECTOMY and radical 2.7644

VULVEKTOMIE WITHOUT-CC

13012 EXENTERACE PANS, RADICAL HYSTERECTOMY and radical 3.0913

VULVEKTOMIE WITH CC

13013 EXENTERACE PANS, RADICAL HYSTERECTOMY and radical 3.0913

VULVEKTOMIE WITH MCC

13021 PERFORMANCES on the UTERUS and ADNEXECH for MALIGNANT DISEASE on 2.3502

OVARIÍCH AND ADNEXECH WITHOUT-CC

13022 PERFORMANCES on the UTERUS and ADNEXECH for MALIGNANT DISEASE on 2.9450

OVARIÍCH AND ADNEXECH WITH CC

13023 PERFORMANCES on the UTERUS and ADNEXECH for MALIGNANT DISEASE on 2.9450

OVARIÍCH AND ADNEXECH WITH MCC

13031 PERFORMANCES on the UTERUS and ADNEXECH for MALIGNANT 1.7187 DISEASE

ELSEWHERE THAN ON THE OVARY AND THE ADNEXECH WITHOUT-CC

13032 PERFORMANCES on the UTERUS and ADNEXECH for MALIGNANT 1.9042 DISEASE

ELSEWHERE THAN ON THE OVARY AND THE ADNEXECH WITH CC

13033 PERFORMANCES on the UTERUS and ADNEXECH for MALIGNANT 2.4980 DISEASE

ELSEWHERE THAN ON THE OVARY AND THE ADNEXECH WITH THE MCC

13041 UTERINE and ADNEXÁLNÍ PERFORMANCES in CA IN SITU 1.0665

AND MALIGNANT DISORDERS WITHOUT CC

13042 UTERINE and ADNEXÁLNÍ PERFORMANCES in CA IN SITU 1.2392

AND MALIGNANT DISEASES WITH CC

13043 UTERINE and ADNEXÁLNÍ PERFORMANCES in CA IN SITU 1.4279

AND MALIGNANT DISEASES WITH MCC

13051 GYNECOLOGICAL LAPAROSCOPY or LAPAROTOMICKÁ 0.4630

STERILIZATION WITHOUT CC

13052 GYNECOLOGICAL LAPAROSCOPY or LAPAROTOMICKÁ 0.7342

STERILIZATION WITH CC

13053 GYNECOLOGICAL LAPAROSCOPY or LAPAROTOMICKÁ 1.2553

STERILIZATION WITH MCC

13061 RECONSTRUCTIVE PERFORMANCES on a WOMAN'S REPRODUCTIVE SYSTEM of 0.8628

WITHOUT CC

13062 RECONSTRUCTIVE PERFORMANCES on a WOMAN'S REPRODUCTIVE SYSTEM of 0.9883

WITH CC

13063 RECONSTRUCTIVE PERFORMANCES on a WOMAN'S REPRODUCTIVE SYSTEM of 1.1526

WITH MCC

13071 VAGINAL, CERVICAL and VULVOVÉ PERFORMANCES without CC 0.2638

13072 VAGINAL, CERVICAL and VULVOVÉ PERFORMANCES with CC 0.4005

13073 VAGINAL, CERVICAL and VULVOVÉ PERFORMANCES with MCC 0.6491

13081 ENDOSCOPIC INTERRUPTION of FALLOPIAN TUBE without CC 0.5487

13082 ENDOSCOPIC INTERRUPTION of FALLOPIAN TUBE with CC 0.5843

13083 ENDOSCOPIC INTERRUPTION of FALLOPIAN TUBE with MCC 0.5843

13091 DILATION, CURETTAGE and KÓNIZACE without-CC 0.2101

13092 DILATION, CURETTAGE and KÓNIZACE with CC 0.2526

13093 DILATION, CURETTAGE and KÓNIZACE with MCC 0.3047

13101 OTHER PERFORMANCES with FAULTS and DISEASES of the FEMALE 0.9031

REPRODUCTIVE SYSTEM WITHOUT CC

13102 OTHER PERFORMANCES with FAULTS and DISEASES of the FEMALE 1.1828

REPRODUCTIVE SYSTEM WITH CC

13103 OTHER PERFORMANCES of the DISORDERS and DISEASES of the FEMALE 2.3877

REPRODUCTIVE SYSTEM WITH MCC

13301 MALIGNANT DISEASE of the FEMALE REPRODUCTIVE SYSTEM 0.5747

WITHOUT CC

13302 MALIGNANT DISEASE of the FEMALE REPRODUCTIVE SYSTEM 0.7072

WITH CC

13303 MALIGNANT DISEASE of the FEMALE REPRODUCTIVE SYSTEM 1.0416

WITH MCC

13311 INFECTION of the FEMALE REPRODUCTIVE SYSTEM without CC 0.2962

13312 INFECTION of the FEMALE REPRODUCTIVE SYSTEM with CC 0.5153

13313 INFECTION of the FEMALE REPRODUCTIVE SYSTEM with MCC 0.5153

13321 MENSTRUAL and other DISORDERS of the FEMALE REPRODUCTIVE 0.1902

SYSTEM WITHOUT CC

13322 MENSTRUAL and other DISORDERS of the FEMALE REPRODUCTIVE 0.3257

SYSTEM WITH CC

13323 MENSTRUAL and other DISORDERS of the FEMALE REPRODUCTIVE 0.6739

SYSTEM WITH MCC

14601 BIRTH CESAREAN SECTION without CC 0.8903

14602 BIRTH CESAREAN SECTION with CC 1.0723

14603 BIRTH CESAREAN SECTION with MCC 1.2703

14611 VAGINAL CHILDBIRTH, STERILIZATION and/or the DILATION of 0.6391

AND KYRETÁŽÍ WITHOUT-CC

14612 VAGINAL CHILDBIRTH, STERILIZATION and/or the DILATION of 0.7571

AND KYRETÁŽÍ WITH CC

14613 VAGINAL CHILDBIRTH, STERILIZATION and/or the DILATION of 0.9687

AND KYRETÁŽÍ WITH THE MCC

14621 VAGINAL CHILDBIRTH with the power, in ADDITION to STERILIZATION and/or 2.4356

DILATION AND CURETTAGE WITHOUT CC

14622 VAGINAL CHILDBIRTH with the power, in ADDITION to STERILIZATION and/or 2.4356

DILATION AND CURETTAGE, WITH CC

14623 VAGINAL CHILDBIRTH with the power, in ADDITION to STERILIZATION and/or 2.4356

DILATION AND CURETTAGE, WITH MCC
14631 VAGINAL CHILDBIRTH without CC 0.4919

14632 VAGINAL CHILDBIRTH with CC 0.5565

14633 VAGINAL CHILDBIRTH with MCC 0.5565

14641 ABORTION dilation and KYRETÁŽÍ, KYRETÁŽÍ or 0.1879 ASPIRATION

HYSTERECTOMIES WITHOUT CC

14642 ABORTION dilation and KYRETÁŽÍ, KYRETÁŽÍ or 0.2202 ASPIRATION

HYSTERECTOMIES WITH CC

14643 ABORTION dilation and KYRETÁŽÍ, KYRETÁŽÍ or 0.2379 ASPIRATION

HYSTERECTOMIES WITH MCC

14651 ABORTION without dilation and CURETTAGE, 0.1741 ASPIRATION CURETTAGE

OR A HYSTERECTOMY WITHOUT CC

14652 ABORTION without dilation and CURETTAGE, 0.1741 ASPIRATION CURETTAGE

OR A HYSTERECTOMY WITH CC

14653 ABORTION without dilation and CURETTAGE, 0.1741 ASPIRATION CURETTAGE

OR A HYSTERECTOMY WITH MCC

14661 POSTPARTUM and POPOTRATOVÉ performance DIAGNOSIS without CC 0.2247

14662 POSTPARTUM and POPOTRATOVÉ DIAGNOSIS of performance issues with CC 0.2247

14663 POSTPARTUM and POPOTRATOVÉ DIAGNOSIS of performance issues with MCC 0.2247

14671 POSTPARTUM and POPOTRATOVÉ DIAGNOSIS without EXERCISING without CC 0.1831

14672 POSTPARTUM and POPOTRATOVÉ DIAGNOSIS without PERFORMANCE with CC 0.1831

14673 POSTPARTUM and POPOTRATOVÉ DIAGNOSIS without MCC'S PERFORMANCE with 0.1831

14681 ECTOPIC PREGNANCY with the performance without the CC 0.9287

14682 ECTOPIC PREGNANCY with the performance with CC 1.1076

14683 ECTOPIC PREGNANCY with the performance with MCC 1.1076

14691 ECTOPIC PREGNANCY without EXERCISING without CC 0.4955

14692 ECTOPIC PREGNANCY without PERFORMANCE with CC 0.4955

14693 ECTOPIC PREGNANCY without EXERCISING with MCC 0.4955

14701 THREATENED ABORTION without CC 0.3099

14702 THREATENED ABORTION with CC 0.4775

14703 THREATENED ABORTION with MCC 0.4775

14711 FAKE BIRTH without CC 0.1513

14712 FAKE BIRTH with CC 0.2160

14713 FAKE BIRTH with MCC 0.2160

14721 OTHER PRENATAL DIAGNOSIS with the performance without the CC 0.2694

OTHER PRENATAL DIAGNOSIS with 14722 performance with CC 0.4812

OTHER ANTENATAL DIAGNOSIS 14723 performance with MCC 0.7161

PRENATAL DIAGNOSIS without OTHER 14731 PERFORMANCE without CC 0.2694

PRENATAL DIAGNOSIS without OTHER 14732 PERFORMANCE with CC 0.3986

PRENATAL DIAGNOSIS without OTHER 14733 PERFORMANCE with MCC 0.3986

15601 newborn, DEAD or TRANSLATED = 5 days without < CC 0.6213

15602 newborn, DEAD or TRANSLATED = 5 days with < CC 0.6213

15603 newborn, DEAD or TRANSLATED = 5 days with < MCC 0.6213

15611 newborn, with the TRANSPLANTATION of ORGAN or EXTRACORPOREAL 9.6517

DIAPHRAGM OXYGENACÍ WITHOUT-CC

15612 newborn, with the TRANSPLANTATION of ORGAN or EXTRACORPOREAL 13.5150

DIAPHRAGM OXYGENACÍ WITH CC

15613 a NEWBORN, with the TRANSPLANTATION of ORGAN or EXTRACORPOREAL 21.4750

DIAPHRAGM OXYGENACÍ WITH MCC

15621 newborn, BIRTH WEIGHT = 1 000 G 2 499 G, with a SERIOUS 2.0587

ANOMALIES OR GENETIC STATUS WITH MCC

15720 newborn, WEIGHT at BIRTH, 2 499 G > SYNDROME 4.1371

RESPIRATORY PROBLEMS

15731 newborn, WEIGHT at BIRTH, with 2 499 G > ASPIRAČNÍM 0.2877

SYNDROME WITHOUT THE CC

15732 newborn, BIRTH WEIGHT > 2 499 G, ASPIRAČNÍM 0.3189

SYNDROME WITH CC

15733 newborn, WEIGHT at BIRTH, with 2 499 G > ASPIRAČNÍM 0.3189

SYNDROME WITH MCC

15741 newborn, BIRTH WEIGHT > 2 499 G, with congenital 0.5998

OR PERINATAL INFECTIONS WITHOUT CC

15742 newborn, BIRTH WEIGHT > 2 499 G, with congenital 0.6603

OR WITH PERINATAL INFECTIONS WITH CC

15743 newborn, BIRTH WEIGHT > 2 499 G, with congenital 0.6603

OR PERINATAL INFECTION WITH MCC

15751 newborn, BIRTH WEIGHT > 2 499 G, without 0.2742

THE BASIC PERFORMANCE WITHOUT CC

15752 newborn, BIRTH WEIGHT > 2 499 G, without 0.3616

THE BASIC PERFORMANCE WITH CC

15753 newborn, BIRTH WEIGHT > 2 499 G, without 0.4100

THE BASIC PERFORMANCE WITH MCC

16011 PERFORMANCES on SPLEEN without CC 2.9427

16012 PERFORMANCES on SPLEEN with CC 2.9427

16013 PERFORMANCES on SPLEEN with MCC 2.9427

16021 OTHER PERFORMANCES for BLOOD DISEASES and STEM 0.6449

BODIES WITHOUT CC

16022 OTHER PERFORMANCES for BLOOD DISEASES and STEM 0.9105

ORGANS WITH CC

16023 OTHER PERFORMANCES for BLOOD DISEASES and STEM 1.7889

ORGANS WITH MCC

16301 AGRANULOCYTOSIS without CC 0.9507

16302 AGRANULOCYTOSIS with CC 1.8640

16303 AGRANULOCYTOSIS with MCC 2.4088

16311 CLOTTING DISORDERS without CC 0.9623

16312 CLOTTING DISORDERS with CC 1.1981

16313 CLOTTING DISORDERS with MCC 1.4580

16321 SICKLE CELL ANEMIA without CC 0.6355

16322 SICKLE CELL ANEMIA with CC 0.8690

16323 SICKLE CELL ANEMIA with MCC 1.3833

16331 DISORDERS of RED BLOOD CELLS, in ADDITION to the SICKLE CELL 0.7405

ANEMIA WITHOUT CC

16332 DISORDERS of RED BLOOD CELLS, in ADDITION to the SICKLE CELL 0.8574

ANEMIA WITH CC

16333 DISORDERS of RED BLOOD CELLS, in ADDITION to the SICKLE CELL 1.1553

ANEMIA WITH MCC

16341 OTHER BLOOD DISORDERS and HEMATOPOIETIC ORGANS without CC 0.5837

16342 OTHER BLOOD DISORDERS and HEMATOPOIETIC organs with CC 0.7890

16343 OTHER BLOOD DISORDERS and HEMATOPOIETIC organs with MCC 1.3641

17011 LYMPHOMA and LEUKEMIA with HIGH PERFORMANCE without the CC 1.1061

17012 LYMPHOMA and LEUKEMIA with a great performance with CC 4.1036

17013 LYMPHOMA and LEUKEMIA with a great performance with MCC 7.5269

17021 LYMPHOMA and LEUKEMIA with another PERFORMANCE without CC 1.3598

17022 LYMPHOMA and LEUKEMIA with another performance with CC 3.9580

17023 LYMPHOMA and LEUKEMIA with another performance with MCC 15.6644

17031 MYELOPROLIFERATIVE DISORDERS and poorly DIFFERENTIATED 1.9219

TUMORS WITH HIGH PERFORMANCE WITHOUT CC

17032 MYELOPROLIFERATIVE DISORDERS and poorly DIFFERENTIATED 3.6862

TUMORS WITH GREAT PERFORMANCE WITH CC

17033 MYELOPROLIFERATIVE DISORDERS and poorly DIFFERENTIATED 6.0986

TUMORS WITH GREAT PERFORMANCE WITH MCC

17041 MYELOPROLIFERATIVE DISORDERS and poorly DIFFERENTIATED 1.4421

TUMORS WITH DIFFERENT PERFORMANCE WITHOUT CC

17042 MYELOPROLIFERATIVE DISORDERS and poorly DIFFERENTIATED 2.4273

TUMORS WITH ANOTHER PERFORMANCE WITH CC

17043 MYELOPROLIFERATIVE DISORDERS and poorly DIFFERENTIATED 4.2073

TUMORS WITH ANOTHER PERFORMANCE WITH MCC

17301 ACUTE LEUKEMIA without CC 2.1693
17302 ACUTE LEUKEMIA with CC 2.1693

17303 ACUTE LEUKEMIA with MCC 4.5385

17311 NEAKUTNÍ lymphoma and LEUKEMIA without CC 1.3000

17312 LYMPHOMA and LEUKEMIA with CC NEAKUTNÍ 2.0183

17313 LYMPHOMA and LEUKEMIA with NEAKUTNÍ MCC 2.8725

17321 RADIOTHERAPY without CC 1.7882

17322 RADIOTHERAPY with CC 2.0199

17323 RADIOTHERAPY with MCC 2.2161

17331 CHEMOTHERAPY without CC 0.9862

17332 CHEMOTHERAPY with CC 0.9862

17333 CHEMOTHERAPY with MCC 1.4119

17341 OTHER MYELOPROLIFERATIVE DISORDERS and DIAGNOSIS of 0.7789

UNDIFFERENTIATED TUMORS WITHOUT CC

17342 OTHER MYELOPROLIFERATIVE DISORDERS and DIAGNOSIS of 1.0228

UNDIFFERENTIATED TUMORS WITH CC

17343 OTHER MYELOPROLIFERATIVE DISORDERS and DIAGNOSIS of 1.2667

UNDIFFERENTIATED TUMORS WITH MCC

CHEMOTHERAPY in ACUTE LEUKEMIA 17351 without CC 16.2576

CHEMOTHERAPY in ACUTE LEUKEMIA 17352 with CC 16.2576

CHEMOTHERAPY in ACUTE LEUKEMIA 17353 with MCC 16.2576

18011 PERFORMANCES for infectious and parasitic diseases without CC 0.2704

18012 PERFORMANCES for infectious and parasitic diseases with CC 4.7634

18013 PERFORMANCES for infectious and parasitic diseases with MCC 15.2891

18021 PERFORMANCES for POSTOPERATIVE and POSTTRAUMATIC INFECTIONS without CC 1.3302

18022 PERFORMANCES for POSTOPERATIVE and POSTTRAUMATIC infections with CC 1.7805

18023 PERFORMANCES for POSTOPERATIVE and POSTTRAUMATIC infections with MCC 3.2029

18301 SEPTICEMIA without CC 1.0857

18302 SEPTICEMIA with CC 1.4738

18303 SEPTICEMIA with MCC 3.5194

18311 POSTOPERATIVE and POSTTRAUMATIC INFECTIONS without CC 0.6324

18312 post-operative and POSTTRAUMATIC infections with CC 0.9376

of POST-OPERATIVE and POSTTRAUMATIC 18313 INFECTION with MCC 1.5810

18321 FEVER of UNKNOWN ORIGIN with NO CC 0.4843

18322 FEVER of UNKNOWN ORIGIN with CC 0.6640

18323 FEVER of UNKNOWN ORIGIN with MCC 0.8842

18331 VIRAL DISEASE without CC 0.4270

18332 VIRAL DISEASE with CC 0.5591

18333 VIRAL DISEASE with MCC 0.6982

18341 other infectious and PARASITIC DISEASES without CC 0.6746

18342 OTHER INFECTIOUS and parasitic diseases with CC 0.9795

18343 OTHER INFECTIOUS and parasitic diseases with the MCC 1.6886

19011 OPERATING PERFORMANCE with the MAIN DIAGNOSIS of MENTAL ILLNESS 1.3250

WITHOUT CC

19012 OPERATING PERFORMANCE with the MAIN DIAGNOSIS of MENTAL ILLNESS 2.9147

WITH CC

19013 OPERATING PERFORMANCE with the MAIN DIAGNOSIS of MENTAL ILLNESS 5.5831

WITH MCC

19301 SCHIZOPHRENIA without CC 1.6977

19302 SCHIZOPHRENIA with CC 2.4278

19303 SCHIZOPHRENIA with MCC 2.4278

19311 PSYCHOSIS without CC 1.5862

19312 PSYCHOSIS with CC 1.5862

19313 PSYCHOSIS with MCC 1.6887

19321 PERSONALITY DISORDERS and mood without CC 1.1678

19322 PERSONALITY DISORDERS and mood with CC 1.3842

19323 PERSONALITY DISORDERS and mood with MCC 2.1624

19331 BIPOLAR DISORDERS without CC 1.7197

19332 BIPOLAR DISORDERS with CC 1.9183

19333 BIPOLAR DISORDERS with MCC 1.9183

19341 DEPRESSION without CC 1.0321

19342 DEPRESSION with CC 1.2129

19343 DEPRESSION with MCC 1.9845

19351 ACUTE reactions, PSYCHO-SOCIAL DISORDERS and NEUROSIS 0.8687

IN ADDITION TO THE DEPRESSION WITHOUT CC

19352 ACUTE reactions, PSYCHO-SOCIAL DISORDERS and NEUROSIS in ADDITION to 0.8687

DEPRESSIVE WITH CC

19353 ACUTE reactions, PSYCHO-SOCIAL DISORDERS and NEUROSIS in ADDITION to 0.9561

DEPRESSIVE WITH MCC

19361 ORGANIC MENTAL DISORDERS and MENTAL RETARDATION without CC 0.9586

19362 ORGANIC MENTAL DISORDERS and MENTAL RETARDATION with CC 0.9586

19363 ORGANIC MENTAL DISORDERS and MENTAL RETARDATION with MCC 1.1401

19371 DEVELOPMENTAL MENTAL DISORDERS without CC 1.2284

19372 DEVELOPMENTAL MENTAL DISORDERS with CC 1.2284

19373 DEVELOPMENTAL MENTAL DISORDERS with MCC 1.2284

19381 COMPULSIVE NUTRITIONAL DISORDERS without CC 3.2215

19382 COMPULSIVE NUTRITIONAL DISORDERS with CC 3.2215

19383 COMPULSIVE NUTRITIONAL DISORDERS with MCC 3.7748

19391 OTHER MENTAL DISORDERS without CC 0.7364

19392 OTHER MENTAL DISORDERS with CC 0.7364

19393 OTHER MENTAL DISORDERS with MCC 0.7364

20301 the HARMFUL USE of ALCOHOL, DRUGS, drugs, a DEPENDENCY on 0.1401

THEM, AGAINST THE ADVICE OF MEDICAL RELEASE CC

20302 the HARMFUL USE of ALCOHOL, DRUGS, drugs, a DEPENDENCY on 0.1401

THEM, RELEASE AGAINST THE ADVICE OF THE DOCTOR WITH THE CC

20303 HARMFUL USE of ALCOHOL, DRUGS, drugs, a DEPENDENCY on 0.1401

THEM, AGAINST THE ADVICE OF THE DOCTOR WITH THE RELEASE OF THE MCC

20311 DEPENDENCY on drugs and alcohol rehabilitation and/or 0.5077

DETOXIFICATION THERAPIES WITHOUT CC

20312 DEPENDENCY on drugs and alcohol rehabilitation and/or 0.5077

DETOXIFICATION THERAPIES WITH CC

20313 DEPENDENCY on drugs and alcohol rehabilitation and/or 0.5077

DETOX THERAPY WITH MCC

20321 HARMFUL use and DEPENDENCE on OPIATES and/or 0.6982

COCAINE WITHOUT CC

20322 HARMFUL use and DEPENDENCE on OPIATES and/or 1.0417

COCAINE WITH CC

20323 HARMFUL use and DEPENDENCE on OPIATES and/or 1.0417

COCAINE WITH MCC

20331 HARMFUL use and DEPENDENCE on ALCOHOL without CC 0.4149

20332 HARMFUL use and DEPENDENCE on ALCOHOL with CC 0.5093

20333 HARMFUL use and DEPENDENCE on ALCOHOL with MCC 0.8676

20341 HARMFUL use and DEPENDENCE on OTHER DRUGS without CC 0.8231

20342 HARMFUL use and DEPENDENCE on OTHER DRUGS with CC 1.0086

20343 HARMFUL use and DEPENDENCE on OTHER DRUGS with MCC 1.0086

21011 MICROVASCULAR TISSUE TRANSFER or SKIN GRAFT at the 2.0716

INJURIES WITHOUT CC

21012 MICROVASCULAR TISSUE TRANSFER or SKIN GRAFT at the 2.0716

INJURIES WITH CC

21013 MICROVASCULAR TISSUE TRANSFER or SKIN GRAFT at the 2.0716

INJURIES WITH MCC

21021 OTHER PERFORMANCES when injuries and COMPLICATIONS without CC 1.3031

21022 OTHER PERFORMANCES when injuries and COMPLICATIONS with CC 3.1269

21023 OTHER PERFORMANCES when injuries and COMPLICATIONS with MCC 7.2698

21301 INJURIES to an UNSPECIFIED LOCATION, or MORE 0.9545

PLACES WITHOUT CC

21302 INJURIES to an UNSPECIFIED LOCATION, or MORE 1.6583

PLACES WITH CC

21303 INJURIES to an UNSPECIFIED LOCATION, or MORE 5.6352

PLACES WITH MCC

21311 ALLERGIC REACTIONS without CC 0.2164

21312 ALLERGIC REACTIONS with CC 0.2940

21313 ALLERGIC REACTIONS with MCC 0.2940

21321 poisoning and TOXIC EFFECTS of DRUGS (DRUGS) without CC 0.3302

21322 poisoning and TOXIC EFFECTS of DRUGS (DRUGS) with CC 0.4866

21323 poisoning and TOXIC EFFECTS of DRUGS (DRUGS) with MCC 1.1026

21331 the COMPLICATIONS in the TREATMENT without CC 0.2699

21332 COMPLICATIONS DURING TREATMENT with CC 0.4733

21333 COMPLICATIONS when TREATING with MCC 1.8128

21341 TORTURED the CHILD or ADULT SYNDROME without the CC 1.9265

21342 SYNDROME TORTURED the CHILD or ADULT with CC 1.9265

21343 SYNDROME TORTURED the CHILD or ADULT with MCC 1.9265

21351 OTHER DIAGNOSES of INJURIES, poisoning and TOXIC EFFECTS of 0.2926

WITHOUT CC

21352 OTHER DIAGNOSES of INJURIES, poisoning and TOXIC EFFECTS of 0.5297

WITH CC

21353 OTHER DIAGNOSES of INJURIES, poisoning and TOXIC EFFECTS of 1.6408

WITH MCC

22501 Burns, TRANSFER to ANOTHER ACUTE CARE 0.2796

WITHOUT CC

22502 Burns, TRANSFER to ANOTHER ACUTE CARE 0.2796

WITH CC

22503 Burns, TRANSFER to ANOTHER ACUTE CARE 0.2796

WITH MCC

22510 EXTENSIVE BURNS with SKIN GRAFT 9.0098

22521 NEROZSÁHLÉ BURNS through the ENTIRE skin with SKIN 2.2526

GRAFT OR INHAL. INJURIES WITHOUT CC

22522 NEROZSÁHLÉ BURNS through the ENTIRE skin with SKIN 11.1469

GRAFT OR INHAL. INJURIES WITH CC

22523 NEROZSÁHLÉ BURNS through the ENTIRE skin with SKIN 11.1469

GRAFT OR INHAL. INJURIES WITH MCC

22530 EXTENSIVE BURNS without SKIN GRAFT 5.0292

22541 BURNS LIMITED SCALE AFFECTING ALL 1.8613

LAYER OF THE SKIN WITHOUT SKIN GRAFT OR INHALATION

INJURY WITHOUT CC

22542 BURNS LIMITED SCALE AFFECTING ALL 1.8613

LAYER OF THE SKIN WITHOUT SKIN GRAFT OR INHALATION

INJURY WITH CC

22543 BURNS LIMITED SCALE AFFECTING ALL 1.8613

LAYER OF THE SKIN WITHOUT SKIN GRAFT OR INHALATION

INJURIES WITH MCC

22551 BURNS LIMITED NEPOSTIHUJÍCÍ ALL 0.8364

THE LAYERS OF THE SKIN WITHOUT CC

22552 BURNS LIMITED NEPOSTIHUJÍCÍ ALL 1.6621

LAYER OF THE SKIN WITH THE CC

22553 BURNS LIMITED NEPOSTIHUJÍCÍ ALL 1.6621

LAYER OF THE SKIN WITH MCC

23011 OPERATIONAL PERFORMANCE with a diagnosis of ANOTHER CONTACT is 1.1763
HEALTH SERVICES WITHOUT CC

23012 OPERATIONAL PERFORMANCE with a diagnosis of ANOTHER CONTACT with 2.2008

HEALTH SERVICES WITH CC

23013 OPERATIONAL PERFORMANCE with a diagnosis of ANOTHER CONTACT is 11.1167

HEALTH SERVICES WITH MCC

23301 REHABILITATION without CC 1.0876

23302 REHABILITATION with CC 1.2711

23303 REHABILITATION with MCC 1.3761

23311 symptoms and ABNORMAL FINDINGS without CC 0.3760

23312 symptoms and ABNORMAL FINDINGS with CC 0.5549

23313 symptoms and ABNORMAL FINDINGS with MCC 0.8464

23321 OTHER FACTORS AFFECTING HEALTH STATUS without CC 0.3362

23322 OTHER FACTORS AFFECTING HEALTH STATUS with CC 0.9063

23323 OTHER FACTORS AFFECTING HEALTH STATUS with MCC 6.1866

24010 HIV with the performance, with several SERIOUS INFECTIONS 0.7420

ASSOCIATED WITH HIV

24020 HIV with the performance, with the ADDITIONAL DIAGNOSIS of HIV-related 2.7662

24031 HIV with the performance, without the ADDITIONAL DIAGNOSIS of HIV-related 0.3606

WITHOUT CC

24032 HIV with the performance, without the ADDITIONAL DIAGNOSIS of HIV-related 0.3606

WITH CC

24033 HIV with the performance, without the ADDITIONAL DIAGNOSIS of HIV-related 0.3606

WITH MCC

24301 HIV with VENTILATION or NUTRITIONAL SUPPORT without CC 0.7583

24302 HIV with VENTILATION or NUTRITIONAL SUPPORT with CC 0.7583

24303 HIV with VENTILATION or NUTRITIONAL SUPPORT with MCC 0.7583

24311 HIV with ANOTHER DIAGNOSIS related to HIV, RELEASED 0.1399

DESPITE MEDICAL RECOMMENDATIONS WITHOUT CC

24312 HIV with ANOTHER DIAGNOSIS related to HIV, RELEASED 0.1399

DESPITE MEDICAL RECOMMENDATIONS WITH CC

24313 HIV with ANOTHER DIAGNOSIS related to HIV, RELEASED 0.1399

DESPITE MEDICAL RECOMMENDATIONS WITH MCC

24320 HIV INFECTIONS ASSOCIATED with SEVERAL SERIOUS 4.3194

WITH HIV

24331 HIV with ANOTHER DIAGNOSIS related to HIV, without a FEW 5.1320

SERIOUS INFECTIONS RELATED TO HIV, TUBERCULOSIS

WITHOUT CC

24332 HIV with ANOTHER DIAGNOSIS related to HIV, without a FEW 5.1320

SERIOUS INFECTIONS RELATED TO HIV, TUBERCULOSIS

WITH CC

24333 HIV with ANOTHER DIAGNOSIS related to HIV, without a FEW 5.1320

SERIOUS INFECTIONS RELATED TO HIV, TUBERCULOSIS

WITH MCC

24341 HIV with ANOTHER DIAGNOSIS related to HIV, without a FEW 0.3905

SERIOUS INFECTIONS ASSOCIATED WITH HIV, WITHOUT

TUBERCULOSIS WITHOUT CC

24342 HIV with ANOTHER DIAGNOSIS related to HIV, without a FEW 0.8974

SERIOUS INFECTIONS ASSOCIATED WITH HIV, WITHOUT

TUBERCULOSIS WITH CC

24343 HIV with ANOTHER DIAGNOSIS related to HIV, without a FEW 3.0764

BINDING OF HIV-RELATED INFECTIONS, WITHOUT

TUBERCULOSIS WITH MCC

24350 HIV without FURTHER DIAGNOSIS HIV-related 2.4998

25011 CRANIOTOMY, a GREAT PERFORMANCE on the SPINE, HIP, and what. At 5.8146

MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC

25012 CRANIOTOMY, a GREAT PERFORMANCE on the SPINE, HIP, and what. At 6.6730

MULTIPLE SIGNIFICANT TRAUMA WITH CC

25013 CRANIOTOMY, a GREAT PERFORMANCE on the SPINE, HIP, and what. At 11.7773

MULTIPLE SIGNIFICANT TRAUMA WITH MCC

25021 OTHER PERFORMANCES in MULTIPLE SIGNIFICANT TRAUMA without CC 5.7233

25022 OTHER PERFORMANCES in MULTIPLE SIGNIFICANT TRAUMA with CC 5.7233

25023 OTHER PERFORMANCES in MULTIPLE SIGNIFICANT TRAUMA with MCC 9.3329

LONG-TERM MECHANICAL VENTILATION in 25030 POLYTRAUMATU > 51.3533

1 008 HOURS (MORE THAN 43 days) with the ECONOMICALLY DIFFICULT

PERFORMANCE

LONG-TERM MECHANICAL VENTILATION when 25040 POLYTRAUMATU > 40.8159

504 HOURS (22-42 days) with an ECONOMICALLY CHALLENGING PERFORMANCE

LONG-TERM MECHANICAL VENTILATION when 25051 POLYTRAUMATU > 25.1438

240 HOURS (11-21 days) with an ECONOMICALLY CHALLENGING PERFORMANCE

WITHOUT CC

LONG-TERM MECHANICAL VENTILATION when 25052 POLYTRAUMATU > 25.1438

240 HOURS (11-21 days) with an ECONOMICALLY CHALLENGING PERFORMANCE

WITH CC

LONG-TERM MECHANICAL VENTILATION when 25053 POLYTRAUMATU > 25.1438

240 HOURS (11-21 days) with an ECONOMICALLY CHALLENGING PERFORMANCE

WITH MCC

LONG-TERM MECHANICAL VENTILATION when 25061 POLYTRAUMATU with 16.0782

KRANIOTOMIÍ > 96 HOURS without CC

LONG-TERM MECHANICAL VENTILATION when 25062 POLYTRAUMATU with 16.0782

KRANIOTOMIÍ > 96 HOURS with the CC

LONG-TERM MECHANICAL VENTILATION when 25063 POLYTRAUMATU with 16.0782

KRANIOTOMIÍ > 96 HOURS with MCC

LONG-TERM MECHANICAL VENTILATION when 25071 POLYTRAUMATU > 15.9856 96

HOURS (5-10 days) with an ECONOMICALLY CHALLENGING PERFORMANCE

WITHOUT CC

LONG-TERM MECHANICAL VENTILATION when 25072 POLYTRAUMATU > 15.9856 96

HOURS (5-10 days) with an ECONOMICALLY CHALLENGING performance with CC

LONG-TERM MECHANICAL VENTILATION when 25073 POLYTRAUMATU > 15.9856 96

HOURS (5-10 days) with an ECONOMICALLY CHALLENGING PERFORMANCE

WITH MCC

25301 DIAGNOSIS on the head, the CHEST and the LOWER 0.8693

DURING MULTIPLE CATASTROPHIC TRAUMA WITHOUT CC

25302 DIAGNOSIS on the head, the CHEST and the LOWER 1.1109

DURING MULTIPLE CATASTROPHIC TRAUMA WITH CC

25303 DIAGNOSIS on the head, the CHEST and the LOWER 2.6759

DURING MULTIPLE CATASTROPHIC TRAUMA WITH MCC

25311 OTHER DIAGNOSES of SERIOUS MULTIPLE TRAUMA without CC 1.4733

25312 OTHER DIAGNOSES of SERIOUS MULTIPLE TRAUMA with CC 1.4733

25313 OTHER DIAGNOSES of SERIOUS MULTIPLE TRAUMA with MCC 1.4733

LONG-TERM MECHANICAL VENTILATION at 25320 POLYTRAUMATU > 139.1328

1 008 HOURS (MORE THAN 43 days)

LONG-TERM MECHANICAL VENTILATION when 25330 POLYTRAUMATU > 45.6220

504 HOURS (22-42 days)

25341 LONG-TERM MECHANICAL VENTILATION at POLYTRAUMATU > 17.2268

240 HOURS (11-21 days) without CC

LONG-TERM MECHANICAL VENTILATION when 25342 POLYTRAUMATU > 17.2268

240 HOURS (11-21 days) with CC

LONG-TERM MECHANICAL VENTILATION when 25343 POLYTRAUMATU > 17.2268

240 HOURS (11-21 days) with MCC

LONG-TERM MECHANICAL VENTILATION when 25361 POLYTRAUMATU > 12.4960

96 HOURS (5-10 days) without CC

LONG-TERM MECHANICAL VENTILATION when 25362 POLYTRAUMATU > 12.4960

96 HOURS (5-10 days) with CC

LONG-TERM MECHANICAL VENTILATION when 25363 POLYTRAUMATU > 12.4960

96 HOURS (5-10 days) with MCC

25370 DEATHS within 5 days FROM RECEIPT at POLYTRAUMATU 2.8388

88871 EXTENSIVE performances that DO NOT RELATE to the MAIN DIAGNOSIS 0.9311

WITHOUT CC

88872 EXTENSIVE performances that DO NOT RELATE to the MAIN DIAGNOSIS 2.1685

WITH CC

88873 EXTENSIVE performances that DO NOT RELATE to the MAIN DIAGNOSIS 5.4836

WITH MCC

88881 PROSTATIC performances that DO NOT RELATE to the MAIN DIAGNOSIS 0.8264

WITHOUT CC

88882 PROSTATIC performances that DO NOT RELATE to the MAIN DIAGNOSIS 0.9413

WITH CC

88883 PROSTATIC performances that DO NOT RELATE to the MAIN DIAGNOSIS 1.0312

WITH MCC

88891 PERFORMANCES limited which DO NOT RELATE to the MAIN 0.4231

THE DIAGNOSIS WITHOUT CC

88892 PERFORMANCES limited which DO NOT RELATE to the MAIN 0.8632

DIAGNOSIS WITH CC

88893 PERFORMANCES limited which DO NOT RELATE to the MAIN 2.2505

DIAGNOSIS WITH MCC

99980 MAIN DIAGNOSIS INVALID AS LAYOFF DIAGNOSIS 0.3834

99990-0.2844

--------- -----------------------------------------------------------------------



Annex 10



The group related to the diagnosis, according to Klasifikace5), with indexes of these groups

used to calculate the value of the CMalfa2008

--------- -----------------------------------------------------------------------

IR-DRG ^ 5) group name Index

--------- -----------------------------------------------------------------------

01351 NON-SPECIFIC STROKE and PRECEREBRÁLNÍ OCCLUSION 0.6548

WITHOUT A HEART ATTACK WITHOUT CC

01352 NON-SPECIFIC STROKE and PRECEREBRÁLNÍ OCCLUSION 0.7858

WITHOUT A HEART ATTACK WITH THE CC

01353 NON-SPECIFIC STROKE and PRECEREBRÁLNÍ OCCLUSION 1.104

WITHOUT A HEART ATTACK WITH MCC

01361 TRANSIENT ISCHEMIC ATTACKS without CC 0.4714

01362 TRANSIENT ISCHEMIC ATTACKS with CC 0.5461

01363 of TRANSIENT ISCHEMIC ATTACK with MCC 0.6632

01421 EPILEPTIC SEIZURES without CC 0.4581

01422 EPILEPTIC SEIZURE with CC 0.578

01423 EPILEPTIC SEIZURE with MCC 1.0264

01451 CONCUSSION without CC 0.2424

01452 CONCUSSION with CC 0.2721

01453 CONCUSSION with MCC 0.4606

OTHER DISORDERS of the EYE without 02321 CC 0.2643

OTHER DISORDERS of the eye with the 02322 CC 0.3109

OTHER DISORDERS of the EYE with 02323 MCC 0.3725

03061 PERFORMANCES on SALIVARY GLAND without CC 0.7122

03062 PERFORMANCES on SALIVARY GLAND with CC 0.8531

03063 PERFORMANCES on SALIVARY GLAND with MCC 1.1991

03081 PERFORMANCES on the neck and NOSE TONSILS without CC 0.3527

03082 PERFORMANCES on the CERVICAL and NASAL ALMONDS with CC 0.448

03083 PERFORMANCES on the CERVICAL and NASAL ALMONDS with MCC 0.7265

03311 BALANCE DISORDERS without CC 0.4264

03312 DISORDERS balance with CC 0.4985

BALANCE DISORDERS with MCC 03313 0.5455

03321 EPISTAXIS without CC 0.2494

03322 EPISTAXIS with CC 0.3032

03323 EPISTAXIS with MCC 0.4016
DISEASES of the TEETH and mouth 03341 without CC 0.497

03342 DISEASES of the TEETH and mouth with CC 0.5843

DISEASES of the TEETH and mouth 03343 with MCC 0.8715

04351 RESPIRATORY SYSTEM infection and inflammation without CC 1.1119

04352 RESPIRATORY SYSTEM infection and inflammation with CC 1.5364

04353 RESPIRATORY SYSTEM infection and inflammation with MCC 3.5769

04391 INTERSTITIAL LUNG DISEASE without CC 0.7743

04392 INTERSTITIAL LUNG DISEASE with CC 0.8131

04393 INTERSTITIAL LUNG DISEASE with MCC 1.1161

05021 PERFORMANCES at the HEART of the HEART without the FLAP LEFT SYLVIAN FISSURE CC 15.9076

05022 PERFORMANCES on the HEART, the HEART LEFT SYLVIAN FISSURE FLAP with CC 16.8148

05023 PERFORMANCES at the HEART the HEART is LEFT SYLVIAN FISSURE FLAP with MCC 20.1459

05041 PERFORMANCES on the FLAP of the HEART without CARDIAC CATHETERIZATION without CC 11.5768

05042 PERFORMANCES on HEART FLAP without CARDIAC CATHETERIZATION with CC 12.1642

05043 PERFORMANCES on the FLAP of the HEART without CARDIAC CATHETERIZATION with MCC 16.3775

05051 CORONARY BYPASS SURGERY with HEART LEFT SYLVIAN FISSURE without CC 9.5838

05052 CORONARY BYPASS SURGERY with HEART LEFT SYLVIAN FISSURE with CC 9.5838

05053 CORONARY BYPASS SURGERY with HEART LEFT SYLVIAN FISSURE with MCC 11.0004

05061 CORONARY BYPASS SURGERY without CARDIAC CATHETERIZATION without CC 7.5139

05062 CORONARY BYPASS SURGERY without CARDIAC CATHETERIZATION with CC 7.9754

05063 CORONARY BYPASS SURGERY without CARDIAC CATHETERIZATION with MCC 8.8554

05101 OTHER PERCUTANEOUS CARDIOVASCULAR PERFORMANCE DURING ACUTE 4.8038

MYOCARDIAL INFARCTION WITHOUT CC

05102 OTHER PERCUTANEOUS CARDIOVASCULAR PERFORMANCE DURING ACUTE 4.8038

MYOCARDIAL INFARCTION WITH CC

05103 OTHER PERCUTANEOUS CARDIOVASCULAR PERFORMANCE DURING ACUTE 6.2605

MYOCARDIAL INFARCTION WITH MCC

05131 OTHER PERCUTANEOUS CARDIOVASCULAR PERFORMANCE without ACUTE 4.508

MYOCARDIAL INFARCTION WITHOUT CC

05132 OTHER PERCUTANEOUS CARDIOVASCULAR PERFORMANCE without ACUTE 4.508

MYOCARDIAL INFARCTION WITH CC

05133 OTHER PERCUTANEOUS CARDIOVASCULAR PERFORMANCE without ACUTE 4.9639

MYOCARDIAL INFARCTION WITH MCC

DUE to the FAILURE of 05151 AMPUTATION of the CIRCULATORY SYSTEM, in ADDITION to the UPPER 1.9141

THE LIMBS AND FINGERS WITH LEGS WITHOUT CC

05152 AMPUTATION DUE to FAILURE of the CIRCULATORY SYSTEM, in ADDITION to the UPPER 2.5869

THE LIMBS AND FINGERS AT THE FOOT WITH CC

DUE to the FAILURE of 05153 AMPUTATION of the CIRCULATORY SYSTEM, in ADDITION to the UPPER 4.2702

THE LIMBS AND FINGERS AT THE FOOT WITH MCC

05171 AMPUTATION of UPPER LIMBS and the FINGER for the DISORDER at the foot of 1.1112

THE CIRCULATORY SYSTEM WITHOUT CC

05172 AMPUTATION of the UPPER LIMB and TOE with FEET for the DISORDER 1.534

THE CIRCULATORY SYSTEM WITH THE CC

05173 AMPUTATION of UPPER LIMBS and the FINGER for the DISORDER at the foot of 3.2858

THE CIRCULATORY SYSTEM WITH MCC

05221 PERCUTANEOUS CORONARY ANGIOPLASTY, STENTS COATED > = 3 16.5466

DURING ACUTE MYOCARDIAL INFARCTION WITHOUT CC

05222 PERCUTANEOUS CORONARY ANGIOPLASTY, STENTS COATED > = 3 16.5466

IN THE ACUTE MYOCARDIAL INFARCTION WITH CC

05223 PERCUTANEOUS CORONARY ANGIOPLASTY, STENTS COATED > = 3 16.5466

IN THE ACUTE MYOCARDIAL INFARCTION WITH MCC

05231 PERCUTANEOUS CORONARY ANGIOPLASTY, STENTS COATED < = 2 7.1902

DURING ACUTE MYOCARDIAL INFARCTION WITHOUT CC

05232 PERCUTANEOUS CORONARY angioplasty, STENTS COATED < = 2 8.3739

IN THE ACUTE MYOCARDIAL INFARCTION WITH CC

05233 PERCUTANEOUS CORONARY ANGIOPLASTY, STENTS COATED < = 2 10.0806

IN THE ACUTE MYOCARDIAL INFARCTION WITH MCC

05241 PERCUTANEOUS CORONARY angioplasty, STENTS when > = 3 9.3031

ACUTE MYOCARDIAL INFARCTION WITHOUT CC

05242 PERCUTANEOUS CORONARY ANGIOPLASTY, STENTS when > = 3 10.3474

ACUTE MYOCARDIAL INFARCTION WITH CC

05243 PERCUTANEOUS CORONARY ANGIOPLASTY, STENTS when > = 3 13.0239

ACUTE MYOCARDIAL INFARCTION WITH MCC

05261 PERCUTANEOUS CORONARY angioplasty, STENTS COATED > = 3 12.7973

WITHOUT THE ACUTE MYOCARDIAL INFARCTION WITHOUT CC

05262 PERCUTANEOUS CORONARY angioplasty, STENTS COATED > = 3 13.4586

WITHOUT THE ACUTE MYOCARDIAL INFARCTION WITH CC

05263 PERCUTANEOUS CORONARY ANGIOPLASTY, STENTS COATED > = 3 13.4586

WITHOUT THE ACUTE MYOCARDIAL INFARCTION WITH MCC

05271 PERCUTANEOUS CORONARY ANGIOPLASTY, STENTS COATED < = 2 6.1329

WITHOUT THE ACUTE MYOCARDIAL INFARCTION WITHOUT CC

05272 PERCUTANEOUS CORONARY ANGIOPLASTY, STENTS COATED < = 2 6.7609

WITHOUT THE ACUTE MYOCARDIAL INFARCTION WITH CC

05273 PERCUTANEOUS CORONARY ANGIOPLASTY, STENTS COATED < = 2 7.3592

WITHOUT THE ACUTE MYOCARDIAL INFARCTION WITH MCC

05281 PERCUTANEOUS CORONARY ANGIOPLASTY, STENTS without > = 3 8.6966

ACUTE MYOCARDIAL INFARCTION WITHOUT CC

05282 PERCUTANEOUS CORONARY ANGIOPLASTY, STENTS without > = 3 9.3463

ACUTE MYOCARDIAL INFARCTION WITH CC

05283 PERCUTANEOUS CORONARY ANGIOPLASTY, STENTS > = 3 without 11.226

ACUTE MYOCARDIAL INFARCTION WITH MCC

05291 PERCUTANEOUS CATHETER ABLATION without ACUTE MYOCARDIAL 9.848

INFARCTION WITHOUT CC

05292 PERCUTANEOUS CATHETER ABLATION without ACUTE MYOCARDIAL 9.848

INFARCTION WITH CC

05293 PERCUTANEOUS CATHETER ABLATION without ACUTE MYOCARDIAL 9.848

INFARCTION WITH MCC

05311 CARDIAC CATHETERIZATION in the ISCHEMIC HEART without CC 0.6336

05312 CARDIAC CATHETERIZATION in the ISCHEMIC HEART with CC 0.7368

05313 CARDIAC CATHETERIZATION in the ISCHEMIC HEART with MCC 0.8109

05391 ATHEROSCLEROSIS without CC 0.439

05392 ATHEROSCLEROSIS with CC 0.6042

05393 ATHEROSCLEROSIS with MCC 0.9448

05401 HYPERTENSION without CC 0.3958

05402 HYPERTENSION with CC 0.4661

05403 HYPERTENSION with MCC 0.5487

06011 LARGE PERFORMANCES on THICK and THIN STŘEVU without-CC 3.3212

GREAT PERFORMANCE on FAT 06012 and THIN STŘEVU with CC 3.9606

GREAT PERFORMANCE on FAT 06013 and THIN STŘEVU with MCC 5.9249

06051 PERFORMANCES on APENDIX without CC 0.7566

06052 PERFORMANCES on APENDIX with CC 0.9897

06053 PERFORMANCES on the APENDIX with MCC 1.6828

LAPAROTOMICKÉ PERFORMANCES when 06081 INGUINAL, Femoral, UMBILICAL 0.4694

OR EPIGASTRIC KÝLE WITHOUT-CC

06082 LAPAROTOMICKÉ PERFORMANCES in the INGUINAL, Femoral, UMBILICAL 0.6714

OR EPIGASTRIC KÝLE WITH CC

LAPAROTOMICKÉ PERFORMANCES when 06083 INGUINAL, Femoral, UMBILICAL 1.0373

OR EPIGASTRIC KÝLE WITH MCC

06311 PEPTIC ULCER and GASTRITIS without CC 0.468

06312 PEPTIC ULCER and GASTRITIS with CC 0.7827

06313 PEPTIC ULCER and GASTRITIS with MCC 1.2081

06331 DIVERTICULITIS, DIVERTICULOSIS and INFLAMMATORY DISEASE 0.5033

THE INTESTINE WITHOUT CC

06332 DIVERTICULITIS, DIVERTICULOSIS and INFLAMMATORY DISEASE 0.6548

THE INTESTINES WITH CC

06333 DIVERTICULITIS, DIVERTICULOSIS and INFLAMMATORY DISEASE 1.4263

THE INTESTINES WITH MCC

06351 OBSTRUCTION of the GASTROINTESTINAL SYSTEM without CC 0.4254

OBSTRUCTION of the GASTROINTESTINAL SYSTEM 06352 with CC 0.6122

06353 OBSTRUCTION of the GASTROINTESTINAL SYSTEM with MCC 1.309

06371 OTHER GASTROENTERITIS and ABDOMINAL PAIN without CC 0.2834

06372 OTHER GASTROENTERITIS and ABDOMINAL PAIN with CC 0.4209

06373 OTHER GASTROENTERITIS and ABDOMINAL PAIN with MCC 0.5866

in ADDITION to LAPAROSCOPIC CHOLECYSTECTOMY, 07031 without CC 1.26

07032 CHOLECYSTECTOMY, LAPAROSCOPIC 1.8644 in ADDITION with CC

in ADDITION to LAPAROSCOPIC CHOLECYSTECTOMY, 07033 with MCC 3.1713

OTHER DISORDERS of the BILIARY TRACT 07341 without CC 0.5266

OTHER DISORDERS of the BILIARY TRACT 07342 with CC 0.7564

07343 OTHER DISORDERS of the BILE DUCTS with MCC 1.0783

08031 FUSION of SPINE, not for the DEFORMITY without CC 5.231

08032 FUSION of the SPINE, NOT for DEFORMITY with CC 5.9789

08033 FUSION of the SPINE, NOT for DEFORMITY with MCC 7.576

08081 PERFORMANCES on the HIPS and thigh BONES, in ADDITION REPLANTACE 2.0973

THE LARGE JOINTS WITHOUT CC

08082 PERFORMANCES on the HIPS and thigh BONES, in ADDITION REPLANTACE 2.4736

THE LARGE JOINTS WITH CC

08083 PERFORMANCES on the HIPS and THIGH BONES, in ADDITION REPLANTACE 3.2418

THE LARGE JOINTS WITH MCC

08101 PERFORMANCES on HIS BACK and neck, in ADDITION to the FUSION of the SPINE without CC 1.2288

08102 PERFORMANCES on HIS BACK and neck, in ADDITION to the FUSION of the SPINE with CC 1.7562

08103 PERFORMANCES on HIS BACK and neck, in ADDITION to the FUSION of the SPINE with MCC 2.3104

08121 CUT INTERNAL FIXATION DEVICE without CC 0.295

REMOVAL of INTERNAL FIXATION DEVICES 08122 with CC 0.3239

REMOVAL of INTERNAL FIXATION DEVICES 08123 with MCC 0.4559

08371 CONSERVATIVE TREATMENT for BACK PROBLEMS without CC 0.502

08372 CONSERVATIVE TREATMENT of BACK PROBLEMS with CC 0.6009

08373 the CONSERVATIVE TREATMENT of BACK PROBLEMS with MCC 0.7086

09301 SERIOUS SKIN DISORDERS without CC 0.79

09302 SERIOUS DISORDERS of the skin with CC 0.8304

09303 SERIOUS DISORDERS of the skin with MCC 0.9999

09321 FLEGMÓNA without CC 0.4996

09322 FLEGMÓNA with CC 0.741

09323 FLEGMÓNA with MCC 0.9489

09341 OTHER DISORDERS of the skin and the BREAST without the CC 0.4071

09342 OTHER DISORDERS of skin and BREAST with CC 0.5775

OTHER SKIN DISORDERS and 09343 BREAST with MCC 0.7576

10041 AMPUTATION of the LOWER LIMB in the ENDOCRINE, NUTRITIONAL 1.8811

AND METABOLIC DISORDERS WITHOUT CC

10042 AMPUTATION of the LOWER LIMB in the ENDOCRINE, NUTRITIONAL 2.246
AND METABOLIC DISORDERS WITH CC

10043 AMPUTATION of the LOWER LIMB in the ENDOCRINE, NUTRITIONAL 2.246

AND METABOLIC DISORDERS WITH MCC

10051 PERFORMANCES on the THYROID and the PARATHYROID GLAND, THYROGLOSSÁLNÍ PERFORMANCE 0.9157

WITHOUT CC

10052 PERFORMANCES on the THYROID and the PARATHYROID GLAND, THYROGLOSSÁLNÍ PERFORMANCES of 1.009

WITH CC

10053 PERFORMANCES on the THYROID and the PARATHYROID GLAND, THYROGLOSSÁLNÍ PERFORMANCE 1.1147

WITH MCC

10301 DIABETES, NUTRITIONAL and other METABOLIC DISORDERS without CC 0.4919

10302 DIABETES, NUTRITIONAL and other METABOLIC DISORDERS with CC 0.604

10303 DIABETES, NUTRITIONAL and other METABOLIC DISORDERS with MCC 0.9586

11051 LESS PERFORMANCES on the KIDNEYS, URINARY TRACT and URINARY 0.9339

BLADDER WITHOUT CC

11052 LESS PERFORMANCES on the KIDNEYS, URINARY TRACT and URINARY 0.9817

BLADDER WITH CC

11053 LESS PERFORMANCES on the KIDNEYS, URINARY TRACT and URINARY 1.4489

BLADDER WITH MCC

11061 PROSTATECTOMY without CC 0.9986

11062 PROSTATECTOMY with CC 1.1386

11063 PROSTATECTOMY with MCC 1.3764

11071 URETHRAL and TRANSURETHRAL PERFORMANCES without CC 0.4571

11072 URETHRAL and TRANSURETHRAL PERFORMANCES with CC 0.5501

11073 URETHRAL and TRANSURETHRAL PERFORMANCES with MCC 0.6704

11321 KIDNEY INFECTION and urinary tract without CC 0.4442

11322 KIDNEY INFECTION and urinary tract with CC 0.6081

11323 KIDNEY INFECTION and urinary tract with MCC 0.8134

11331 BLADDER STONES with EXTRACORPOREAL SHOCK WAVE LITOTRYPSÍ without-CC 0.4037

11332 BLADDER STONES with EXTRACORPOREAL SHOCK WAVE LITOTRYPSÍ with CC 0.5688

11333 BLADDER STONES with EXTRACORPOREAL SHOCK WAVE LITOTRYPSÍ with MCC 0.5688

11341 BLADDER STONES without EXTRACORPOREAL LITOTRYPSE without-CC 0.2971

11342 BLADDER STONES without EXTRACORPOREAL LITOTRYPSE with CC 0.4181

11343 BLADDER STONES without EXTRACORPOREAL LITOTRYPSE with MCC 0.5754

12021 PERFORMANCES on the PENIS without CC 0.3858

12022 PERFORMANCES on the PENIS with CC 0.5571

12023 PERFORMANCES on the PENIS with MCC 0.5571

12031 TRANSURETHRAL PROSTATECTOMY without CC 0.8386

12032 TRANSURETHRAL PROSTATECTOMY with CC 1.0148

12033 TRANSURETHRAL PROSTATECTOMY with MCC 1.0148

12051 CIRCUMCISION without CC 0.2569

12052 CIRCUMCISION with CC 0.28

12053 CIRCUMCISION with MCC 0.3494

13011 EXENTERACE PANS, RADICAL HYSTERECTOMY and radical 2.7644

VULVEKTOMIE WITHOUT-CC

13012 EXENTERACE PANS, RADICAL HYSTERECTOMY and radical 3.0913

VULVEKTOMIE WITH CC

13013 EXENTERACE PANS, RADICAL HYSTERECTOMY and radical 3.0913

VULVEKTOMIE WITH MCC

13021 PERFORMANCES on the UTERUS and ADNEXECH for MALIGNANT DISEASE on 2.3502

OVARIÍCH AND ADNEXECH WITHOUT-CC

13022 PERFORMANCES on the UTERUS and ADNEXECH for MALIGNANT DISEASE to 2.945

OVARIÍCH AND ADNEXECH WITH CC

13023 PERFORMANCES on the UTERUS and ADNEXECH for MALIGNANT DISEASE to 2.945

OVARIÍCH AND ADNEXECH WITH MCC

13051 GYNECOLOGICAL LAPAROSCOPY or LAPAROTOMICKÁ 0.463 STERILIZATION

WITHOUT CC

13052 GYNECOLOGICAL LAPAROSCOPY or LAPAROTOMICKÁ 0.7342 STERILIZATION

WITH CC

13053 GYNECOLOGICAL LAPAROSCOPY or LAPAROTOMICKÁ 1.2553 STERILIZATION

WITH MCC

13071 VAGINAL, CERVICAL and VULVOVÉ PERFORMANCES without CC 0.2638

13072 VAGINAL, CERVICAL and VULVOVÉ PERFORMANCES with CC 0.4005

13073 VAGINAL, CERVICAL and VULVOVÉ PERFORMANCES with MCC 0.6491

13081 ENDOSCOPIC INTERRUPTION of FALLOPIAN TUBE without CC 0.5487

13082 ENDOSCOPIC INTERRUPTION of FALLOPIAN TUBE with CC 0.5843

13083 ENDOSCOPIC INTERRUPTION of FALLOPIAN TUBE with MCC 0.5843

13311 INFECTION of the FEMALE REPRODUCTIVE SYSTEM without CC 0.2962

13312 INFECTION of the FEMALE REPRODUCTIVE SYSTEM with CC 0.5153

13313 INFECTION of the FEMALE REPRODUCTIVE SYSTEM with MCC 0.5153

14601 BIRTH CESAREAN SECTION without CC 0.8903

14602 BIRTH CESAREAN SECTION with CC 1.0723

14603 BIRTH CESAREAN SECTION with MCC 1.2703

14611 VAGINAL CHILDBIRTH, STERILIZATION and/or DILATION and KYRETÁŽÍ 0.6391

WITHOUT CC

14612 VAGINAL CHILDBIRTH, STERILIZATION and/or DILATION and KYRETÁŽÍ 0.7571

WITH CC

14613 VAGINAL CHILDBIRTH, STERILIZATION and/or DILATION and KYRETÁŽÍ 0.9687

WITH MCC

14631 VAGINAL CHILDBIRTH without CC 0.4919

14632 VAGINAL CHILDBIRTH with CC 0.5565

14633 VAGINAL CHILDBIRTH with MCC 0.5565

14641 ABORTION dilation and KYRETÁŽÍ, KYRETÁŽÍ or 0.1879 ASPIRATION

HYSTERECTOMIES WITHOUT CC

14642 ABORTION dilation and KYRETÁŽÍ, KYRETÁŽÍ or 0.2202 ASPIRATION

HYSTERECTOMIES WITH CC

14643 ABORTION dilation and KYRETÁŽÍ, KYRETÁŽÍ or 0.2379 ASPIRATION

HYSTERECTOMIES WITH MCC

14651 ABORTION without dilation and CURETTAGE, 0.1741 ASPIRATION CURETTAGE

OR A HYSTERECTOMY WITHOUT CC

14652 ABORTION without dilation and CURETTAGE, 0.1741 ASPIRATION CURETTAGE

OR A HYSTERECTOMY WITH CC

14653 ABORTION without dilation and CURETTAGE, 0.1741 ASPIRATION CURETTAGE

OR A HYSTERECTOMY WITH MCC

14701 THREATENED ABORTION without CC 0.3099

14702 THREATENED ABORTION with CC 0.4775

14703 THREATENED ABORTION with MCC 0.4775

14711 FAKE BIRTH without CC 0.1513

14712 FAKE BIRTH with CC 0.216

14713 FAKE BIRTH with MCC 0.216

15691 newborn, BIRTH WEIGHT of 2 000-2 499 G, without 0.9626

THE BASIC PERFORMANCE WITHOUT CC

15692 newborn, BIRTH WEIGHT of 2 000-2 499 G, without 1.9467

THE BASIC PERFORMANCE WITH CC

15693 newborn, BIRTH WEIGHT of 2 000-2 499 G, without 4.2844

THE BASIC PERFORMANCE WITH MCC

15751 newborn, BIRTH WEIGHT > 2 499 G, without a BASIC 0.2742

PERFORMANCE WITHOUT CC

15752 newborn, BIRTH WEIGHT > 2 499 G, without a BASIC 0.3616

PERFORMANCE WITH CC

15753 newborn, BIRTH WEIGHT > 2 499 G, without BASIC 0.41

PERFORMANCE WITH MCC

18311 POSTOPERATIVE and POSTTRAUMATIC INFECTIONS without CC 0.6324

18312 post-operative and POSTTRAUMATIC infections with CC 0.9376

of POST-OPERATIVE and POSTTRAUMATIC 18313 INFECTION with MCC 1.581

18331 VIRAL DISEASE without CC 0.427

18332 VIRAL DISEASE with CC 0.5591

18333 VIRAL DISEASE with MCC 0.6982

20301 the HARMFUL USE of ALCOHOL, DRUGS, DRUG ABUSE, DEPENDENCE on THEM, 0.1401

THE RELEASE AGAINST THE DOCTOR'S RECOMMENDATIONS WITHOUT CC

20302 the HARMFUL USE of ALCOHOL, DRUGS, DRUG ABUSE, DEPENDENCE on THEM, 0.1401

WITH THE RELEASE OF THE DOCTOR'S RECOMMENDATION AGAINST CC

20303 HARMFUL USE of ALCOHOL, DRUGS, DRUG ABUSE, DEPENDENCE on THEM, 0.1401

THE RELEASE OF THE DOCTOR'S RECOMMENDATION WITH MCC

20331 HARMFUL use and DEPENDENCE on ALCOHOL without CC 0.4149

20332 HARMFUL use and DEPENDENCE on ALCOHOL with CC 0.5093

20333 HARMFUL use and DEPENDENCE on ALCOHOL with MCC 0.8676

--------- -----------------------------------------------------------------------



Annex 11



The amount of the reimbursement of health care under section 7

-------- ----------------------------------------------- ---------------------------------------------------------

Code Enforcement regulatory restrictions of the above remuneration

-------- ----------------------------------------------- ---------------------------------------------------------

00901 Examination and treatment of a registered combination of 00901, 00902, 00946

the insured person or unable to report in one 00947

Examination of the State of teeth, periodontal disease, mucous calendar quarter. You can report 1/1

and the soft tissues of the oral cavity, jaw on the insured's State of the year within the care

and mezičelistních relations, medical histories, and adults and children individual dental care 368 Czk

determination of the treatment plan in the context of care and adolescents.

paid for by health insurance. Training expertise-014 with acknowledgement of

(only once per insured person)/kontrola systematic participation in the system of training

oral hygiene, hygiene of interdental, actions of the lifelong education of dental

massage, removal of tartar, including doctors ^ 6)

the treatment of common conditions and inflammation of the gingiva

and the mucous membranes of the oral cavity, periodontal disease

(periodontal abscess, thrush treatment

of herpes or dekubitu caused by scanning

replacement and other) treatment dentitio

difficilis regardless of the number of visits.

-------- ----------------------------------------------- ---------------------------------------------------------

00902 Repeated examination and treatment in the context of the Combined Code 00901, 00902, 00946 or

preventive care 00947 not kick in one calendar

Repeated examination of the State of teeth, quarter. You can report 1/1 year

periodontal disease and soft tissue, mucous cavity of the policyholder within individual care

oral. Control of oral hygiene, adults and under the individual care of 294 Czk

interdental hygiene, including denture care of children up to 6 years; 2/year within

common afflictions, and inflammation of the gingiva and mucosa of the individual dental care of children and adolescents
oral, periodontal disease (periodontal from 6 to 18 years of age, pregnant women, 2 x in

abscess, oral thrush, treatment of herpes, or during pregnancy.

dekubitu caused by sensor replacement and expertise-014 with acknowledgement of

other) treatment dentitio difficilis without systematic participation in the system of training

regardless of the number of visits. Topical application of actions of the lifelong education of dental

fluoride preparations, according to doctors with the use of ^ 6).

Annex No. 1 of the Act.

-------- ----------------------------------------------- ---------------------------------------------------------

00903 Requested examination by an expert or you cannot combine with code 00908. Can be

specialist report 1/1 day. Expertise-014 with

Examination by an expert or a specialist certificate of continuous participation in the

on the basis of the recommendation of another doctor (in the system of lifelong training events

urgent States even without a recommendation), the training of dental practitioners ^ 6); 015; 605.200 Czk

a short written report. Not picking

treatment.

-------- ----------------------------------------------- ---------------------------------------------------------

00904 Dental examination of the registered hours can 1/1 year only in the context of

the insured person from 1 year to 6 years under the code and, where applicable, 00947 00902

preventive care diagnosis of 012-dental examination. 105 Eur

Expertise-014.

-------- ----------------------------------------------- ---------------------------------------------------------

Dental treatment to the insured's 00906 hours can 1/1 day.

6 years or hendikepovaného policyholders expertise-014.

Remuneration takes into account the increased time

performance of the insured's treatment. Holder

confirmation of systematic participation in system 95 Czk

courses for lifelong learning

dentists ^ 7) hours can even when in

the requested care of undocumented

the insured person.

-------- ----------------------------------------------- ---------------------------------------------------------

Dental treatment the insured 00907 from 6 years To report 1/1 day.

to 15 years only when visiting kurativní (cannot be

Remuneration takes into account the increased time sheet codes 00901, 00902, 00903,

performance of the insured's treatment. Holder, 00909 00946, 00947 and diagnosis of 012-

the confirmation of continuous participation in the system of dental examinations). 68 Czk

training events for lifelong learning expertise-014.

dentists ^ 7) hours can even when

the requested care of undocumented policy holder.

-------- ----------------------------------------------- ---------------------------------------------------------

00908 Acute treatment and examination cannot be combined with code and 00909 00903.

unregistered beneficiary within hours can 1/1 day.

emergency services expertise-014.

Acute treatment of accidental insured persons outside the

framework of preventive care. Treatment includes 295 Czk

examination, palliative treatment in

endodoncy, amputation and pulp, exstirpaci

temporary fill, topical treatments

gingiva/lining, conservative treatment

dentitio difficilis or parodontálního

drain the abscess, Exchange, repair/adjustment of the fixed

or dentures in the doctor's Office

and the like.

-------- ----------------------------------------------- ---------------------------------------------------------

00909 Clinical dental examinations cannot be combined with the codes, 00901

Examination of expert clinical 00902, 00903, 908.00945, 00946 and

workplace on the basis of the recommendation of another 00947. Combined skódem 00907

doctor (when urgent States even without the report cannot be independently with the diagnosis of 012

recommendations), a short written report. -dental examination. The code can be nasmlouvat 410 Czk

May not establish treatment. even by the dental device

and the Dental Research Institute.

You can report 1/1 day.

When the diagnosis requiring recurring

You can visit vykázatjen once,

with cleft defects, cancer

and Traumatology diagnosis report can be

only once, at the start of treatment.

Expertise-014; 015.

-------- ----------------------------------------------- ---------------------------------------------------------

00910 Making x-ray-intraorálního you can report without restrictions.

slide the expertise-014; 015; 605.

Making a radiograph on the Special

dentálním x-ray apparatus or other

imaging method (condition is 70 CZK

the slide).

Has medical facilities, which

indicates the snapshot (even when making

the slide in another health care facility).

-------- ----------------------------------------------- ---------------------------------------------------------

00911 Making x-ray-extraorálního you can report without restrictions.

slide the expertise-014; 015; 605.

The making of a skiagrafie skull different

projections for each frame. Exhibits

medical devices that frame 225 Czk

indicate, in the case of expertise and 015

radiograph of the hand (determination of the phase

the growth of the skeleton).

-------- ----------------------------------------------- ---------------------------------------------------------

00912 contrast medium Filling the salivary glands can be kick-without restrictions.

Earth, dilation, salivary glands, and expertise-014 with proof of continuous

the ducts of the contrast medium. Subsequent participation in the system of training events

x-ray examination is reported from the code of the lifelong education of dental

00911 or 00913 medical facilities, lékařů6]; 605.581 Eur

that snapshot indicates.

-------- ----------------------------------------------- ---------------------------------------------------------

00913 Making ortopantomogramu hours can 1/2 years (limitation of

The making of a extraorálního panoramic frequencies do not pay for the expertise of 605,

slide on a special x-ray 015 and for confirmation of expertise 014

the device. Has medical facilities, systematic participation in the system of training

that snapshot indicates. the actions of the lifelong education of dental 275 Czk

lékařů6]; 015; 605.

-------- ----------------------------------------------- ---------------------------------------------------------

00914 Evaluation ortopantomogramu you can report 1/1 frame/1

Evaluation of panoramic x-ray medical equipment.

frame arches and the skeleton of the jaws, expertise-014; 015; 605.

or other extraorálních images.

Medical device that shows 70 CZK

indicates the snapshot (even when making

the slide in another medical devices);

in the case of the insured's submit to another

a dentist who holds a

confirmation of systematic participation in the system

courses for lifelong learning

dentists ^ 7), this code can report the

medical device.

-------- ----------------------------------------------- ---------------------------------------------------------

00915 Making telerentgenového slide lbi hours can 1/1 year.

Making remote x-ray snapshot of expertise-014 with proof of continuous

LBI on a special x-ray machine. participation in the system of training events

Medical device that shows the lifelong education of dental

snapshot indicates. ^ 6 practitioners); 015; 605.270 Czk

-------- ----------------------------------------------- ---------------------------------------------------------

00916 anesthesia on the foramen mandibulae and hours can-without restrictions.

infraorbitale expertise-014; 015; 605.

The application of injectable anesthesia on the foramen

mandibulae (the application is included in the

nervus buccalis) and foramen infraorbitale 100 Czk

(the application is included on the nervus

The Palatinus), in all cases, if the

anesthesia is indicated by a physician.

-------- ----------------------------------------------- ---------------------------------------------------------

00917 Anesthesia infiltrační hours can-without restrictions.

Application of injectable anesthesia for every expertise-014; 015; 605.

Sextant including anesthesia on the foramen

the foramen mentale, palatinum maius and

the foramen incisivum. Anestezovaná counts 80 CZK

the area, not the number of strokes; in all the

the cases, if the anesthesia is indicated

doctor.

-------- ----------------------------------------------- ---------------------------------------------------------
00920 Treatment of tooth decay-permanent tooth-tooth/hours can 1 l/day.

composite fill location-tooth.

Treatment of dental caries of the standing of the tooth expertise-014; 015; 605.

composite fillings for insured persons under 18

years in the range of the Studio including, regardless of 315 Czk

the number of pads fills or any number of

small fillings on one tooth.

-------- ----------------------------------------------- ---------------------------------------------------------

00921 Treatment of tooth decay-permanent tooth hours can 1 tooth/365 days.

Treatment of tooth decay finally fills, limiting the frequency of senetýká cases, when

regardless of the number of pads fills or repeated fill is made due to the

any number of minor complications insets on a single treated tooth decay or

the tooth, when you use the samopolymerujících accident-in this case the fill 220 Czk

composite materials in the scope of the canine teeth present with another diagnosis. Before

including, and nedózovaného in the entire amalgam for 1 year can be vykázatvýplň in the case of

the range. high cavities in baby přizávažných

of the total, or diseases

damage of teeth.

Location-tooth.

Expertise-014; 015; 605.

-------- ----------------------------------------------- ---------------------------------------------------------

00922 Treatment of tooth decay-a temporary tooth Can declare 1 tooth/6 months.

Treatment of dental caries of the temporary restrictions on frequency of tooth senetýká in cases where the

Finally, regardless of the number of repeated the fill is made due to the

fill any number of faces or minor complications treated tooth decay or

fill in one of the tooth and the material used. accident-in this case the fill 126 Usd

reported with another diagnosis. Earlier than

6 months can be vykázatvýplň in the case of

high přizávažných cavities in baby Grand

diseases.

Location-tooth.

Expertise-014; 015; 605.

-------- ----------------------------------------------- ---------------------------------------------------------

00923 conservative treatment dental complications cannot be combined with code 00925.

decay-permanent tooth hours can 1/1 channel/1 tooth. For more

Includes Palliative performance, mechanical, than one Canal jenutno demonstrate

chemical and drug preparation radiograph.

and provisional restorations. Location-tooth. 181 Usd

After clinching the endodontickém treatment of the tooth expertise-014; 015; 605.

for each full root canal

the standard material in accordance with Annex No 1

the law. The number of visits to a not selected.

-------- ----------------------------------------------- ---------------------------------------------------------

00924 conservative treatment of complications of dental hours can 1/1 channel/1 tooth.

tooth decay-temporary location-tooth.

After clinching the endodontickém treatment expertise-014; 015; 605.

temporary tooth standard material

According to the annex No. 1 of the Act method vital 176 Czk

or mortální amputation of 1 x. When the eventual

exstirpaci each filled root

Canal. Treatment is possible, if it is

temporary tooth clinically hard. According to the

up to half of the x-ray resorbtion

the root.

-------- ----------------------------------------------- ---------------------------------------------------------

00925 conservative treatment dental complications cannot be combined with code 00923.

caries (II). -permanent tooth hours can 1/1 channel/tooth.

Includes Palliative performance, mechanical, For more than one channel to be

drug preparation and makeshift demonstrate radiograph.

the fill. After clinching the endodontickém location-tooth. 265 Usd

treatment of the tooth using standard material expertise-014; 015; 605.

According to the annex No. 1 of the Act, for each

full root canal agreed

When using the standard procedure

the registered material. The number of visits

does not act. Even when the treatment of the tooth using the method

apexifikace.

-------- ----------------------------------------------- ---------------------------------------------------------

conservative treatment of chronic 00931 hours can 1/1 year.

periodontal disease expertise-014 with proof of continuous

Periodontal examination, examination of the participation in the system of training events

using CPITN index of lifelong education, dental

determination of the treatment plan, doctors start ^ 6). 700 Czk

conservative treatment-eliminate dental

Stone, education and motivation for oral

hygiene.

-------- ----------------------------------------------- ---------------------------------------------------------

00932 Maintenance treatment of chronic diseases Can report 3/1 year.

periodontal disease In the third report in code should be

A comprehensive examination of periodontal treatment on the basis of assessed by using of

the classification of diseases in the examination using CPITN index.

of CPITN index, when expertise-014. 243 Usd

fixed parodontologický index CPI 2-3,

or other parodontologických indices

and investigative methods in the course of the

Periodontal treatment, not in the context of the

preventive care. The continuation of the conservative

treatment (initial or maintenance stage)-

control of oral hygiene by using the

the specified parodontologických index

(for example, PBI, API and the like), which

the value must be recorded in the

documentation, the removal of tartar,

remotivace and correction of specific methods

oral hygiene, removal of the local

irritation of the periodontal disease. Temporary splints from free

hand to stabilize drooling with weakened

periodontal disease (code 00938) and subgivingivální

treatment (code 00935) is recorded separately.

-------- ----------------------------------------------- ---------------------------------------------------------

00933 surgical treatment of periodontal disease can be kick-without restrictions.

small scale location-tooth.

Performed surgery expertise-014 with proof of continuous

in the mukogingivální area, building on the participation in the system of training events

conservative treatment of chronic diseases of the lifelong education of dental 420 Czk

periodontal disease (gingivektomie with a sculpture) ^ 6 practitioners).

for each tooth.

-------- ----------------------------------------------- ---------------------------------------------------------

00934 surgical treatment of periodontal disease can be kick-without restrictions.

a large range of expertise-014 with proof of continuous

Surgical procedures building on the participation in the system of training events

conservative treatment of chronic diseases of lifelong education, dental

periodontal disease leading to deepening the vestibule doctors ^ 6). 1 000 Czk

and performance with the by mukoperiostálního

lobe, leading to the removal of periodontal

Clin-for each sextant. You cannot declare

performances with guided tissue regeneration

and implantation.

-------- ----------------------------------------------- ---------------------------------------------------------

Subgingivální treatment of Instrumental 00935 hours can 1/1 tooth/365 days.

delete the contents of the parodontálního trunk Localization-tooth.

(subgingiválního Tartar and plaque), expertise-014 with proof of continuous

removal of nekrotického cement, ohlazení participation in the system of training events

the surface of the tooth root and its control. the lifelong education of dental 84 Usd

You can make small instruments, practitioners ^ 6).

ultrasonic or laser equipment or

their combinations.

-------- ----------------------------------------------- ---------------------------------------------------------

00936 removal, and ensure the transfer of the transplant hours can-without restrictions.

Surgery leading to the acquisition of expertise-014 with proof of continuous

slizničního or bone graft. participation in the system of training events

lifelong education, dental

^ 6 practitioners); 605.600 Czk



-------- ----------------------------------------------- ---------------------------------------------------------

00937 Articulation of the teeth Can report 1/1 year.

After the implementation of the overall zábrusu occlusion and expertise-014 with proof of continuous

the articulation of the teeth on the basis of the term of the participation to the system of training events

examination of the stomatognátního system. Be lifelong training of dental
demonstrate models before and after the treatment. ^ 6 practitioners). 433 Czk

-------- ----------------------------------------------- ---------------------------------------------------------

00938 Temporary splints to stabilize the teeth with the hours can 1/1 tooth/365 days.

Localization of periodontal disease-weakened tooth.

Temporary splints from a free hand to expertise-014; 015.

stabilize the teeth with compromised periodontal disease

made in accordance with Annex No. 1 of Act 44 Usd

(self-polymerizing resin composite).

Recorded for each tooth.

-------- ----------------------------------------------- ---------------------------------------------------------

a comprehensive examination and proposal 00940 treatment hours can 1/1 year.

diseases of the oral mucosa expertise-014 with proof of continuous

For a comprehensive examination of the oral mucosa, the participation in the system of training events

the diagnosis. lifelong education, dental

^ 6 practitioners). 700 Czk

-------- ----------------------------------------------- ---------------------------------------------------------

00941 Inspection examination and treatment the disease Can declare-without restrictions.

the oral mucosa expertise-014 with proof of continuous

When control tests during treatment. participation in the system of training events

lifelong education, dental

^ 6 practitioners). 300 Czk

-------- ----------------------------------------------- ---------------------------------------------------------

00943 Measurement of galvanic currents Can declare-without restrictions.

Measurement of galvanic currents in the oral cavity expertise-014 with proof of continuous

When the examination of mucosal changes and measure participation in the system of training events

impedance. lifelong education, dental

^ 6 practitioners); 605.88 Usd

-------- ----------------------------------------------- ---------------------------------------------------------

You cannot declare a targeted examination 00945 in combination with codes

The examination focused on specific problems, 00901, 00902, 00909, 903.00908

the insured person. For the insured, registered, 00931 00932, 940.00941, 00946,

If the agreed long-term 00947, 00981, 983.00984.

the hosts and the care provided within hours can-without restrictions, while treatment 10 CZK

expertise, even for unregistered in 015 several visits (endodontic

policy holders. treatment, prosthetic replacements

and others) only once.

Expertise-014; 015.

-------- ----------------------------------------------- ---------------------------------------------------------

the examination and treatment of 00946 registered 00901, 00902 combination of codes,

the insured person and cannot even 00946 00947 report

Examination of the State of teeth, periodontal disease, in one kalendářnímčtvrtletí.

mucous membranes and soft tissues of the oral cavity, the State Can declare 1/1 year on the insured's

JAWS and mezičelistních relations, history and in the care of adult 336 Czk

determination of the treatment plan in the context of care and individual dental care for children and

the coverage of health insurance. Puppy training.

(only once on the insured's/control expertise-014.

oral hygiene, hygiene, interdental

massage, including the removal of tartar

the treatment of common conditions and inflammation

gingiva and mucosa of the oral cavity,

periodontal disease (periodontal abscess,

treatment of herpes or thrush, dekubitu

due to the sensor replacement and others)

dentitio difficilis treatment regardless of

the number of visits.

-------- ----------------------------------------------- ---------------------------------------------------------

00947 Repeated examination and treatment in the context of the Combined Code 00901, 00902, 00946 and

preventive care and cannot declare 00947 in one calendar

Repeated examination of the State of teeth, quarter.

periodontal disease and soft tissue, mucous cavity Can report 1/1 year to insured persons under the

oral. Control of oral hygiene, care of adults and within individual 263 Usd

interdental hygiene, including treating the dental care of children do6 years; 2/year within

common afflictions, and inflammation of the gingiva and mucosa of the individual dental care of children and adolescents

oral, periodontal disease (periodontal from 6 to 18 years of age, pregnant women, 2 x

abscess, oral thrush, treatment of herpes, or during pregnancy.

dekubitu caused by sensor replacement and expertise-014.

other) treatment dentitio difficilis without

regardless of the number of visits. Local application

with the use of fluoride products

Annex No. 1 of the Act.

-------- ----------------------------------------------- ---------------------------------------------------------

temporary tooth Extraction 00949 hours can 1/1.

Temporary tooth extraction, or radixu (without the Localization-tooth.

subsequent surgical intervention) including expertise-014; 015; 605.

event. separation of radixů, exkochleace

granulation, sutures and bleeding 87 Czk

compression tamponádou.

-------- ----------------------------------------------- ---------------------------------------------------------

the permanent tooth Extraction 00950 hours can 1/1.

Extraction of standing tooth or radixu (no Localization-tooth.

subsequent surgical intervention) including expertise-014; 015; 605.

any separation of radixů, exkochleace

granulation, sutures and bleeding 168 Czk

compression tamponádou.

-------- ----------------------------------------------- ---------------------------------------------------------

00951 hard tissues of the oral cavity Surgery hours can-without restrictions.

small scale location-tooth.

The extraction of the tooth or radixu with the Cabinet of expertise-014; 605.

mukoperiostálního lobe and hemiextrakce

or levelness bezzubého alveolárního 525 Czk

Tip in the range of sextantu to one or

surgical revision of the extraction wound.

-------- ----------------------------------------------- ---------------------------------------------------------

00952 hard tissues of the oral cavity Surgery hours can-without restrictions.

a large range of expertise-014 with proof of continuous

The extraction of the tooth or radixu with the participation in the system by training events

mukoperiostálního lobe near the lifelong training of dental

risk of anatomical structures, or doctors ^ 6); 605.1 155 Czk

requiring removal of the greater part of the bone,

primary closure of oroantral communications,

levelness bezzubého alveolárního tip

in the scope of more than one sextant,

exstirpace cyst over 1 cm, the removal of

sekvestru, artrocentáza

temporomandibulárního joint or

antrotomie and the like.

-------- ----------------------------------------------- ---------------------------------------------------------

Surgical treatment of tooth retention 00953 hours can 1/1.

Removal of the tissues lying in the path of the eruption of the tooth location-tooth.

and the mobilization of the tooth into the direction of the desired flare expertise-014 with proof of continuous

(including the lifting mukoperiostálního lobe, participation in the system of training events

sculptures of the soft tissues, bone supporting the lifelong learning of dental 630 Czk

graft, wire fixation of the stroke, doctors stuck ^ 6); 015; 605.

as the Castle).

-------- ----------------------------------------------- ---------------------------------------------------------

Konzervačně-00954 surgical treatment of complications can be kick-no limit (per each

tooth decay treated root).

Fold the mukoperiostálního lobe, removal of the Localization-tooth.

bone periapikálně, root amputation of expertise-014; 605.

Tip, exkochleace, toileta root and bone, Czk 420

suture (including peroperačního

the performance). Also periapikální and exkochleace

exstirpace odontogenní cysts within 1 cm.

-------- ----------------------------------------------- ---------------------------------------------------------

00955 Surgery of the soft tissues of the oral cavity and the hours can-without restrictions.

its around a small range of expertise-014; 015; 605.

Perform minor surgical procedures,

for example, dekapsulace, frenulektomie,

Elimination of interferences of ligament 420 Czk

bars, podjazyková frenulektomie, excision

blowing the Ridge-for each sextant,

removal of the lesions into 2 cm, suture wounds

mucous membranes or skin into 5 cm or earth

and salivary gland duct lavage.

-------- ----------------------------------------------- ---------------------------------------------------------

00956 Surgery of the soft tissues of the oral cavity and the hours can-without restrictions.
her large scale expertise-014 with proof of continuous

Deleting a retention podjazykové salivary participation in the system of training events

cyst excision of blowing the Ridge more lifelong learning, dental

extent than a sextant, the removal of the lesion doctors ^ 6); 605.900 Czk

over 2 cm, oral vestibuloplastika without

graft-for each sextant, suture wounds

mucous membranes or skin above 5 cm, exstirpace

mukokely mucous membranes of the oral cavity or

diagnostic excision, sialototomie.

-------- ----------------------------------------------- ---------------------------------------------------------

00957 Traumatology hard tissues of the cavity can be kick-without restrictions.

oral small expertise-014; 015; 605

The treatment of the consequences of the accident and the alveolár bone

small scale, including simple fixation

plastic material, possibly a shortened 420 Czk

wire splint.

-------- ----------------------------------------------- ---------------------------------------------------------

00958 Traumatology of the hard tissues of the oral cavity Can declare-without restrictions.

large scale location-jaw (for each treated

Reduction and fixation of fractures of the alveolár bone of the upper jaw),.

the lower jaw fractures and neck lower expertise-014 with proof of continuous

the jaw without significant dislocation. participation in the system of training actions 750 Czk

lifelong learning practitioners ^ 6); 605.

-------- ----------------------------------------------- ---------------------------------------------------------

00959 Intraoral incision hours can-without restrictions.

Treatment of inflammation of intraoral incisions with any Localization-quadrant.

the dilation, and the introduction of the Expertise by launching the exudate-014; 015; 605.105 Eur

the drain.

-------- ----------------------------------------------- ---------------------------------------------------------

00960 External incision can be kick-out

The treatment around the jaw inflammation of the outer incisí, medical devices without restriction.

including dilation, with the launch of exudate and expertise-014 with acknowledgement of

the introduction of the drain. systematic participation in the system of training

the actions of the lifelong education of dental 600 Czk

^ 6 practitioners); 605.

-------- ----------------------------------------------- ---------------------------------------------------------

00961 Treatment of complications of surgical interventions may be reporting a 5/10 days.

in the oral cavity expertise-014; 015; 605.

The introduction of the drain or of the packing, the application

plastic bandage, fluid wounds, local

therapeutic means. In addition to building 45 Czk

the late postextrakčního bleeding, review

extraction wounds, muscle volume rehabilitation

exercise and physical therapy.

-------- ----------------------------------------------- ---------------------------------------------------------

00962 conservative treatment temporomandibulárních you can report 2/1 year (limit frequencies

disorders does not apply to the expertise of the 605 014, 015 and

Examination temporomandibulárního joint, with proof of continuous participation in the system

documenting the disease and blue courses for lifelong learning

treatment of temporomandibulární disorders of the dental practitioners ^ 6). 300 Czk

(for example, mezičelistní fixation, physical expertise-014; 015; 605.

therapy or manual repozicí).

-------- ----------------------------------------------- ---------------------------------------------------------

00963 Injections i. m. i. a. i. d., s. c. Hours can-without restrictions.

Includes injectable drugs, including application expertise-014; 015; 605.53 Usd

its price, if not applied substance covered by

in a different way.

-------- ----------------------------------------------- ---------------------------------------------------------

00965 Time spent under a dentist Cannot report along with the power to transport 210 Czk

immobile had expertise-014; 605.

-------- ----------------------------------------------- ---------------------------------------------------------

00966 Signal performance-information about the release you can declare-without restrictions.

The decision on the temporary work expertise-014.

the inability or Decision about the need for

care (care)

The performance shows doctor who 5 CZK

exposing the decision on temporary work

the inability, or the decision on the need for

care (care).

-------- ----------------------------------------------- ---------------------------------------------------------

00967 Signal performance-information about the release you can declare-without restrictions.

Decision on termination of temporary work expertise-014.

the inability or Decision about their

needs care (care)

The performance shows doctor who 5 CZK

ended the decision on temporary work

the inability or Decision

about the need for care (care), if

terminating the incapacity or

If the present reasons for being treated

Member of the household, or for the treatment of

or care of a child under 10 years of age the parent.

-------- ----------------------------------------------- ---------------------------------------------------------

00968 Stomatochirurgic treatment hours can 1/1 day only

the insured in connection with unregistered codes 00951, 00952, 00953,

medical equipment, which is covered by 956.00957 00954 00955,, 00958, 00960,

specialized 00962 stomatochirurgických.

centres of expertise-014 with proof of continuous 1 000 Czk

Treatment based on the recommendation of another participation in the system of training events

doctor (when urgent States even without the lifelong education of dental

the recommendation), the written report. ^ 6 practitioners).

-------- ----------------------------------------------- ---------------------------------------------------------

Removal of the fixed compensation 00970-for each of the hours can 1/2 years.

pilířovou construction Cannot report for temporary compensation.

Removing the fixed compensation impact of localization tool-tooth.

or rozbroušením of the Crown and its expertise-014; 015; 605.

deformation. 83 Usd

-------- ----------------------------------------------- ---------------------------------------------------------

Temporary protective Crown 00971 hours can 1/2 years.

Adaptation and fixation of ready-made Crown to the Localization-tooth.

protection of the preparovaného frangovaného or expertise-014; 015; 605.

otherwise, destruovaného tooth, or

individual protective Crown made 69 Czk

razidlovou method in the patient's mouth.

Includes the repeated deployments.

-------- ----------------------------------------------- ---------------------------------------------------------

00972 Patch fixed compensation in the doctor's Office Can report 2/1 year.

Removing and replacing the fixed compensation. You cannot report on temporary compensation.

Construction or repair of facets in a fixed location-tooth.

refund in the mouth (standard material expertise-014; 015; 605.

According to the annex No. 1 of the Act). 72 Czk

-------- ----------------------------------------------- ---------------------------------------------------------

00973 Repair or adjust the dentures Can report 5/1 year.

Cannot be in the surgery report when submitting new

Fix or simple adjustment removable dentures (first two months

refunds in the doctor's Office without following on after the surrender of new dentures).

other laboratory processing. Location-jaw. 39 Czk

Expertise-014; 015; 605.

-------- ----------------------------------------------- ---------------------------------------------------------

00974 Surrender dental product, you can report-no limit

Medical device shows when expertise-014; 015; 605.

submission of dental product (code

is only used for reporting separately

posted in medicinal products and $ 0

dental products (03s).

-------- ----------------------------------------------- ---------------------------------------------------------

00975 Protective bridge made razidlovou hours can 1/5 years.

method of localization-quadrant.

A makeshift bridge to protect the stuffed expertise-014.

the teeth and keep okluzních relations. Bridge

is made directly in the mouth of the policyholder Czk 607

razidlovou method. The evaluation is

included and repeated deployments.

-------- ----------------------------------------------- ---------------------------------------------------------
00981 orthodontic anomalies Diagnostics Can report 1/1 client and health

The guide includes dental equipment.

examinations, comprehensive orthodontic expertise-015.

examination, the founding of the medical

the documentation. This code initiates 600 Czk

orthodontic treatment and reporting codes

expertise, 015.

When the takeover already treated the insured person is

you need to start your own orthodontic treatment

the entrance examination, by founding his own

documentation and reporting of code 00981.

-------- ----------------------------------------------- ---------------------------------------------------------

00982 treatment orthodontic anomalies Can report 1/1 jaw.

fixed orthodontic appliances apparatus on one location-jaw.

Dental arch expertise-015.

Initiation of treatment orthodontic anomalies

fixed orthodontic appliances on one appliance-1 300 Czk

the dental arch. Includes the deployment of elements of the

fixed appliance including the preparation of the teeth.

-------- ----------------------------------------------- ---------------------------------------------------------

treatment of orthodontic anomalies 00983 Check with hours can 1/1 quarter for 4 years.

the use of fixed orthodontic appliance expertise-015.

It applies to the control procedure of the treatment and

adjustments on fixed apparatus on one and two

Dental arches, and it as code 800 Czk

00982 or 00994.

It applies to all controls of fixed

apparatus in a given quarter and on the control of

scanning apparatus used in parallel.

-------- ----------------------------------------------- ---------------------------------------------------------

00984 Check treatment orthodontic anomalies Can report 1/1 quarter for 4 years.

other procedures than using fixed unable to report for treatment in the phase of retention

the orthodontic appliance or in the monitoring of growth and development

Check the procedure of treatment according to the treatment plan of the teeth and jaw bezaktivní treatment.

and functions of sensing apparatuses, including their expertise-015. 210 Czk

editing. To track the progress of changes after

orthodontically indicated extraction without

apparatus. It applies to all controls

scanning apparatus in a given quarter.

-------- ----------------------------------------------- ---------------------------------------------------------

end of treatment orthodontic anomalies 00985 with hours can 2/1 jaw.

the use of fixed orthodontic appliance with time lapse 3let can be

After the end of treatment orthodontic anomalies kick 1 x on čelistv following the

removal of fixed orthodontic appliance code 00982 and 1 x on the jaw in the following

1 the dental arch, zábrus teeth, including code 00994. 700 Czk

any analysis models (does not include location-jaw.

any manufacture and analysis expertise-015.

telerentgenu and ortopantomonogramu).

-------- ----------------------------------------------- ---------------------------------------------------------

Check the retention phase 00986 or active hours can 1/1 half-year, for a maximum

monitoring at the stage of growth and development for 4 years.

Check the insured person before the beginning or after the expertise-015.

their active phase of orthodontic treatment

transmitter or fixed devices by 220 Czk

a treatment plan. Components can also be

the use of fixed or removable plates,

retainerů or other retention devices.

-------- ----------------------------------------------- ---------------------------------------------------------

the determination of the growth phase can be 00987 report 2/1 client. 53 Usd

The determination of the growth phase of the insured-expertise-015.

skeletal age evaluation of x-ray

slide the hand or neck vertebrae.

-------- ----------------------------------------------- ---------------------------------------------------------

Analysis of telerentgenového slide 00988 lbi hours can 1/1 year.

Evaluation of profile, expertise-015 116 Czk

zadopředního remote x-ray

frame using special measuring lbi.

-------- ----------------------------------------------- ---------------------------------------------------------

Analysis of orthodontic models 00989 hours can 1/1 year. 315 Kč

Evaluation of orthodontic models of expertise-015

Dental arches and surrounding tissues, including

any other special measurements.

-------- ----------------------------------------------- ---------------------------------------------------------

00990 Diagnostic orthodontic reconstruction Can report 1/1 jaw.

the localization model-jaw.

Reconstruction of the teeth orthodontic model expertise-015

one jaw of the diagnostic or

the model of the operation of the JAWS to the surgical 473 Czk

purposes.

-------- ----------------------------------------------- ---------------------------------------------------------

00991 Deployment prefabricated hours can 1/1 jaw.

intraorálního arc location-jaw.

Palatal or lingual expansion expertise-015.

or the anchor wire arc or lipbumper

factory made, their adaptation and 173 Usd

planting the device on the rings.

-------- ----------------------------------------------- ---------------------------------------------------------

00992 Deployment extraorálního stroke or facial Can report 1/1 client.

the expertise of the mask-015

Deployment of intra-extraorálního wire

the arc (bridle), or Chin pads and

ortodontní cervical caps or straps, or 210 Czk

facial mask type, Hickham Delaire and

Similarly, for the purpose of anchoring, extraorálního

including lessons on how to use and

illustration for the demonstration.

-------- ----------------------------------------------- ---------------------------------------------------------

You can establish a partial arc 00993 report 4/1 half (1 x on the quadrant). 300 Czk

Preparation and partial linkage wire expertise-015.

the arch in the range up to 6 teeth into locks

or kanyl as parts of fixed appliance.

-------- ----------------------------------------------- ---------------------------------------------------------

00994 starting treatment orthodontic anomalies Can report 1/1 jaw until the age of 10 years.

small fixed orthodontic appliances apparatus on location-jaw.

one dental arch expertise-015.

Initiation of treatment orthodontic anomalies

fixed orthodontic appliances apparatus on a 900 Czk

the dental arch in the mixed dentition for

a protrusion defect with incizálním schůdkem 9 mm

and more crossing the bite, the diastema is greater than

44 mm, zákus retention or dystopia of the upper

pipe cutter. Includes the deployment of elements of a fixed

apparatus.

-------- ----------------------------------------------- ---------------------------------------------------------



1) Council Regulation (EEC) No 1408/71 of 14 June. June 1971 on the application of

of social security schemes to employed persons and their families

moving within the community and Council Regulation (EEC) No 574/72 of the Council

21 June. in March 1972, laying down detailed rules for the application of regulation

(EEC) No 1408/71 on the application of social security schemes to

employed persons and their families moving within the community. From

1.5. 2010 European Parliament and Council Regulation No 883/2004 on the

coordination of social security systems, including its amendments (regulations

(EC) no 988/2009), and the regulation of the European Parliament and of the Council no 987/2009

laying down the procedure for implementing Regulation (EC) No 883/2004 on the

coordination of social security systems.



2) for example, a communication from the Ministry of Foreign Affairs No. 130/2002 SB., m.

with the negotiation of the Treaty of between the Czech Republic and the Federal Republic of

Yugoslavia on social security, the communication of the Ministry of foreign

things no 82/2000 Sb. m. s., the negotiation of the Treaty between the Czech Republic and

The Republic of Croatia on social security, the Ministry of communication

Foreign Affairs No 135/2004 Sb. m. s., the negotiation of the agreement between the Czech

Republic and the Republic of Turkey concerning social security, communication

Ministry of Foreign Affairs No. 2/2007 Sb. m. s., the negotiation of the Treaty

between the Czech Republic and the Republic of Macedonia concerning social security.



3) Decree No. 134/1998 Coll. issuing the list of health interventions

with point values, as amended.



4) section 10 of Act No. 526/1990 Coll., on prices, as amended by the Act No. 261/2007

SB.



The price regulation Department of health no 1/2010/INDIVIDUAL INCOME amount 9.

MZ.



5) the communication from the CZECH STATISTICAL OFFICE No. 432/2009 Coll., on the updating of the classification

hospitalized patients (IR-DRG).



^ 6) section 22 of Act No. 95/2004 Coll., on conditions for being accessed and the recognition of

professional competence and specialized competence to perform
the medical professions of doctor, dentist and pharmacist, as amended by

amended.